Patients’ and healthcare professionals’ perceptions of blood transfusion by Volkmer, B.
              
City, University of London Institutional Repository
Citation: Volkmer, B. (2019). Patients’ and healthcare professionals’ perceptions of blood 
transfusion. (Unpublished Doctoral thesis, City, University of London) 
This is the accepted version of the paper. 
This version of the publication may differ from the final published version. 
Permanent repository link:  https://openaccess.city.ac.uk/id/eprint/25137/
Link to published version: 
Copyright: City Research Online aims to make research outputs of City, 
University of London available to a wider audience. Copyright and Moral Rights 
remain with the author(s) and/or copyright holders. URLs from City Research 
Online may be freely distributed and linked to.
Reuse: Copies of full items can be used for personal research or study, 
educational, or not-for-profit purposes without prior permission or charge. 
Provided that the authors, title and full bibliographic details are credited, a 
hyperlink and/or URL is given for the original metadata page and the content is 
not changed in any way. 









Patients’ and Healthcare Professionals’ 





A thesis submitted for the degree of 
 




City, University of London 
 




Table of Contents 
3 
Table of Contents 
List of Tables .............................................................................................. 8 
List of Figures ........................................................................................... 10 
Acknowledgements ................................................................................... 11 
Declaration ................................................................................................ 13 
Abstract ..................................................................................................... 14 
List of Abbreviations ............................................................................... 16 
1 General introduction ........................................................................ 18 
 Patient-centred healthcare ........................................................... 18 
1.1.1 Frequently provided healthcare interventions ...................... 20 
 Blood transfusion – Historical overview ..................................... 22 
1.2.1 First transfusion use ............................................................. 22 
1.2.2 Transfusion-associated infections ........................................ 23 
1.2.3 Tainted blood scandals ......................................................... 24 
 Healthcare professionals’ perceptions of blood transfusion ........ 26 
1.3.1 Appropriate use of blood transfusions ................................. 26 
1.3.2 Transfusion alternatives ....................................................... 27 
1.3.3 Patients’ and HCP’ transfusion perceptions ......................... 27 
 Theoretical perspective ................................................................ 29 
1.4.1 Perceptions of health threats ................................................ 29 
1.4.2 Perceptions influencing behaviour ....................................... 31 
1.4.3 Assessing patients’ perceptions ........................................... 32 
1.4.4 Theoretical perspective (HCPs) ........................................... 35 
 Summary ..................................................................................... 37 
1.5.1 Aims of this programme of research .................................... 38 
 Structure of this thesis ................................................................. 38 
2 Patients’ and Health Care Professionals’ Perceptions of Blood 
Transfusion: A Systematic Review ......................................................... 40 
 Introduction ................................................................................. 40 
2.1.1 Aims of the systematic review ............................................. 45 
2.1.2 Systematic review objectives: .............................................. 45 
2.1.3 Research questions: .............................................................. 45 
 Methods ....................................................................................... 46 
2.2.1 Design .................................................................................. 46 
2.2.2 Study selection criteria ......................................................... 46 
Table of Contents 
4 
2.2.3 Identification and selection of relevant studies.................... 47 
2.2.4 Study screening .................................................................... 48 
2.2.5 Data extraction and synthesis .............................................. 49 
2.2.6 Quality assessment of included studies ............................... 50 
2.2.7 Data analysis ........................................................................ 50 
 Results ......................................................................................... 51 
2.3.1 Study characteristics ............................................................ 52 
2.3.2 Patients and HCPs participating in included studies ........... 64 
2.3.3 Research designs and assessment approaches ..................... 65 
2.3.4 Quality appraisal of included studies ................................... 66 
2.3.5 Time points patients’ perceptions assessed (in relation to the 
transfusion) ......................................................................................... 67 
2.3.6 Blood components, donation methods or alternatives 
investigated ......................................................................................... 68 
2.3.7 Citation of theory ................................................................. 69 
 Perceptions of blood transfusion ................................................. 69 
2.4.1 Inductive qualitative synthesis ............................................. 70 
2.4.2 Changes in perceptions over time ........................................ 75 
2.4.3 Relationship between themes............................................... 76 
 Discussion ................................................................................... 79 
3 Mapping of blood transfusion perceptions constructs with 
treatment perceptions frameworks. ....................................................... 86 
 Background ................................................................................. 86 
3.1.1 Chapter objective and methods ............................................ 91 
 Results ......................................................................................... 93 
3.2.1 Mapping summary: ............................................................ 107 
 Discussion ................................................................................. 112 
4 Exploring perceptions of blood transfusion in haematology ...... 116 
 Introduction ............................................................................... 116 
4.1.1 Background ........................................................................ 116 
4.1.2 Aims of the current study................................................... 121 
4.1.3 Objective ............................................................................ 121 
4.1.4 Research questions ............................................................. 121 
 Methods ..................................................................................... 122 
4.2.1 Study design ....................................................................... 122 
4.2.2 Ethical approval ................................................................. 122 
4.2.3 Setting and participants ...................................................... 122 
Table of Contents 
5 
4.2.4 Sampling ............................................................................ 122 
4.2.5 Recruitment ........................................................................ 124 
4.2.6 Materials ............................................................................. 125 
4.2.7 Procedure............................................................................ 127 
4.2.8 Analysis .............................................................................. 129 
 Results ....................................................................................... 133 
4.3.1 Participants recruited .......................................................... 133 
4.3.2 Perceptions of blood transfusion ........................................ 138 
 Discussion ................................................................................. 176 
5 BOOST: Building Optimised Outpatient Services in Transfusion: 
A focus group study ................................................................................. 185 
 Introduction ............................................................................... 185 
5.1.1 Study aims .......................................................................... 192 
5.1.2 Research Questions: ........................................................... 193 
 Methods ..................................................................................... 193 
5.2.1 Study design ....................................................................... 193 
5.2.2 Ethical approval ................................................................. 194 
5.2.3 Study branding ................................................................... 194 
5.2.4 Participants ......................................................................... 194 
5.2.5 Recruitment ........................................................................ 195 
5.2.6 Focus group procedure ....................................................... 195 
5.2.7 Confidentiality ................................................................... 199 
5.2.8 Data analysis ...................................................................... 199 
5.2.9 Reliability ........................................................................... 201 
 Results ....................................................................................... 202 
5.3.1 Focus groups and sample characteristics ........................... 202 
5.3.2 Follow on questionnaire response rate ............................... 203 
5.3.3 Inductive analysis of focus group and questionnaire data . 203 
5.3.4 Service improvement strategies ......................................... 215 
 Discussion ................................................................................. 237 
6 General Discussion .......................................................................... 244 
 Findings ..................................................................................... 244 
6.1.1 Study 1: Patients’ and HCPs’ perceptions of blood 
transfusion: A systematic review ...................................................... 244 
6.1.2 Theoretical mapping........................................................... 246 
6.1.3 Study 2: Exploring perceptions of blood transfusion in 
haematology ...................................................................................... 246 
Table of Contents 
6 
6.1.4 Study 3: BOOST: Building Optimised Outpatient Services in 
Transfusion ....................................................................................... 247 
 Contribution to the literature ..................................................... 249 
6.2.1 Blood transfusion ............................................................... 249 
6.2.2 Treatment perceptions........................................................ 250 
6.2.3 Behaviour change .............................................................. 251 
 Strengths and limitations of the research .................................. 252 
6.3.1 Strengths ............................................................................ 252 
6.3.2 Limitations ......................................................................... 253 
6.3.3 Strengths and limitations of the theoretical approach ........ 254 
 Implications for future research ................................................ 257 
6.4.1 Relationships between constructs and the inclusion of 
psychosocial variables ...................................................................... 257 
6.4.2 Longitudinal research ........................................................ 259 
6.4.3 HCPs’ perceptions research ............................................... 260 
 Implications for practice ........................................................... 261 
6.5.1 Decision making ................................................................ 261 
6.5.2 Patient involvement in their transfusions........................... 263 
6.5.3 Service improvement strategies ......................................... 264 
7 Conclusion and recommendations ................................................ 266 
 Recommendations for research and practice summary ............. 267 
7.1.1 Research ............................................................................. 267 
7.1.2 Practice............................................................................... 267 
8 Dissemination .................................................................................. 268 
9 References ....................................................................................... 270 
10 Appendices ................................................................................... 288 
 Appendix 1: Systematic review publication ............................. 288 
 Appendix 2: Systematic review, scoping and full search strategies
 298 
 Appendix 3: Systematic review data extraction form ............... 300 
 Appendix 4: Table of theories identified in the systematic review
 307 
 Appendix 5: Themes and subthemes identified in Study 1 inductive 
synthesis ............................................................................................... 310 
 Appendix 6: Study 2 ethics approval letter ............................... 316 
 Appendix 7: Data saturation table for haematology interview Study 
2 320 
 Appendix 8: Study 2 patient recruitment log ............................ 328 
Table of Contents 
7 
 Appendix 9: Study 2 participant information sheet (patients) .. 330 
 Appendix 10: Study 2 participant information sheet (HCPs) 333 
 Appendix 11: Study 2 consent form ...................................... 336 
 Appendix 12: Study 2 Demographic questionnaire (patients)
 337 
 Appendix 13: Study 2 HCP demographic questionnaire ....... 341 
 Appendix 14: Coding book for Study 2 haematology interview 
transcripts ............................................................................................. 343 
 Appendix 15: Reasons for patient exclusion from study 2 .... 346 
 Appendix 16: Study 3 ethics approval letter .......................... 347 
 Appendix 17: Study 3 participant information sheet ............. 348 
 Appendix 18: Study 3 recruitment flyer............................. 352 
 Appendix 19: Study 3 consent form ...................................... 353 
 Appendix 20: BOOST Study 3 PowerPoint slides ................ 356 
 Appendix 21: Study 3 participant ‘follow on’ questionnaire 357 
 Appendix 22: Reflective diary from study 3 focus groups .... 360 
 
 





T +44 (0)20 7040 5060
www.city.ac.uk   Academic excellence for business and the professions
THE FOLLOWING PART OF THIS THESIS HAS BEEN REDACTED
FOR COPYRIGHT REASONS: 
Appendix 1: ..............................................................................................................288-297
List of Tables 
8 
List of Tables 
Table 1 Systematic review study inclusion criteria...................................... 49 
Table 2 Systematic review included studies and participant characteristics 55 
Table 3 Perceptions of blood transfusion: inductive synthesis themes and 
subthemes ..................................................................................................... 71 
Table 4 Mapping of treatment perceptions and blood transfusion perceptions 
constructs ..................................................................................................... 94 
Table 5 Study 2 interview topic guide questions ....................................... 126 
Table 6 Study 2 patient participant characteristics .................................... 134 
Table 7 Study 2 healthcare professional participant characteristics .......... 136 
Table 8 Study 2 constructs from the blood transfusion conceptual model 
(patients) with themes, frequency counts and supporting quotes listed ..... 139 
Table 9 New haematology patient constructs, with themes, frequencies and 
quotes per theme listed ............................................................................... 147 
Table 10 Frequencies and elaboration of patients’ responses per construct
 .................................................................................................................... 151 
Table 11 Study 2 constructs from the blood transfusion conceptual model 
(HCPs) with themes, frequency counts and supporting quotes listed ........ 155 
Table 12 New haematology HCP constructs and themes, frequencies and 
quotes per theme listed ............................................................................... 163 
Table 13 Frequencies and elaboration of HCPs’ responses per construct . 167 
Table 14 Study 2 patient and HCP themes with agreement ratings ........... 171 
Table 15 Study 3 constructs presented to the focus groups for discussion 196 
Table 16 Focus groups and participants ..................................................... 202 
List of Tables 
9 
Table 17 Themes and subthemes inductively generated from the focus group 
data ............................................................................................................. 205 
Table 18 Themes and subthemes inductively generated from the 
questionnaire data....................................................................................... 212 
Table 19 Service improvement strategies from focus groups and 
questionnaires ............................................................................................. 217 
Table 20 Service improvement strategies from questionnaires only ......... 225 
Table 21 Mapping of strategies to original patient constructs ................... 236 
List of Figures 
10 
List of Figures 
Figure 1 The common-sense self-regulation model (Leventhal et al., 1980), 
CS-SRM figure adapted from Horne (2003) ................................................ 30 
Figure 2 Treatment perceptions and the common-sense model of self-
regulation (Horne 2003) ............................................................................... 34 
Figure 3 Sequence of studies and chapters of the current research programme
 ...................................................................................................................... 39 
Figure 4 Systematic review PRISMA diagram ............................................ 52 
Figure 5 Systematic review reported themes of perceptions by publication 
years ............................................................................................................. 76 
Figure 6 Conceptual model of blood transfusion perceptions ..................... 78 
Figure 7 Conceptual model of patients’ blood transfusion perceptions in 
haematology ............................................................................................... 153 
Figure 8 Conceptual model of HCPs’ blood transfusion perceptions in 
haematology ............................................................................................... 169 
Figure 9 COM-B Model (Michie et al., 2011) and Theoretical Domains 
Framework (TDF) (Michie et al., 2005) domains linkage ......................... 191 
Figure 10 Behaviour Change Wheel (Michie, van Stralen & West, 2011) 192 
Figure 11 Frequency of TDF (Michie et al., 2005) domains and service 






I wish to express my immense gratitude to my academic supervisors for 
supporting me throughout this research project. Thank you to Professor Jill 
Francis for re-introducing me to the field of Health Psychology and 
supporting me to get up and running with the PhD. An amazingly big thank 
you to Dr Fabiana Lorencatto, my second supervisor. You have supported me 
immensely throughout this whole journey, providing me with such expert and 
considered guidance. I have learnt so much from both of you and have many 
fond memories of being involved with our wider colleagues in the 
Implementation Research Group. I have particularly enjoyed meeting and 
working with Dr Natalie Gould, Stephen McIntyre, Dr Riya Patel, Dr Andrea 
Patey and Dr Mandy Sekhon. Thank you all for the help you provided me 
with, it has been lovely getting to know you all.   
Thank you also to the wonderfully supportive friends that I have made at City 
through the PhD journey, in particular Dr Ryc Acquino, Nafiso Ahmed, Dr 
Afnan Aljaffary, Aliya Amirova, Dr Miriam Ashford and Dr Marie-Rose 
Dwek. You have all really been there for me and I have enjoyed so much 
sharing experiences with you and being there for you through the highs and 
tougher times of your PhD journeys too.  
I wish to express wider gratitude to the welcoming researchers, teaching and 
professional staff that I met and interacted with at the School of Health 
Sciences. In particular Dr Shashi Hirani for providing supervisory support 
during my final writing up year and to other staff including Dr Martin 
Cartwright, Dr Mark Haddad, Tracy Rowson and Alison Welton. 
Acknowledgements 
12 
I wish to thank Dr Simon Stanworth for providing me with excellent clinical 
and supportive guidance throughout this project. It has been a pleasure to 
work with you. I wish to thank site staff at NHS hospitals for allowing me to 
conduct my research at their sites and to the kind patients and healthcare 
professionals who I interacted with to obtain these findings, this research has 
truly been about you. In addition, I wish to acknowledge my current 
colleagues in the Physiotherapy Department at King’s College London. It has 
been very helpful to discuss my research and experience with you all and to 
have exposure to the work of King’s, helping me to remain productive whilst 
completing my PhD.  
On a personal level, I thank my family and friends for supporting me through 
this journey and providing me with continuous encouragement. I share my 
achievements with you and personally recognise how much you have all been 




This research has been carried out within the Health Services Research and 
Management Division at City, University of London (School of Health 
Sciences) under the supervision of Professor Jill Francis, Dr Fabiana 
Lorencatto and Dr Shashi Hirani.  
I confirm that this thesis is my own work and publications and conference 
attendance associated with this research has been noted in the Dissemination 
section. All information derived from other sources has been indicated with 
the use of references throughout the thesis.  








Blood transfusions are frequently provided to patients at risk of severe 
bleeding or on a repeated basis for patients with anaemia or blood 
disorders. The treatment perceptions literature indicates that perceptions 
influence how patients cope with their conditions and adhere to treatment. 
Healthcare professionals’ (HCPs’) perceptions are likely to influence 
shared decision-making and their practice. However, how patients and 
HCPs perceive blood transfusions, and how this may vary across patient 
groups, is unclear.  
Objectives:  
This research aimed to explore patients’ and HCPs’ perceptions of blood 
transfusion. Specific research questions were: 1) which perceptions of   
transfusion are reported by patients and HCPs in the literature? 2) to what 
extent do themes of patients’ perceptions correspond with the broader 
treatment perceptions literature? 3) what are repeatedly-transfused 
haematology patients’ and HCPs’ perceptions of transfusion? 4) to what 
extent do HCPs recognise patients’ reported perceptions in their practice 
and are practice changes to improve patients’ experiences required? 
Methods:  
This was a mixed-methods programme of research involving three studies: 
Study 1: A systematic review of patients’ and HCPs’ perceptions of blood 
transfusion and development of a conceptual model of blood transfusion 
perceptions. This was followed by a theoretical mapping exercise to 
compare the model to existing treatment perceptions frameworks. Study 2: 
A semi-structured interview study with 14 haematology patients and 14 
HCPs about their perceptions of blood transfusion. Study 3: A focus group 
(n=3) and questionnaire study of 19 HCPs’ views of haematology patients’ 
perceptions and their views about potential service improvement strategies, 
subsequently mapped to a behaviour change framework (Behaviour 
Change Wheel). HCPs’ reported constraints and enablers to implementing 
these strategies were mapped to the Theoretical Domains Framework 
(TDF) of behaviour change.    
Results: 
Study 1: 41 papers reporting patients’ and HCPs’ perceptions were 
included in the systematic review (15 patient studies, 26 HCPs). 
Transfusion was perceived as carrying low to moderate risk, but risk 
perceptions and negative emotions were associated with the use and 
consideration of transfusion alternatives. The data were synthesised into 
six constructs to form a conceptual model: ‘Safety/risk,’ ‘Negative 
emotions’, ‘Alternatives’, ‘Health benefits’, ‘Necessity’ and ‘Decision 
making’. Theoretical mapping confirmed these constructs as broadly 
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consistent with constructs from existing treatment perceptions frameworks 
and models.  
Study 2: Patients and HCPs reported views about the benefits of transfusion 
for haematology patients, yet some patients and HCPs reported concerns 
about the downsides of transfusion. ‘Organisational constraints’ were 
raised by HCPs about delivering transfusions in pressurised services and 
patients discussed the burden of receiving repeated transfusions.  
Study 3: 17 service improvement strategies were proposed, corresponding 
to seven BCW functions: (e.g. ‘Service provision’ (home transfusion), 
‘Environmental restructuring’ (remote blood screening)). 
Constraints/enablers mapped to the TDF: (e.g. ‘Skills’ (HCP 
communication skills training), ‘Environmental context and resources’ 
(funding, time)). Potential techniques to address constraints and enablers 
included providing ‘Information about health consequences’ to address the 
domain, ‘Beliefs about consequences’. 
Conclusion: 
This research provides a theoretical and empirical overview of blood 
transfusion perceptions, including themes shared by patients and HCPs and 
themes that were unique to one of these groups. There is scope to more 
greatly involve patients in their transfusions where, in haematology, 
repeated and lengthy transfusion appointments place burden on patients. 
The conceptual models provide direction for such consultations. 
Interventions to enhance haematology patients’ experiences and to 
remediate service pressures can be developed further.
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1 General introduction 
This chapter outlines the rationale for this programme of research on patients’ 
and healthcare professionals’ (HCPs’) perceptions of blood transfusion. It 
will describe the current context of patient-centred healthcare, introduce the 
context of blood transfusion and outline supporting theoretical models. This 
chapter also presents the overall objectives of this programme of research 
with a description of the conducted studies.  
 Patient-centred healthcare 
Patients receiving healthcare in many countries prior the 1980’s would have 
been exposed to a paternalistic model of healthcare. This model accepted the 
healthcare professional (HCP) as the responsible experienced authority of a 
patient’s treatment and care, executing treatment decisions based on clinical 
knowledge and governed by professional codes of ethics (Charles et al., 
1999). In recent years the health care context has shifted, such that, there has 
been a considerable rise in the number of medicines available and a shift in 
illnesses from being acute to being chronic, with multiple medicines being 
used to treat complex conditions (Charles et al., 1997). Limitations of the 
paternalistic approach were highlighted, in that the approach restricted patient 
involvement and patients sharing their treatment preferences, despite them 
having the lived experience of the illness or symptoms (McNichol, 2012). As 
HCPs needed to understand how treatments benefitted the patient, they began 
to work more closely with patients and caregivers, with it being important to 
consider the benefits of treatments for the patients weighed up by potential 
risks (Charles et al., 1999). HCPs began to elicit patients’ treatment 
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preferences and obtain more formal patient consent for taking proposed 
treatments, giving rise to the use of informed and shared models of treatment 
decision making (Charles et al., 1999). 
A shared model of treatment decision-making provides patients with an 
opportunity to be more involved in their healthcare, by discussing proposed 
treatment options and raising their values, preferences, beliefs and illness 
knowledge (Charles et al., 1999). This approach encourages HCPs to involve 
patients as co-producers of health and autonomous partners in treating, 
managing and preventing disease (Coulter, 2011). ‘Patient-centred care’ 
embodies this position, with care delivery being responsive to patients’ 
physical, emotional and social needs, with interactions with HCPs needing to 
be informative, empathetic, empowering and supportive of patients’ values 
and preferences (Coulter, 2011; Mead et al., 2000).  
Efforts to increase patient participation and the greater shift towards patient-
centred care, moves patients towards becoming active consumers or users of 
their healthcare (McNichol, 2012), which is a major goal of health systems 
(The Health Foundation, 2014). Patient charters have often been set up by 
governments to protect patients’ rights and to stipulate their access 
entitlements and rights about being involved in decisions about their care 
(National Health Service, 2019). Many initiatives are in place to support 
patients in this role, such as standardised decision-making tools (Hrisos et al., 
2013) and strengthening patient participation to encourage greater patient 
communication of their preferences, such as patient questioning of treatment 
options, their benefits and harms (Joseph-Williams et al., 2017; Stiggelbout 
et al., 2012).  
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Patient participation in treatment consultations has been found to be 
associated with greater patient understanding about their treatments, greater 
adherence, satisfaction with their doctor’s behaviour and the visit and less 
treatment decision regret (Stevenson et al., 2004). In spite of this, patients 
often do not get the opportunity to share their beliefs, experiences and 
medicine preferences in consultations (Stevenson et al., 2004). This research 
found that HCPs tend to dominate treatment discussions (Stevenson et al., 
2004) or alternatively some patients prefer to adopt a more passive role in the 
treatment decision-making, often as a way to cope (Swainston et al., 2012). 
Some patients with breast cancer have been identified as remaining passive 
to minimise the emotional impact of difficult decisional trade-offs (e.g., long-
term survival vs. breast loss) (Lazarus et al., 1984b; Luce, 2005). There are 
barriers that HCPs recognise to implementing shared decision-making, in 
particular time constraints in clinical consultations, lack of applicability due 
to patient characteristics and the clinical situation (Légaré et al., 2008).  
1.1.1 Frequently provided healthcare interventions 
For treatments that are frequently prescribed, HCPs may fall into automatic 
prescribing patterns (Presseau et al., 2014). In the UK, 43% of men and 50% 
of women report to taking at least one prescribed medicine, such as 
cholesterol-lowering statins, high blood pressure medicines and painkillers 
(NatCen Social Research, 2015). As a large proportion of the population will 
be exposed to frequently prescribed treatments, often taken on a long-term 
basis. Thus, it is important for patients’ perceptions of such treatments to be 
elicited and widely considered. This is because the treatment may be taken on 
a long-term basis and patients’ beliefs may change over a period of time as 
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their circumstances and experiences alter, with the repeat prescriptions not be 
reviewed. General public issues may fuel wider debate too, such as the need 
for patient involvement in choice to prevent treatment overuse (Malhotra et 
al., 2015).  
A healthcare intervention that is frequently provided internationally is blood 
transfusion, which involves donor blood being transfused into another person. 
Blood transfusion has evolved into one of the most frequently administered 
healthcare interventions for all aged patients with a range of healthcare 
conditions (American National Red Cross, 2018a). In low- and middle-
income countries transfusions are commonly used to manage pregnancy-
related complications and for supportive care in cardiovascular or transplant 
surgery, massive trauma, and therapy for solid and haematological 
malignancies in high income countries (World Health Organization, 2017). 
Approximately 36,000 red blood cell units are transfused in the US daily 
(American National Red Cross, 2018a). In the UK for the year of 2000-2001, 
1.7 million transfusions were estimated to be given, approximating at costs of 
£635 per red blood cell transfusion for each patient (Varney et al., 2003). 
Although some blood transfusion use has decreased, for example, for UK 
surgical use, transfusions related to hip and knee arthroplasty operations show 
increases in use (northern England, 1999-2009) (Tinegate et al., 2013).  
Patients will receive transfusions for different reasons and at different 
frequencies. Some patients will receive emergency one-off transfusions (e.g. 
in a trauma situation) that they are often only made aware of afterwards and 
some patients will receive transfusions on a repeated routine basis. Patients 
who are conscious during the transfusion will be able to form perceptions of 
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transfusion before, during and after transfusion. Patients with chronic 
diseases like myeloma or non-Hodgkin’s lymphoma will often need 
transfusions during their treatment to manage cancer-related anaemia which 
reduces their red blood cells (45-90% of patients) (European Hematology 
Association, 2012). Transfusions are also used to treat inherited blood 
disorders such as thalassemia or sickle cell anaemia (NHS Choices, 2018). 
These factors hold the potential for patients to form different perceptions of 
transfusion for different contexts. Patients will ultimately have different 
experiences of receiving transfusions, which can impact on their healthcare 
experience, and extent of involvement in shared decision making. Thus, there 
is a need to explore patients’ perceptions of blood transfusion further.  
 Blood transfusion – Historical overview 
1.2.1 First transfusion use 
Blood transfusion was first officially used in 1818 to treat gastric carcinoma 
(Jones, 2015). The processes were continuously improved with the discovery 
of international blood groups (O, A, B, AB) occurring in the early 1900s, as 
well as methods being found to overcome shortages in blood donors (Jones, 
2015). This led to more regulated practices such as the American Red Cross 
beginning its National Blood Donor Service in 1941 to collect blood for the 
US military; and extending it in 1948 for civilians (American National Red 
Cross, 2018b). With donor blood being transfused extensively during 
wartime, supplies of blood were depleting and the first cell separator was 
created in 1951, allowing for whole blood to be separated into its different 
components (i.e. plasma, platelets, red blood cells), with the end products 
being called ‘component therapy’ (Jones, 2015). Hence, blood transfusions 
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are distinguished by the components to be transfused, whereby patients may 
only need an element of the whole blood, making a single donation optimised 
for use by multiple recipients. For example, using the red blood cells to 
improve oxygen delivery to tissues, platelets to reduce, minimise or prevent 
bleeding, or plasma for blood-clotting (Arya et al., 2011; JPAC, 2018).  
1.2.2 Transfusion-associated infections 
Medical institutions and the public have always been increasingly reliant on 
blood transfusions, which provide blood depended upon in many areas of 
clinical practice, such as to reduce mortality from heavy bleeding or for 
planned surgical procedures. However, from the 1960s serious issues arose 
that threatened the safety of widely used blood supplies, and a shift occurred 
that caused perceptions of blood transfusion safety to alter. Hepatitis C was 
found to be contractible through blood transfusion, having a 10% 
transmission risk in the 1970s (Koerner et al., 1998). Alongside this, 
widespread public fears arose in the 1980s about the risk of AIDS being 
transferrable through blood transfusions and donor restrictions were put into 
place. Restrictions on donors were mainly targeted at homosexual or bisexual 
men with multiple partners and blood banks stopped recruiting from AIDS 
high risk groups (Perkins et al., 2010). In 1984, public confidence in the blood 
banks was reportedly lost and investigations were reported by the Centre for 
Diseases Controls, providing evidence that AIDS may be transmitted by 
blood (Curran et al., 1984). By 1987 estimated figures by Peterman et al., 
(1987) reported that nearly 29,000 US transfusion recipients were infected 
with HIV, with 12,000 still alive and at risk of developing AIDS (cited in 
(Perkins et al., 2010)). These transmissions and associated mortalities 
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occurred at a time where AIDS was feared in society fuelled by high profile 
media coverage of prominent celebrities dying of AIDS and widespread 
discrimination of HIV/AIDS suffers (HIV.gov, 2018; Wellings, 1988).  
1.2.3 Tainted blood scandals 
The initial discovery of transfusion-associated infections was followed by 
highly publicised global tainted blood scandals, which abetted the negative 
shift in societal perceptions of blood transfusion.  Public trust in the safety of 
blood was weakened as reports were published of the scale of HIV infected 
blood use in haemophilia treatments. By the 1980s over 4,500 people with 
haemophilia and bleeding disorders were infected with HIV, hepatitis B and 
C, and a range of other blood-borne viruses in the UK (The Haemophilia 
Society, 2017a). Over 2,000 people have subsequently died in the UK and a 
full public inquiry in the UK is ongoing (The Haemophilia Society, 2017b). 
Victims of transfusion-induced HIV infections report undergoing personal 
trauma, for instance through having to deal with their HIV infection on top of 
the initial (often life-threatening illnesses), mitigating the need for a 
transfusion in the first place (Gallo-Silver, 1993).  
It is unclear how patients currently receiving blood transfusions perceived 
this crisis, and if this impacts on their perceptions of receiving blood. Patients 
facing the prospect of receiving transfusions may be confronted with difficult 
choices, due to transfusion being life-saving or assisting them to improve their 
health, whilst evoking concern because transfusions are not risk free. In the 
general public, there is some evidence that the intense media coverage of the 
tainted blood issues influenced perceptions of transfusion acceptance and its 
association with HIV and AIDS (Finucane et al., 2000). Although the last 
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confirmed HIV (transfusion) transmission case was reported in 2009 (UK) 
(Murphy et al., 2013b), societal concern about blood safety was at one time 
elevated, with Watkins et al., (2012) suggesting that this is primarily because 
of ‘historical problems relating to viral transmission via the blood supply’ 
(Watkins et al., 2012).  
In spite of this, there is also some public understanding across many European 
countries, that transfusions are safer than, for example, 10 years ago, 
especially viewed so by younger respondents (aged 15-24) (European 
Commission, 2010). This wide-reaching survey is informative, however, 
included many younger respondents, who may not be typical transfusion 
patients, i.e., not experiencing older aged related disorders. There are also 
undiscovered and emergent risks associated with transfusion, such as 
Creutzfeldt-Jakob Disease (Llewelyn et al., 2004) or severe risks that are 
perhaps less well known to the general public, for instance the risk of 
suffering an adverse reaction to the transfusion or the transfusion causing lung 
injury (Eder et al., 2013). Therefore, while blood transfusions are widely 
used, investigating patients’ perceptions of transfusion is important to 
identify if patients hold concerns. A patient’s ‘public’ beliefs will be modified 
and ‘heightened’ into a real-life scenario once becoming a patient (Leventhal 
et al., 1980) and negative media portrayals are likely to fuel these perceptions 
(Finucane et al., 2000).   
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 Healthcare professionals’ perceptions of blood transfusion 
1.3.1 Appropriate use of blood transfusions  
In addition to patients’ beliefs, healthcare professionals’ (HCPs’) perceptions 
of blood transfusions are equally important to consider as they will ultimately 
be making the clinical decisions about prescribing transfusions to their 
patients. Although blood transfusions are used widely under improved 
regulation (Epstein, 2010 cited in (Watkins et al., 2012)) and clinical 
guidelines, they are often overused by HCPs. In the UK it is estimated that 
20% of transfusions are prescribed outside of clinical guideline 
recommendations (Estcourt, 2010; Stanworth et al., 2011). Along with other 
clinical interventions, such as antibiotics and cardiac stents, blood 
transfusions are cited as one of the most overused treatments by The 
American Medical Association (Goodnough, 2013; Sadana et al., 2018).  
Despite transfusion guidance being available to inform HCPs about when 
blood should be transfused (Joint United Kingdom Blood Transfusion and 
Tissue Transplantation Services Professional Advisory Committee (JPAC), 
2019) there is evidence that blood transfusions are overused in a range of 
clinical contexts (NHS Blood and Transplant, 2019). This can have serious 
health implications for patients, such as through experiencing an adverse 
reaction to the transfusion (Murphy et al., 2013b). Clinical trials have shown 
that more restrictive transfusion practices are equivalent or better than liberal 
practices (Goodnough et al., 2013). The advantages of this are that restrictive 
practices may reduce patient exposure to the aforementioned risks and also 
other adverse events, such as transfusion related acute lung-injury or acute 
transfusion reactions, which may not be preventable (Goodnough et al., 2013; 
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Serious Hazards of Transfusion (SHOT), 2017). It is thus important to 
understand how HCPs perceive transfusion and how this impacts their 
practice, potentially driving overuse and misuse. A greater understanding of 
HCPs’ perceptions can also help form the basis of interventions to target 
transfusion overuse and misuse and guide quality improvement initiatives.  
1.3.2 Transfusion alternatives  
Patient Blood Management is an evidence-based multidisciplinary, 
multimodal and individualised approach to optimise the care of patients who 
might need blood transfusion (Carson et al., 2016). Initiatives such as these 
exist to ensure that donated blood is conserved and that patients only receive 
transfusions when deemed necessary and that all alternatives to transfusion 
have been considered (Goodnough et al., 2012). Blood sparing alternatives 
are methods such as intraoperative cell salvage and pre-operative autologous 
donation (PAD) procedures, in which patients receive their own blood post-
surgery rather than allogeneic (donor) blood. Prescribing patients with 
intravenous iron is another method to spare allogeneic blood, which has been 
found to reduce surgical patients’ hospital stays, enhance the restoration of 
iron stores and improve patients’ Hb (haemoglobin) blood levels four weeks 
after surgery (Froessler et al., 2016). It is important to understand how HCPs 
perceive these transfusion alternatives, for example as effective in particular 
situations or less readily available or convenient, all of which may contribute 
to transfusion overuse. 
1.3.3 Patients’ and HCP’ transfusion perceptions 
Blood transfusion clinical guidelines often stipulate that patients should be 
informed about available alternatives to transfusion and/or allogeneic blood 
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transfusion, as appropriate and have the opportunity to discuss such 
alternatives with HCPs, alongside discussing the risks and benefits of 
transfusion (SaBTO, 2011). Transfusions may also be prescribed to 
unconscious patients, requiring the HCP(s) to make the initial decision, and 
then gain retrospective consent from the patients or family members (SaBTO, 
2011).  HCPs’ perceptions may, however, be divergent from their patients’ as 
they do not experience the illness themselves (Eccles et al., 2005). It would 
be important to investigate how divergent patients’ and HCPs’ perceptions 
are, as perceptions are likely to be exchanged during the clinical encounter. 
Patients and HCPs may also hold specific perceptions of transfusion of 
different blood components (e.g. platelets or red blood cells). This would raise 
insight into the nature and variability of perceptions of blood transfusion from 
key informants; patients and HCPs.   
Differences in treatment perceptions of patients and HCPs have been reported 
in other disease areas, such as for research on the kidney disease trajectory 
with elderly patients and their nephrologists (Schell et al., 2012). In this study, 
most patients focussed on the present instead of responding to challenges and 
the uncertainties with their dialysis therapy (Schell et al., 2012). 
Nephrologists tended to avoid uncertainty and instead applied a sense of 
urgency to educate and prepare patients to begin treatment, with a tendency 
to focus on communicating with patients using lab data (Schell et al., 2012). 
Similar findings may be evident for transfusions, which are required to be 
delivered in emergency scenarios. Patients may similarly focus on their 
present need for the transfusion and require support post-transfusion to deal 
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with concerns that may arise, especially if transfusions need to be provided 
on a repeated basis. 
Understanding patients’ and HCPs’ perceptions of blood transfusion would 
profile how both groups consider transfusion as a healthcare intervention. 
‘Perceptions’ can be understood as thoughts, views, beliefs, opinions or 
representations, which are commonly considered as a cognitive component 
of illness representations. For example, how a treatment may be used to 
control a health threatening situation (e.g. ‘my treatment will help to control 
my symptoms’) (Leventhal et al., 1980). Exploring patients’ and HCPs’ 
perceptions of blood transfusion can be facilitated by health psychology 
theory and models of treatment perceptions, with theory providing a 
systematic way to understand events or situations (Glanz et al., 2005) and 
theoretical models used to illustrate a theory’s causal mechanisms. Blood 
transfusion is offered as a health care intervention when patients face health 
threats and, in turn, transfusion could also be perceived as a health threatening 
intervention itself (e.g. as a ‘risky’ treatment). Therefore, it is important to 
consider patients’ and HCPs’ perceptions of blood transfusion from a 
theoretical perspective.  
 Theoretical perspective 
1.4.1 Perceptions of health threats 
When people face health threatening situations (e.g. the onset of symptoms 
or an illness diagnosis) they will often take on an active problem solving role 
to reduce the health threat that they are exposed to (Leventhal et al., 1980; 
Leventhal et al., 1984). Leventhal’s Common Sense Self-regulation Model 
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(CS-SRM) (Leventhal et al., 1980; Leventhal et al., 1984) (Figure 1) was 
developed to show that when a health threat is faced, such as symptoms or 
illness, people process cognitive and emotional representations of the threat 
in parallel. Representations are defined as individuals’ common-sense 
definitions of the threat (Leventhal et al., 1980). When facing a health threat 
people will ask themselves questions such as ‘What is this health threat?’, 
‘What can I objectively do about it?’, ‘How do I feel about it?’ and ‘What can 
I do to make myself feel better about it?’ (Hale et al., 2007). In the ‘cognitive 
representations’ box of Figure 1 five stable cognitive dimensions are 
commonly used to understand how individuals make sense of their illness: 
identity (threat label), time-line (i.e. duration, recovery time), causes (i.e. 
stress or injury), control (degree to which the illness can be prevented,  cured 
and kept from progressing) and consequences (imagined and real) (Leventhal 
et al., 1998).  
 
Figure 1 The common-sense self-regulation model (Leventhal et al., 1980), 
CS-SRM figure adapted from Horne (2003) 
As described by the CS-SRM (Leventhal et al., 1980; Leventhal et al., 1984), 
emotional responses, which are processed in parallel to cognitive 
representations, are most commonly fear-related responses such as anxiety 
and worry (other emotions such as depression and anger may also occur) 
(Cameron, 2003). To manage perceived risks, individuals will develop coping 
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procedures, which are the cognitive and behavioural actions that are taken (or 
not taken) to enhance health and prevent, treat (i.e. cure or control) and 
rehabilitate from illness (Leventhal et al., 1998). This could involve 
procedures such as increasing exercise to improve fitness, however, if the 
change is more ambiguous (e.g. when experiencing fatigue), taking rest may 
be the chosen coping course. Each coping procedure is shaped by the 
representation of the problem (Leventhal et al., 1998).  
1.4.2 Perceptions influencing behaviour  
Perceptions are widely known to influence health behaviours, such as patient 
adherence to medicine (Horne et al., 1999a). As transfusions are often 
provided on a one-off basis or prescribed and administered in the hospital 
context by HCPs, relevant behaviours in the blood transfusion context could 
include consenting to the transfusion (patients) or prescribing the transfusion 
(HCPs) etc. Accepting a blood transfusion for a patient with anaemia, for 
example, will be thought about in terms of the severity of the anaemia etc., 
such as ‘will the transfusion help to resolve the anaemia?’, and ‘what are my 
feelings towards this?’. Some patients may ‘problem solve’ by declining 
transfusions or wishing to pursue alternative options, having firstly 
considered the pros and cons. Patients who also consider their symptoms or 
illness and the health threat may still view transfusions cautiously and hesitate 
to accept them. As representations and coping procedures are linked, the 
procedure adopted will be evaluated and appraised for its success in helping 
to reduce the health threat and new updated perceptions of the threat will be 
formed. For instance, if the transfusion was accepted, and considered by the 
patient as an effective strategy to resolve the anaemia, the patient will form 
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new perceptions of the initial threat, such as that anaemia is controllable. If 
no adverse effects are experienced, this coping strategy will be reinforced, 
and representations amended accordingly. In summary, how patients perceive 
and engage with treatments is essential for patients’ broader health-related 
problem solving and illness recovery.  
Coping procedures may be problem-focused and directed at altering and 
managing the problem causing distress, and / or additionally individuals may 
use emotional-focused coping to regulate their emotional responses, such as 
maintaining hope and optimism (Lazarus et al., 1984b). For coping to be 
effective, a good match or fit between coping efforts and patients’ agendas, 
such as their values, beliefs and preferred coping styles must be met (Lazarus 
et al., 1984a). For instance, if a patient accepted a transfusion but reluctantly, 
they may be worried in the longer-term about their decision, or patients may 
face little choice but to accept the transfusion. Ultimately when patients face 
treatment choices, they will need to evaluate how efficacious the proposed 
treatment will be for their condition and weigh this up against potential risks 
or costs and perceived need (Horne, 2003). Obtaining a balanced perspective 
on these issues may assist patients in reaching an informed decision, feeling 
reassured about their condition and reducing elevated perceptions of their 
condition as a health threat.  
1.4.3 Assessing patients’ perceptions 
Illness Perceptions Questionnaires were developed in response to growing 
interest to understand the nature of patients’ illness-related coping and for 
developing interventions to facilitate self-management in chronic illness  
(Moss-Morris et al., 2002; Weinman et al., 1996). These measures were 
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flexible for adaptation for specific patient groups or in relation to specific 
health threats or contexts but were structured around the five illness 
representations domains of the model (Leventhal et al., 1980). With the 
growing use of this measure, researchers sought to discover ways to develop 
measures more specifically addressing treatment perceptions and Horne, 
Weinman and Hankins (1999) developed a questionnaire to identify medicine 
perceptions called the Beliefs about Medicines Questionnaire (BMQ). The 
BMQ informs the health outcome of treatment adherence (Horne et al., 
1999b) and assesses General medicine beliefs and medicine ‘Specific’ beliefs, 
which provided evidence for a Necessity-Concerns framework. This 
framework shows that higher adherence is associated with stronger 
perceptions of the ‘necessity’ of a specific treatment and fewer ‘concerns’ 
about the treatment (Horne et al., 2013).  
The CS-SRM (Leventhal et al., 1980) is widely considered to understand the 
role of treatment beliefs within the illness representations domains, and how 
this may have an influence on behaviours, such as treatment adherence 
(Horne, 2003). This is particularly for patients making treatment decisions, 
with their perceptions of the treatment informing their illness representations 
and emotional responses, and subsequently coping outcomes, as shown in the 
extended treatment perceptions and CS-SRM model (Figure 2) (Horne, 
2003). This extended model indicates that treatment perceptions will inform 
coping procedures, specifically treatment adherence. This occurs when 
individuals form cognitive and emotional representations of treatments, 
informing their illness representations, but treatment perceptions will 
influence adherence and non-adherence also via the selection of coping 
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procedures (highlighted boxes and arrows). This model has received some 
empirical support for the acceptance or rejection of HIV treatment (Horne et 
al., 2001), with patient acceptance to HIV medicine regimens (HAART) 
influenced by patients’ determination to be adherent and thus finding 
solutions to adherence problems (Vervoort et al., 2009). As supported by the 
Necessity-Concerns framework, studies have reported reasons that HAART 
was declined, for example, if patients were doubtful about their personal 
necessity for HAART, had concerns about the adverse effects of taking 
HAART and satisfaction with the amount of personal control over the 
decision (Cooper et al., 2002).  
 
Figure 2 Treatment perceptions and the common-sense model of self-
regulation (Horne 2003) 
The treatment perceptions literature provides an overarching framework to 
support an investigation of patients’ perceptions of blood transfusion. Further 
research is warranted to investigate how closely patients’ perceptions may fit 
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to these models, as patients may perceive transfusions differently to typical 
medicines or treatments. Blood is not a chemically derived substance or an 
operative procedure; therefore, it could be perceived differently as the donor 
blood is of human origin, perhaps sharing some similarity to how patients 
may perceive other infused interventions or transplants. Although patients 
need to attend hospital sites for transfusions, patients largely do not need to 
adhere to transfusion regimens and do not administer them by themselves in 
the community. Thus, many models may not contain perceptions appropriate 
for transfusion patients requiring HCP interaction to prescribe and administer 
the ‘treatment’. This makes this topic novel and noteworthy to explore, with 
the potential to develop the existing treatment perceptions evidence base.  
1.4.4 Theoretical perspective (HCPs) 
As transfusion is a healthcare intervention prescribed and administered by 
HCPs, it is essential to jointly understand their perceptions, with investigating 
HCPs’ perceptions alongside patients’ advisory in the treatment perceptions 
literature. This is because HCPs’ beliefs about treatments may influence their 
willingness to recommend the treatment to patients (Armstrong et al., 1996; 
Horne, 1999). Some studies have found HCPs’ perceptions of treatments to 
be divergent from patients, with one study reporting that patients compared 
to pharmaceutical specialists held stronger beliefs about the harmful nature 
of medicines, whilst the specialists held stronger beliefs about medicine 
overuse (Ramström et al., 2006). Ramström et al., (2006) utilised the BMQ 
in their study and indicated that HCPs’ perceptions may be able to be 
organised into the same content themes to those of patients. Analysing 
patients’ and HCPs’ perceptions coincidently will retain any side-by-side 
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comparison of both groups’ viewpoints, whilst allowing scope for divergent 
perceptions between both groups to emerge. It is important to profile 
perceptions held by both patients and HCPs due to patient and HCP 
collaborative exchanges, in which HCPs provide their expertise to help 
patients self-regulate their health states (Scott et al., 2013).  
Although there is an existing treatment perceptions theoretical evidence based 
to draw on; the extent to which theory has been applied to blood transfusion 
perceptions research is unclear. Given that it is the patient that self-regulates 
their health states, self-regulation or treatment perceptions models may be 
more applicable to patients. HCPs’ perceptions may, however, manifest as a 
contextual factor, influencing patients’ perceptions, with the information that 
HCPs share to patients informing how patients perceive their treatment 
options. The extended CS-SRM (Horne, 2003) also allows for HCPs’ 
perceptions of treatments (e.g. needs and concerns on behalf of the patient 
taking the treatment) to be recognised. Currently HCPs’ perceptions are often 
investigated in studies supported by behaviour change theories, such as those 
underpinning implementation research, such as The Theoretical Domains 
Framework (TDF) (Michie et al., 2005). The TDF integrates a range of 33 
behaviour change theories and 128 theoretical constructs into 14 domains 
representing the range of individual, socio-cultural and environmental 
influences on behaviour (Cane et al., 2012). TDF based research has been 
used to explore influences on behaviour, for example, discussing human 
papillomavirus (HPV) vaccination with patients (McSherry et al., 2012), 
routinely ordering pre-operative tests (Patey et al., 2012) and error-free 
prescribing (Duncan et al., 2012). The TDF provides a theoretical basis for 
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implementation studies, providing good coverage of potential reasons for 
slow diffusion of evidence into practice and a method for progressing from 
theory-based investigation to intervention (Atkins et al., 2017). As blood 
transfusion is a clinical area routinely audited for transfusion use, with 
interventions often applied to curtail overuse (Gould et al., 2014), theoretical 
frameworks such as the TDF may be recognised in the transfusion perceptions 
literature.  
 Summary 
There is demonstrable gap in the theoretical literature on patients’ and HCPs’ 
transfusion perceptions, therefore there is a need for a theory informed 
investigation of this topic. Through this the perceptions of both patients and 
HCPs could be profiled to show how transfusions are perceived and to detect 
any similarity or difference in perceptions between both groups (e.g. infection 
risk concerns of patients but overlooked by HCPs with more expert medical 
knowledge). Associated topics such as the patient’s role in decision making 
and health behaviours, such as accepting and prescribing transfusion, are 
embedded into this topic. This is because although HCPs are the responsible 
authority prescribing the transfusion, patients often hold an active role in 
deciding whether they agree that a transfusion is the best intervention to treat 
their health condition. If patients hold concerns about transfusions that are not 
resolved through the decision-making process, strategies to enhance shared 
decision making, amend services or provide interventions to support 
transfusion patients to cope may need to be generated.  
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1.5.1 Aims of this programme of research 
The over-arching aim of this programme of research is to explore patients’ 
and HCPs’ perceptions of blood transfusion. A sequence of studies was 
conducted. First, a systematic review was conducted to identify and 
synthesise what is already known about how HCPs and patients perceive 
transfusions. Second, qualitative research explored more in-depth gaps 
identified in the systematic review regarding transfusion perceptions. The 
third element of this research aimed to build on the former study and identify 
ways to improve transfusion practice.    
 Structure of this thesis  
Figure 3 portrays the sequence of the three studies reported in this thesis. 
Study 1. Systematic review of patients’ and HCPs’ perceptions of blood 
transfusion; Study 2. Explorative study of significant research gaps in this 
field using qualitative research; Study 3. Exploration of the implications of 
the findings from study 2. Future research is indicated in the overall 
Discussion and Conclusion chapters of this thesis.  
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Figure 3 Sequence of studies and chapters of the current research programme
Chapter 5: Study 3: Exploratory study based on the findings of Study 2
Objective: To explore implications from the findings of Study 2 to enhance 
transfusion practice
Methodology: Qualitative research
Chapter 6: General Discussion
Chapter 7: Conclusions and recommendations
Chapter 3: Theoretical linkage between constructs of blood transfusion 
perceptions and the broader literature
Chapter 4: Study 2: Exploratory study of an identified research gap from 
Study 1
Objective: To address emergent research gaps for further exploration of patients' 
and HCPs' perceptions of blood transfusion
Methodology: qualitative research
Chapter 2: Study 1: Systematic Review of Patients' and HCPs' Perceptions of 
Blood Transfusion
Objective: To discover which perceptions of blood transfusion have been reported 
for patients and HCPs in the published literaure. 
Methodology: systematic review and qualitative synthesis of perceptions
Chapter 1: General introduction to the topic of patients' and healthcare 
professionals' (HCPs') perceptions of blood transfusion
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2 Patients’ and Health Care Professionals’ Perceptions of 
Blood Transfusion: A Systematic Review 
This chapter reports a systematic review of patients’ and healthcare 
professionals’ (HCPs’) perceptions of blood transfusion. This is the first study 
in this programme of research, conducted to consolidate the evidence base on 
this topic. This systematic review has since been published (citation below, 
Appendix 1: Systematic review publication) and this chapter presents an 
updated version of the review with the searches re-run in February 2019.  
Abdul-Aziz, B., Lorencatto, F., Stanworth, S. J., & Francis, J. J. (2018). 
Patients' and health care professionals' perceptions of blood transfusion: a 
systematic review. Transfusion, 58 (2), 446-455 
 Introduction 
Blood transfusion is a healthcare intervention frequently prescribed to a wide 
range of patients (American National Red Cross, 2018a). Transfusions are 
provided either as a single transfusion episode for planned elective or 
emergency procedures (e.g. surgery involving blood loss), or repeatedly for 
patients with haematological blood disorders (Tinegate et al., 2013). It is 
important to understand transfusion perceptions because when patients 
experience illness or symptoms that may require treatment, they form 
perceptions of the possible treatments, such as the treatment’s potential to 
control the health threat, or they evaluate perceptions of treatment risks 
compared to benefits (Horne, 2003). A treatment may also, however, be 
perceived as health threatening and people may reject treatments because they 
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fear that taking the treatment may diminish their quality of life (Horne, 2003; 
Siegel et al., 1999).  
Transfusions may be perceived by patients as risky as since around 1984, 
significant media attention was given to the discovery that HIV was 
transmittable through blood transfusions, which caused thousands of HIV / 
AIDS related infections and deaths (Perkins et al., 2010). Some public views 
of blood transfusion remain to be associated with perceptions of risk, and 
associated with HIV and AIDS (Finucane et al., 2000) despite the low actual 
risk (National Institutes of Health, 2012.; Zou et al., 2010). As members of 
the public are potential blood transfusion recipients, such findings suggest 
that if becoming a patient requiring a transfusion, patients may view 
transfusions as risky, but that these views may not align with current evidence 
and clinical safety guidelines. 
As there are a broad range of patients receiving transfusions for different 
illnesses or to support different medical procedures, perceptions of 
transfusion across patients may be variable. Perceptions may vary between 
different groups of transfusion patients receiving different blood components, 
such as red blood cells, transfused following significant blood loss or for 
anaemia, white blood cells to fight infections, or platelets to help blood 
clotting (NHS Blood and Transplant, 2016). Some patients may also have the 
option to be considered for donor (allogeneic) blood sparing alternatives or 
autologous procedures. Patients receiving transfusions in non-emergency 
situations may also form different perceptions at different time points relative 
to a transfusion, such as before, during or after transfusion. These perceptions 
will influence how patients choose to cope with aspects of their recovery and 
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regulate their health (Leventhal et al., 1997) (e.g. emotional focussed coping 
and being hopeful that the transfusion will improve their health as it starts to 
take effect). Thus, gaining a detailed understanding of how perceptions of 
blood transfusion vary for these different components or donation methods 
may be useful to HCPs as they prescribe transfusions to patients and help 
patients recover from ill health post-transfusion.  
It is important to equally explore both patients’ and HCPs’ perceptions as 
both groups are equally involved in the transfusion - one as a prescriber and 
one as a recipient, so cross-comparable or wide varying beliefs may be 
revealed. A wide range of HCPs are involved in transfusion decision-making 
and blood product administration, including consultants, registrars, 
technicians, nurses and general practitioners (GPs) (NHS Blood and 
Transplant, 2012). HCPs often work in multi-disciplinary transfusion teams 
to implement patient blood management strategies to treat patients and 
enhance patient safety (Goodnough et al., 2012). Yet, different professional 
groups may perceive transfusion differently to patients and across HCP 
groups. HCPs’ views of treatments are informed by their knowledge of the 
relevant clinical evidence and their own clinical experience (Insel et al., 2005; 
Ramström et al., 2006). HCPs’ perceptions and knowledge naturally 
influence clinical decision-making, in which patients may be involved to 
differing extents (Friedman et al., 2015).  
Clinical decisions about transfusion may involve a consideration of 
alternatives to transfusion that reduce the need for a transfusion. Possible 
alternatives are considered as key issues to discuss with patients when 
obtaining informed consent as advised by the UK Safety of Blood, Tissues 
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and Organs Committee (SaBTO) (JPAC, 2019; SaBTO, 2011). National 
Institute for Health and Care Excellence (NICE) guidelines recommend the 
consideration of alternatives such as oral iron before surgery for patients with 
iron deficiency anaemia, or the use of strategies such as cell salvage, where 
loss blood is retained and re-transfused back to the patient (Padhi et al., 2015). 
Alternatives are reported to be underused (Murphy et al., 2013a) and 
transfusion prescribed inappropriately, a problem which persists despite 
reductions and fluctuations in the use of some blood components (Murphy et 
al., 2013b). Hence, investigating the perceptions of HCPs alongside patients 
across a broad range of clinical contexts may identify factors that lead to the 
inappropriate use of some blood products or the underuse of blood-sparing 
alternatives.  
Systematic reviews are commonly conducted to comprehensively identify all 
relevant studies to answer a particular question, whilst assessing the validity 
“soundness” of each study (Petticrew et al., 2006). A review can include a 
narrative component to present the findings of studies in their own terms or 
integrate a qualitative analysis to synthesise findings across studies to identify 
recurrent or important themes arising from the body of literature (Mays et al., 
2005). A systematic review can thus be used to narratively describe how 
perceptions were assessed (e.g. cross-sectional study using a questionnaire), 
alongside extracting and qualitatively analysing and synthesising the content 
of the perceptions. Meta-analyses are also used to collate quantitative data 
presented in multiple studies, however, data presenting textual perceptions 
that patients and HCPs hold would not be suitable for this type of review. 
Bayesian meta-analysis may offer an approach to combine qualitative and any 
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questionnaire or quantitative data but are complex to implement with the 
technique facing methodological issues (Dixon-Woods et al., 2005).  
As the size and scale of the evidence base is uncertain for this topic of 
patients’ and HCPs’ perceptions of blood transfusion, a systematic review is 
warranted to consolidate published evidence to date. A title search of 
systematic reviews of the topic of ‘patients’ and HCPs’ perceptions of blood 
transfusion’ was performed in January 2014 in two online databases: 
University of York Centre for Reviews and Dissemination and The Cochrane 
Database of Systematic Reviews, identifying that no systematic review on 
this topic had previously been published in these libraries (Appendix 2: 
Systematic review, scoping and full search strategies). 
It is often concluded that a substantial proportion of studies identified in 
reviews fail to make explicit reference to theory (Michie et al., 2010). 
Systematic reviews would benefit from reporting the extent to which theory 
informs the design and methodological approach of studies because theory 
can provide a conceptual basis to understand perceptions and clarify 
theoretical constructs influencing behaviour. If theory has been minimally 
utilised in past research, subsequent studies could become theory informed to 
highlight key relationships between theoretical constructs, which influence 
behaviour. For instance, existing studies could be examined to determine their 
theoretical underpinning, with this information used to understand the 
research area more theoretically, utilising this knowledge for subsequent 
research.  
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2.1.1 Aims of the systematic review 
This systematic review aimed to narratively present and qualitatively 
synthesise the reported healthcare literature to identify adult transfusion 
patients’ and HCPs’ perceptions of blood transfusion. Adult patients were 
selected because they are the main transfusion recipient group, with an ageing 
population increasing further demand for transfusion (Greinacher et al., 2011; 
World Health Organization, 2017). This review was designed without 
geographical boundaries due to the extensiveness of the use of transfusions 
globally and that issues in blood transfusion, such as the tainted blood 
scandals, occurred on a global scale. In the review, emergent themes were 
identified and developed from the primary studies with consideration given 
to how themes may inter-relate.  
2.1.2 Systematic review objectives:  
1. To systematically review the literature reporting adult patients’ and 
HCPs’ perceptions of blood transfusion, describing the design and 
characteristics of included studies.  
2. To identify and synthesise the reported transfusion perceptions and 
identify over-arching themes related to perceptions of blood 
transfusions, and proposed relationships between themes.  
2.1.3 Research questions: 
1. Whose perceptions have been investigated? 
2. What are the reported methods used to assess perceptions? 
3. At which time points (in relation to the transfusion) were perceptions 
assessed? 
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4. Have perceptions been differentiated between the different blood 
components or transfusion methods? 
5. To what extent has theory been used to explore transfusion 
perceptions? 
6. Which content themes of perceptions of blood transfusion have been 
identified and how do the themes relate to one another? 
7. How were the emergent themes distributed across the chronological 
years of study publication? 
 Methods  
2.2.1 Design  
Systematic review: qualitative narrative synthesis 
2.2.2 Study selection criteria 
Empirical studies were eligible for inclusion if they investigated blood 
transfusion perceptions of: 1) adult patients who had either received a 
transfusion, or were being prepared for a transfusion (i.e. transfusion was not 
100% guaranteed to take place, for instance patients undergoing pre-operative 
assessments and consenting to transfusion or donating blood for pre-operative 
autologous donation (PAD)); and/or 2) all grades of professionally registered, 
adult-treating HCPs (i.e. excluding paediatricians) with potential 
responsibility for ordering a transfusion or treating transfusion patients in 
primary, tertiary or secondary care centres (e.g. not military zones).  
Blood transfusion was considered as a healthcare intervention using any 
blood component or donation method (e.g. PAD or blood-sparing alternative, 
such as cell salvage). Perceptions of blood transfusion practice, such as 
Chapter 2 Systematic review 
47 
satisfaction with the service, recall of informed consent, training, policy and 
transfusion administration procedures were considered to be outside of the 
scope of the review. This was to retain the focus on patients’ and HCPs’ 
perceptions of transfusion, with associated topics, such as satisfaction with 
service and training, arguably independent topics for separate research. 
Studies were required to be reported in English language, in peer-reviewed 
journals, and accessible in full text. Papers reporting primary studies in the 
reference lists of systematic reviews that were identified by the search were 
also eligible for inclusion.  
No limiters were applied to geographical region. The publication date of 
studies was from 1984 onwards; 1984 marking the date of a potential shift in 
perceptions of blood transfusion after the link between blood transfusion and 
AIDS transmission was announced (Perkins et al., 2010). 
2.2.3 Identification and selection of relevant studies 
Searches were run initially in February 2014 and updated in November 2015 
and February 2019. Selection of electronic databases and development of the 
search strategy were conducted in collaboration with an Information 
Specialist experienced in conducting blood transfusion systematic reviews. 
The following databases were searched: Cochrane Central Register of 
Controlled Trials, the Cochrane Database of Systematic Reviews, Database 
of Abstracts of Reviews of Effects, Ovid MEDLINE, EMBASE, PsycINFO 
and PsyARTICLES.  
Search terms for the scoping search included synonyms for perception from 
the literature; representation or belief (Horne et al., 1999b; Leventhal et al., 
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1980) (perception* or representation* or belie*) and were connected using 
the ‘AND’ operator to the term ‘blood transfusion’. For the final searches, 
search terms related to three domains: 1) blood transfusion (e.g. red cell 
transfusion*); 2) perceptions (e.g. belie* or attitude); and 3) participant group 
(patients or HCPs, e.g. medical staff or clinician*). The ‘blood transfusion’ 
and ‘perceptions’ search domains were connected using the adjacent (four) 
operator, in which search terms in one domain were triggered when occurring 
within four words from terms in the other domain. The ‘participant group’ 
domain was connected to the combined ‘blood transfusion’ and ‘perceptions’ 
domains using the ‘AND’ Boolean operator. The search was applied to the 
studies’ title and abstract fields (see Appendix 2: Systematic review, scoping 
and full search strategies). 
Four criterion papers that reported patients’ and HCPs’ perception of blood 
transfusion were used to guide selection of the search terms and to validate 
the search through appearing in the search (Adams et al., 2011; Fitzgerald et 
al., 1999; Francis et al., 2009a; Islam et al., 2012).  
2.2.4 Study screening  
Studies identified via the search strategy were screened for inclusion against 
six inclusion criteria (Table 1). The criteria were independently piloted by 
two reviewers on 50 titles and abstracts to assess reliability. All studies were 
screened by the main reviewer at the title and abstract, and subsequently at 
the full text level. The review team independently assessed 1% (n=29) of 
randomly selected titles and abstracts excluded by the main reviewer for the 
2014 and 2015 searches to evaluate the validity of the screening decisions. 
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Any studies failing to meet all inclusion criteria either at the title and abstract 
or full text level were excluded.    
Table 1 Systematic review study inclusion criteria 
No. Inclusion criterion 
1 Full text English Language publication from a peer reviewed journal 
2 Published since 1984 
3 Assessing perceptions of blood transfusion of any blood component 
4 Reporting empirical data about perceptions of blood transfusion 
through a primary study  
5 Participant sample including patients and / or HCPs 
6 Reported participant samples not below 18 years old or HCPs who 
treat patients below 18 years old  
2.2.5 Data extraction and synthesis 
A data extraction form was developed and piloted on the first five included 
studies. In total, 25 data elements were extracted under the headings: Study 
details, Study characteristics, Sampling frame and sample characteristics, 
Data collection methods, Analysis, Results, Conclusions and 
recommendations (see Appendix 3: Systematic review data extraction form).  
Reliability analysis was performed on two elements of data extracted: 1) 
presence / absence of theory; and 2) reported perceptions. For presence / 
absence of theory, similar to methods used in other systematic reviews 
(Colquhoun et al., 2013), the name of the theory was documented as well as 
where theory was mentioned in the paper. The main reviewer extracted all 
data, noting whether theory was reported to inform the study materials (e.g. 
questionnaires/ topic guides). If study materials were not published, study 
authors were contacted by e-mail to request a copy of the materials. 
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Colleagues (AP, FL) with experience in identifying theory, independently 
assessed the presence or absence of theory for a randomly selected sub-
sample of 10% of studies from the 2014 and 2015 searches. For the reported 
perceptions, results sections of each article were read by the main reviewer 
(BV) and only data related to perceptions of blood transfusion meeting the 
inclusion criteria were extracted. Such data points included excerpts of both 
raw data (i.e. participant quotes and/or quantitative findings) and/or text 
reporting results as interpreted by study authors. A second reviewer (FL) 
independently extracted the perceptions from 10% of a randomly selected 
sub-sample of studies from the 2014 and 2015 searches, and reliability was 
assessed using percentage agreement. 
2.2.6 Quality assessment of included studies 
Quality was assessed for descriptive purposes rather than to inform study 
inclusion/exclusion. Studies were appraised for quality by BV using validated 
quality assessment checklists for evaluating primary research papers from a 
variety of fields (Kmet et al., 2004) (Appendix 3). Scores produced using the 
checklists, tailored for quantitative (14 items) and qualitative (10 items) study 
designs, were converted into percentages (number of quality criteria met, out 
of the total number of quality items). Domains of quality that were assessed 
through the checklists included sample selection criteria, data collection, 
results verification procedures and reflexivity (Kmet et al., 2004).  
2.2.7 Data analysis  
Extracted data were tabulated for analysis and reported using narrative 
summary for all extracted data other than the reported perceptions (Dixon-
Woods et al., 2005). A four-stage inductive qualitative synthesis (Thomas, 
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2003) was conducted to synthesise and interpret reported perceptions. First, 
BV classified the extracted perceptions into categories using in vivo coding, 
where actual phrases from the excerpts were retained and used to name the 
categories (Thomas, 2006). Second, the main reviewer organised the 
categories into subthemes using techniques from thematic analysis; searching 
for themes, whereby the inter-relationships between categories are 
considered, (i.e. ‘ongoing awareness’ and ‘conditional awareness’ may be 
classified under a broad initial theme of ‘awareness’) (Braun et al., 2006). 
The themes and subthemes were discussed with the review team to reach 
consensus on a refined set of themes (synthesis stage 3). The main reviewer 
then investigated relationships between the themes (e.g. the extent to which 
some subthemes mapped across themes) (synthesis stage 4) and produced a 
conceptual model to display key relationships. The model was revised until 
secondary reviewers agreed with the presentation of the model.  
 Results 
The original 2014 search retrieved 3,134 results. A further 473 results were 
retrieved in the first update in 2015 and a further 391 in the 2019 update. A 
further two papers were identified from a systematic review (Ngo, 2013) 
identified in the 2014 search (Amin et al., 2004; Moxey et al., 2005), resulting 
in a total of 3,076 papers for title and abstract screening. 100% agreement on 
screening decisions was reached. As displayed in the PRISMA Diagram 
(Figure 1), 41 papers published between 1990 and 2018 were included in the 
systematic review.  
 














2.3.1 Study characteristics 
Fifteen papers included in the systematic review investigated patients’ 
perceptions of blood transfusion (Cheung et al., 2014; Court et al., 2011; 
Davis et al., 2012b; Graham et al., 1999; Khan et al., 2012; Lee et al., 1998; 
Lee et al., 1997; Luby et al., 2001; Murphy et al., 1997a; Shah et al., 2012) 
(Adams et al., 2011; Fitzgerald et al., 1999; Moxey et al., 2005; Orme et al., 
2013) (Ryblom, 2015). Twenty-six papers investigated HCPs’ perceptions 
(Adusei et al., 2018; Al-Riyami et al., 2016; Amin et al., 2004; Cozzolongo 























 Records after duplicates 
removed (n = 3,076) 
Titles and abstracts 
screened (n = 3,076) 
Studies identified 
through included 
reviews (n = 2) 
Records identified 
through original 2014 
search 
(n = 3,134) 
Titles and abstracts excluded  
(n = 2,983) 
Reasons: 
Duplicates (15), Dissertation/ conference 
abstract (4), blank (1), own publication 
(1) 
1.Not English language abstract (0) 
2.Published before 1984 (0) 
3.Not assessing perceptions of BT (2847)  
4.Not reporting empirical data (85) 
5.Non patient/ HCP sample groups (20)  
6.Samples below 18 years or HCPs for 
samples below 18 years (10)  
Full-text studies 
assessed for eligibility 
(n= 93) 
Full-text studies excluded 
(n = 54) 
Reasons:  
Duplicate (2), Review paper (1),  
Not full text (18) 
1.Not English language full text (5) 
2.Published before 1984 (0) 
3.Not assessing perceptions of BT (20) 
4.Not reporting empirical data about 
perceptions of BT (1) 
5.Non patient/ HCP sample groups (6)  
6.Samples below 18 years or HCPs for 
samples below 18 years (1)  
Studies included in 
qualitative synthesis (n= 41) 
• Quantitative n = 30 
• Qualitative n = 9 
• Mixed methods n= 2  
Records identified through 
updated searches (2015: n = 473) 
(2019: n = 391) 
Figure 4 Systematic review PRISMA diagram 
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Hartford et al., 2015; Lee et al., 2003; Leibovitz et al., 2004; Lowe et al., 
2001; Manzini et al., 2018; Müller et al., 2014; Salem-Schatz et al., 1990; 
Soares et al., 2017; Tavares et al., 2015; Thonneau et al., 1991; Torella et al., 
2001; Vetter et al., 2014; von Babo et al., 2018) (Francis et al., 2009a; Graham 
et al., 2002; Heddle et al., 2012; Islam et al., 2012; Treloar et al., 2001) 
(D'Souza et al., 2004) (Table 2). 
Three papers explored patients’ and HCPs’ perceptions concurrently; 
however, either the HCP perceptions were excluded as the HCP-component 
of the study included perceptions outside of the scope of this review (i.e. 
perceptions of informed consent documentation (Davis et al., 2012b) or the 
content of transfusion consultations (Khan et al., 2012)) or the patients 
formed an ineligible group being hospital patients but not transfusion 
recipients (or patients being prepared for a transfusion) (Graw et al., 2018).  
Table 2 summarises the main characteristics of included studies and 
participants. The majority of studies were conducted in the UK (n=12) (Court 
et al., 2011; D'Souza et al., 2004; Davis et al., 2012b; Ferguson et al., 2001; 
Francis et al., 2009a; Heddle et al., 2012; Khan et al., 2012; Lowe et al., 2001; 
Manzini et al., 2018; Murphy et al., 1997a; Orme et al., 2013; Torella et al., 
2001) were multi-site (i.e. the study was conducted at more than one health 
facility) (n=22 ) (Amin et al., 2004; Cozzolongo et al., 2005; D'Souza et al., 
2004; Davis et al., 2012b; Ferguson et al., 2001; Francis et al., 2009a; Graham 
et al., 2002; Graham et al., 1999; Hartford et al., 2015; Heddle et al., 2012; 
Islam et al., 2012; Lee et al., 1998; Leibovitz et al., 2004; Lowe et al., 2001; 
Luby et al., 2001; Manzini et al., 2018; Moxey et al., 2005; Müller et al., 
2014; Salem-Schatz et al., 1990; Torella et al., 2001; Treloar et al., 2001; von 
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Babo et al., 2018) and in secondary healthcare settings (n=33) (Adams et al., 
2011; Adusei et al., 2018; Al-Riyami et al., 2016; Court et al., 2011; Davis et 
al., 2012b; Ddungu et al., 2018; Fitzgerald et al., 1999; Francis et al., 2009a; 
Graham et al., 2002; Graham et al., 1999; Graw et al., 2018; Hartford et al., 
2015; Heddle et al., 2012; Islam et al., 2012; Khan et al., 2012; Lee et al., 
2003; Lee et al., 1998; Lee et al., 1997; Leibovitz et al., 2004; Luby et al., 
2001; Manzini et al., 2018; Moxey et al., 2005; Müller et al., 2014; Murphy 
et al., 1997a; Ryblom, 2015; Salem-Schatz et al., 1990; Shah et al., 2012; 
Soares et al., 2017; Tavares et al., 2015; Torella et al., 2001; Treloar et al., 
2001; Vetter et al., 2014; von Babo et al., 2018). 
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Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 





Sweden (1) Secondary h/c Mixed 
methods 
16 transfusion patients Age: 67-91 (mean 74) 
Male 8, female 8 




Blood transfusion need of >6 
months and a minimum 










25 patients prepared 
for a transfusion 
Age: 38–84 (mean 61) 
Male 11, Female 14 
Diagnoses: oncologic 
(19), Myelodysplastic 
syndrome (2), Not 
reported (4) 




Hospice Interview 10 transfusion 
recipients 
Age: 67 - 95 (mean 79.5) 
Male 7, Female 3 
Diagnoses: 
myelodysplasia (7), non-
Hodgkin's lymphoma (1), 
myelofibrosis (1), 
sideroplastic anemia (1). 
Davis et al., 
(2012) 
UK, London 
& Oxford (2) 





operative + regular 
recipients; ambulatory 
hematology) 
Age: 18–93 (mean 60) 
















Age: (mean 33)               
Male 50, Female 91 
Occupation = 80 
housewives, 20 manual 
labourers, & 20 office 
workers. 
Reason:  surgical blood 
loss (77), anemia (28), 
generalized weakness 
(15) & trauma (13). 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   











Age: (mean 33 for males, 







Secondary h/c Interview 21 transfusion 
recipients 
Age: (n) 
18–30      2 
31–50      2 
51–70      7 
71–90      10 
Male 5, Female 16 
 
Reason: all anemia 





Secondary h/c Interview 19 transfusion 
recipients 
Age: (n)  
21-30:  3 
31-50:  4 
51-70:  8 
71-90:  4 
Male 14, Female 5 
 
Diagnoses: cancer (6), 
clotting disorders (2), 
organ failure (2), 






Secondary h/c Cross 
sectional  
51 transfusion 
recipients (medical / 
surgical wards) 
Age: 17-82 years 
Male 34, Female 17 NR 





Secondary h/c Cross 
sectional 
14 patients attending 
surgical pre-







Secondary h/c Cross 
sectional 
80 Cardiac patients 
(40 PAD / 40 non-
PAD)  
& 73 Orthopedic 
patients (38 PAD / 35 
non-PAD). 
Age: (mean) 59.0 Cardiac 
PAD / 63.5 Cardiac non-
PAD / 63.2 Orthopedic 
PAD / 71.5 Orthopedic 
non-PAD. 
Reason: Range of 
surgical procedures. 
 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   
Male = 88 Cardiac PAD / 
80 Cardiac non-PAD / 40 
male Orthopedic PAD / 34 
male Orthopedic non-
PAD. 




ts & Maine 
(3) 




412 patients (prior to 
PAD)  
Age (mean) 56.05 (15.14) 
Female 230 
Mean annual income ($) 
44,924                          
College education 66 
Patients scheduled for 
autologous donation 
before planned surgical 
procedures 




Secondary h/c  Cross 
sectional  
235 patients (prior / 
following PAD) 
Age: (mean) 50.45              
Female 63 %                   
Mean household income = 
$57993                         
College education 64%  
Patients scheduled for 
autologous donation 
before planned surgical 
procedures  










Age: 21-84 years             
Male 141, Female 201  
Post-operative: 66 
transfusion recipients 
(66·7% elective) / 26 non-
recipients (80·8% 
elective). 












clinics      
Interview 23 transfusion 
recipients 
6 PAD recipients 
9 other (post-surgical 
patients) * 
Age: (n) 30–39: 0 / 40–49: 
3 / 50–59: 2 / 60-69: 9 / 
70–79: 18 / 80+: 6  
 


















Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 




Ghana (1) Secondary h/c Cross 
sectional 
100 HCPs (Doctor 3, 
Pharmacist 6, Nurse 
49, Midwife 5, 
Physician Assistant 6, 
Biomedical Assistant 
6, Laboratory 
technician 7, Others 
18)* 
Aged between 20- 30 
years (76%), 31-40 (18%), 
41-50 (6%) 
Male 53, Female 47 NR 
Ddungu et 
al., (2018) 




practicing at Uganda 
Cancer Institute from 
June to September 
2014 
NR NR 




Secondary h/c Cross 
sectional 
185 nurses (117 
registered nurses, 10 
nursing auxiliaries, 55 
nursing students, and 
3 status not defined) 
Age: (years) 23-47, 
median 31 
Gender: male 50 (27 %) 
Marital status, n 
Single 95, Married 79, 
Divorced 9, Widowed 2 
 
Blood donor, n 95 










Secondary h/c Cross 
sectional 
788 medics (surgeons 
(244; 31%), 
anaesthetists (165; 
25%) and medical 
specialists (379, 44%)) 
3% of respondents did not 
prescribe blood 
components whilst the 
others were equally 
divided amongst those 
who prescribe weekly, 
monthly or less frequently 
Clinical experience: 40% 
had work experience of 
more than 15 years, 
33.5% from 5 to 15 years 
and 26.5% <5 years. 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   
site per 
country) 




Secondary h/c Cross 
sectional 
560 medics (297 
(53%) of the 
participants were 
residents, 263 (47%) 
attending physicians) 
The majority of 
participants lived in the 
German-speaking part of 















Age: (years): 27-76, mean 
37.94 years (median 33.5) 
Gender: 49 female 
(54.4%), male 41 (46.6%) NR 
Al-Riyami et 
al., (2016) 
Oman (1) Secondary h/c Cross 
sectional 
114 Physicians 
(Interns 43, Residents 
28, Senior House 
officers 13, Registrars 
30) * 
Clinical areas: 
Anesthesia 8 physicians, 
Obstetrics and 
gynecology 15, 
Hematology 19, Internal 
Medicine 19, Pediatrics 
25, Surgery 28 
Gender: Female 70 
(61.4%), Male 44 (38.6%) 
Previous involvement in 
the transfusion consent 
process was declared by 
77% of physicians. NR 
Tavares et 
al., (2015) 
Brazil (1) Secondary h/c Cross 
sectional 
209 nurses (29 nurses, 
146 nursing 
Age: (years) 22-61 (mean 
38.2) 
Gender: female (81.8%) 
An average of 144.25 
months of training, 147.07 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   
technicians & 34 
nursing assistants) * 
Most common clinical 
areas: Hospitalization 
Unit - Adult (n=56 
nurses), Intensive Care 
Units (n=54), Emergency 
Room Units (32) 










216 Physicians (94%), 




medicine (36%), surgery 
(34%), paediatrics (19%), 
anaesthesia (10%), and 
other (1%). 
47% were postgraduate 
(resident) trainees 





Secondary h/c Cross 
sectional  
73 Anesthesiologists’ 
(n=34) & surgeons 
(n=39) 
Age: 47 (mean) in years 
Gender (m=68): Male 54, 
female 14 
Post residency practice 
duration (mean 14 years) 




Secondary h/c Cross 
sectional 
46 Intensive Care Unit 
(ICU) physicians & 
fellows 
Age: 20–35 year 24% 
36–50 year 63%, 51–65 
year 13% 
Gender: 65% male 
Critical care specialist 
72% 
Fellow training in 





USA (6 site: 2 
in US) 
Secondary h/c Interview 
(n=7) & focus 
group (n=12) 
72 in/outpatient nurses 
and physicians (Italy 
only) 
sampled from diverse 
clinical areas* 
NR NR 




Secondary h/c Interview 10 ICU physicians Gender: 9 male, 1 female Variations in training & 
practice in transfusion  














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 






Secondary h/c Interview 11 ICU consultants Gender: 10 male, 1 female  
Age: 36–52 years  
1 to 21 years  
Cozzolongo 




Primary h/c Cohort study 
design 
306 (time 1)/ 170 (time 







Primary h/c Mixed 
methods 
488 GPs NR NR 













45 physicians (28 
internists, 10 
cardiovascular 







Secondary h/c Cross 
sectional  
274 physicians (79 
Internists, 69 
oncologists, 79 
Geriatricians, 47 family 
physicians) 
 
74 nurses (oncology 
&internal medicine 
wards) 
Gender (n female / male): 
Internists 16 / 63   
Oncologists 24 / 45  
Geriatricians   21 / 58  
Family physicians 26 / 21  
Nurses 72 / 2 
 
Age (mean): Internists   47, 
Oncologists 49, 
Geriatricians 53, Family 
physicians 44, Nurses 43   
Years of practice (mean) 
Internists 20, Oncologists 
21, Geriatricians 25, 
Family physicians 17, 
Nurses 20. 





Secondary h/c Cross 
sectional  
33 physicians, 43 
residents (21 family 
medicine, 19 internal 
Gender: 51% female 
Age: (mean) 33  
Family status: 54% 
married, 30% with children 
NR 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   












or laboratory medicine 












88 GPs, 143, 
Anaesthetists NR NR 





Primary h/c Cross 
sectional  
88 GPs, 143, 
Anaesthetists 
Gender: 264 male, 233 
female  
Age (mean): 35.8 
 






Secondary h/c Cohort study 
design 
571 surgeons n per 
year:  151 (1990), 226 
(1994) & 194 (1999)  
(sampled from diverse 















Primary h/c       Cross 
sectional 
6 doctors (family 
planning) NR NR 














Reported reasons for 
the transfusion or 
diagnoses (n) / Years of 
clinical experience   
Salem-
Schatz et al., 
(1990) 
USA, (3) Secondary h/c Cross 
sectional 
survey  
76 surgeons, 46 
anesthesiologists NR 
Clinical role: n=50 
attending physicians & 72 
residents. 
* Decision rule applied - non-eligible samples (i.e. *pediatricians, post-surgical patients) represent less than 50% of the total sample, data inseparable from other samples’ data, therefore all data extracted.                                 
NR = not reported in papers  
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2.3.2 Patients and HCPs participating in included studies 
In total, 1,574 patients participated in the included studies (48% male, aged 
between 18-95 years). The majority of participants were of Caucasian 
ethnicity (73% reported for n=2 studies) (Adams et al., 2011; Davis et al., 
2012b) and from diverse income and educational backgrounds (n=6 studies) 
(Davis et al., 2012b; Lee et al., 1998; Lee et al., 1997; Luby et al., 2001; 
Moxey et al., 2005; Shah et al., 2012). 
Patients were classified for this review as either transfusion recipients (n=8 
studies) (Adams et al., 2011; Davis et al., 2012b; Fitzgerald et al., 1999; Luby 
et al., 2001; Murphy et al., 1997a; Orme et al., 2013; Ryblom, 2015; Shah et 
al., 2012) or patients being prepared for a transfusion (n=5 studies) (Cheung 
et al., 2014; Khan et al., 2012) (Graham et al., 1999; Lee et al., 1998; Lee et 
al., 1997). Two studies included both patient groups (Court et al., 2011; 
Moxey et al., 2005). Patients were broadly classified as: 1) receiving 
transfusions in the context of surgery only (n=6 studies) (Court et al., 2011; 
Graham et al., 1999; Khan et al., 2012; Lee et al., 1998; Lee et al., 1997; 
Moxey et al., 2005); 2) mixed groups of transfusion recipients participating 
in the same study (n=6 studies in total,(Cheung et al., 2014; Shah et al., 2012) 
n=4 studies including surgical patients) (Davis et al., 2012b; Fitzgerald et al., 
1999; Luby et al., 2001; Murphy et al., 1997a); 3) receiving regular 
transfusions every two to four weeks (Orme et al., 2013) or monthly (Ryblom, 
2015); or 4) receiving transfusions for anaemia (Adams et al., 2011).  
In total, 4,841 HCPs participated in included studies with a greater number of 
female HCPs (n=659) versus male (n=552) when reported in ten studies only 
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(Adusei et al., 2018; Al-Riyami et al., 2016; Francis et al., 2009a; Graw et al., 
2018; Islam et al., 2012; Lee et al., 2003; Leibovitz et al., 2004; Soares et al., 
2017; Tavares et al., 2015; Vetter et al., 2014). Age ranged from 20 years to 
65 years approximated from studies including age demographics and age 
means. Thirteen studies investigated a mix of HCP professions (Adusei et al., 
2018; Amin et al., 2004; Ferguson et al., 2001; Hartford et al., 2015; Heddle 
et al., 2012; Lee et al., 2003; Leibovitz et al., 2004; Lowe et al., 2001; Manzini 
et al., 2018; Müller et al., 2014; Salem-Schatz et al., 1990; Treloar et al., 2001; 
Vetter et al., 2014) and equally thirteen studies assessed one HCP speciality 
or seniority (i.e. physicians / consultants (Al-Riyami et al., 2016; Cozzolongo 
et al., 2005; Ddungu et al., 2018; Francis et al., 2009a; Islam et al., 2012; von 
Babo et al., 2018), surgeons (Torella et al., 2001), GPs (D'Souza et al., 2004; 
Thonneau et al., 1991), nurses (Graw et al., 2018; Tavares et al., 2015), 
anaesthesiologists (Soares et al., 2017) and hospital managers or 
representatives (Graham et al., 2002). HCPs had between 1 and 15 years + 
reported clinical experience (Francis et al., 2009a; Leibovitz et al., 2004; 
Manzini et al., 2018; Tavares et al., 2015; Vetter et al., 2014).  
2.3.3 Research designs and assessment approaches 
Cross-sectional designs were most common, using participant self-report 
questionnaires (Adusei et al., 2018; Al-Riyami et al., 2016; Amin et al., 2004; 
Cheung et al., 2014; Court et al., 2011; Davis et al., 2012b; Ddungu et al., 
2018; Graham et al., 1999; Graw et al., 2018; Hartford et al., 2015; Khan et 
al., 2012; Lee et al., 2003; Lee et al., 1997; Leibovitz et al., 2004; Lowe et al., 
2001; Luby et al., 2001; Manzini et al., 2018; Müller et al., 2014; Murphy et 
al., 1997a; Salem-Schatz et al., 1990; Shah et al., 2012; Soares et al., 2017; 
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Tavares et al., 2015; Thonneau et al., 1991; Vetter et al., 2014; von Babo et 
al., 2018) (Table 2). Some included studies reported pilot testing all or some 
of the materials (14 HCP studies (D'Souza et al., 2004; Ddungu et al., 2018; 
Francis et al., 2009a; Graham et al., 2002; Hartford et al., 2015; Heddle et al., 
2012; Islam et al., 2012; Lee et al., 2003; Leibovitz et al., 2004; Salem-Schatz 
et al., 1990; Soares et al., 2017; Tavares et al., 2015; Treloar et al., 2001; von 
Babo et al., 2018) and four patient studies (Cheung et al., 2014; Davis et al., 
2012b; Lee et al., 1997; Ryblom et al., 2015)). Four studies reported the use 
of validated study materials (Court et al., 2011; Ryblom et al., 2015; Tavares 
et al., 2015; Vetter et al., 2014). Materials were published in reports of 
fourteen studies (Adams et al., 2011; Al-Riyami et al., 2016; Amin et al., 
2004; Cheung et al., 2014; Ddungu et al., 2018; Francis et al., 2009a; Graw 
et al., 2018; Islam et al., 2012; Khan et al., 2012; Manzini et al., 2018; Murphy 
et al., 1997a; Orme et al., 2013; Torella et al., 2001; von Babo et al., 2018) 
and additional materials were received from seven study authors (Adusei et 
al., 2018; Heddle et al., 2012; Lee et al., 1998; Luby et al., 2001; Moxey et 
al., 2005; Müller et al., 2014; Ryblom et al., 2015) of 27 who were contacted.  
2.3.4 Quality appraisal of included studies 
Overall, the quality of the set of included studies was moderate to high. 
Quality appraisal ratings ranged from 45-100%. Seventeen studies (Adams et 
al., 2011; Amin et al., 2004; Court et al., 2011; Ddungu et al., 2018; Francis 
et al., 2009a; Graham et al., 1999; Graw et al., 2018; Islam et al., 2012; Lee 
et al., 1997; Manzini et al., 2018; Moxey et al., 2005; Orme et al., 2013; 
Ryblom et al., 2015; Salem-Schatz et al., 1990; Soares et al., 2017; Tavares 
et al., 2015; von Babo et al., 2018) scored higher than 90%, with 90% 
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considered by the review team members as the threshold indicating a high-
quality study. Studies detailing steps taken to analyse and verify the data 
received, for example, received high-quality assessment scores of more than 
90%. Studies where explanation was not provided of how the participants 
were selected, to ensure less biased response, received low scores (<65%) 
(Cozzolongo et al., 2005; Khan et al., 2012; Shah et al., 2012; Thonneau et 
al., 1991; Torella et al., 2001).  
2.3.5 Time points patients’ perceptions assessed (in relation to the 
transfusion) 
Besides the five studies investigating the perceptions of patients being 
‘prepared for a transfusion’ (Cheung et al., 2014; Graham et al., 1999; Khan 
et al., 2012; Lee et al., 1998; Lee et al., 1997), only three studies reported the 
time point at which the patients’ perceptions were assessed. This was either 
within 48 hours of the transfusion (Davis et al., 2012b), ‘about 24 hours after 
the transfusion’ (Adams et al., 2011) (i.e. post-transfusion inpatients) and 
before and after (day 1, 2, 3, 4 and 7) a two-unit red blood cell transfusion 
(Ryblom et al., 2015). The majority of patient studies, however, did not report 
investigating patients’ perceptions before transfusion, and no study reported 
assessing patients’ perceptions during transfusion with recruitment targeted 
to inpatients who have received transfusions (Adams et al., 2011; Davis et al., 
2012b; Fitzgerald et al., 1999; Luby et al., 2001; Murphy et al., 1997a; Shah 
et al., 2012).  
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2.3.6 Blood components, donation methods or alternatives 
investigated 
The majority of study authors (n=24, 58%) did not report which blood 
component, donation method or alternative was being investigated (Adams et 
al., 2011; Adusei et al., 2018; Al-Riyami et al., 2016; Amin et al., 2004; 
Cheung et al., 2014; Court et al., 2011; Cozzolongo et al., 2005; D'Souza et 
al., 2004; Davis et al., 2012b; Fitzgerald et al., 1999; Graw et al., 2018; 
Hartford et al., 2015; Heddle et al., 2012; Khan et al., 2012; Lee et al., 2003; 
Leibovitz et al., 2004; Luby et al., 2001; Murphy et al., 1997a; Orme et al., 
2013; Salem-Schatz et al., 1990; Shah et al., 2012; Tavares et al., 2015; 
Thonneau et al., 1991; Vetter et al., 2014). Autologous transfusion (PAD) was 
the most commonly specified donation method (n=8 studies), either 
independently  (Lee et al., 1998; Moxey et al., 2005) or compared with 
allogeneic transfusion  (Graham et al., 1999; Lee et al., 1997) and other 
alternatives (Ferguson et al., 2001; Graham et al., 2002; Lowe et al., 2001; 
Torella et al., 2001; Treloar et al., 2001). Red blood cells were investigated 
in seven studies, either in isolation (Ryblom et al., 2015; Salem-Schatz et al., 
1990; von Babo et al., 2018) or compared with alternatives (Manzini et al., 
2018; Soares et al., 2017) or the alternative of ‘monitoring’ (i.e. ‘managing a 
patient with borderline haemoglobin by watching and waiting instead of 
transfusing red cells’) (Francis et al., 2009a; Islam et al., 2012) or platelets, 
whole blood transfusion and alternatives (Ddungu et al., 2018). One study 
assessed HCPs’ perceptions of transfusion of fresh frozen plasma (FFP) 
(Müller et al., 2014). 
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2.3.7 Citation of theory 
Reliability analysis of the presence or absence of theory, and the location 
where theory was cited reached 100% agreement. Twelve unique theories 
were identified across 11 papers, including theoretical models (e.g. 
Psychometric Model of Perceived Risk (Slovic, 1987) (see Appendix 4: Table 
of theories identified in the systematic review). Three studies cited multiple 
theories (Ferguson et al., 2001; Lee et al., 1998; Lowe et al., 2001) and in 
eight papers theory was cited in the introduction and discussion as well as 
being applied in the methods to inform the design of the study or study 
materials (Amin et al., 2004; Ferguson et al., 2001; Francis et al., 2009a; 
Islam et al., 2012; Khan et al., 2012; Lee et al., 2003; Lee et al., 1998; Salem-
Schatz et al., 1990). Study authors based study materials on theory, for 
example by developing interview topic guides based on the Theoretical 
Domains Framework (TDF) (Michie et al., 2005) or survey questions to 
examine risk perceptions (Ferguson et al., 2001; Francis et al., 2009a; Islam 
et al., 2012; Lee et al., 1998; Salem-Schatz et al., 1990). Six theories 
(Theories 2-7, Appendix 4) consist of predominantly risk-related constructs 
(i.e. mental representations of hazards in terms of their dread or unknown risk 
potential) (Slovic, 1987). Thus, the theoretical basis to the existing blood 
transfusion perceptions literature focuses largely on risk.  
 Perceptions of blood transfusion   
Reliability of the extracted perceptions from 10% of papers (n= 4 papers) by 
two reviewers was between 83% and 100%, with disagreements discussed 
until 100% agreement was reached for each paper.  
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2.4.1 Inductive qualitative synthesis 
In total, 104 data points (excerpts of data containing reported perceptions) 
were extracted across the 41 studies. Data points often contained more than 
one reported perception. These reported perceptions were synthesised by BV 
into 195 initial subthemes that were then further synthesised into 13 initial 
over-arching themes. These 13 themes and subthemes were iteratively 
consolidated into six over-arching themes of perceptions of blood transfusion. 
For example, initial subthemes of ‘infection’ and ‘safety’ were combined to 
an over-arching theme labelled ‘safety/risk’. ‘Concern/worry’ and 
‘fear/dread’ subthemes were consolidated into an over-arching theme labelled 
‘Negative emotions’. The final six themes contained 25 subthemes and can 
be considered as either cognitive or emotional (‘Safety / risk,’ ‘Negative 
emotions’, ‘Alternatives’, ‘Health benefits’ and ‘Necessity’) or behavioural: 
‘Decision making’. Cognitive or emotional themes contain patients’ and 
HCPs’ perceptions as either thoughts or emotions experienced or 
hypothetically considered in relation to transfusion. For the ‘Decision 
making’ theme the content represents perceptions that may result in 
behaviours, which are observable in the clinical setting (e.g. patients not 
questioning transfusion decisions, HCP prescribing behaviours). 
Data points from the findings of papers included in the updated searches 
(n=32 of 104) were embedded into the existing thematic structure, with new 
subthemes generated when the data could not be coded into the existing 
structure of themes/subthemes. Table 3 shows the six themes and their 
subthemes. New subthemes generated from the latest search have been 
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marked with a *. Example quotes for each subtheme are provided in 
Appendix 5: Themes and subthemes identified in Study 1 inductive synthesis. 
Table 3 Perceptions of blood transfusion: inductive synthesis themes and 
subthemes 
Themes 
Safety / risk Negative 
emotions 







































































































































    
* new subtheme generated from updated search results 
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Summary of themes 
Safety / risk: Patients and HCPs reported a low perceived risk of contracting 
an illness from contaminated blood (Graham et al., 2002; Graw et al., 2018; 
Lee et al., 1997; Lowe et al., 2001; Moxey et al., 2005), with one study 
reporting decreases over time in GPs’ perceptions of blood transfusion risk 
(Cozzolongo et al., 2005). Blood transfusion was ranked as having low / 
intermediate risk in comparison to other hazards (e.g. skiing, alcohol, nuclear 
reactors (Ferguson et al., 2001; Lee et al., 2003) ) and treatments (e.g. surgery 
or anaesthetic) (Court et al., 2011; Fitzgerald et al., 1999). Platelets were 
associated in one study with higher disease transmission risk than other blood 
components, thus used with caution (Ddungu et al., 2018). Some patients 
reported risks associated with transfusions as being somewhat acceptable and 
unavoidable (Fitzgerald et al., 1999). Some HCPs reported confidence in the 
safety of blood (Amin et al., 2004), whereas others  acknowledged potential 
danger associated with transfusion, such as  if errors (Heddle et al., 2012) or 
complications such as transfusion-associated circulatory overload, allergic 
reactions, transfusion-related acute lung injury, bacterial contamination or 
infection-transmission occurred (Adusei et al., 2018; Manzini et al., 2018; 
Müller et al., 2014; Soares et al., 2017).  
 Negative emotions: Many factors, such as disease or infection risk (Adams 
et al., 2011; Moxey et al., 2005), adverse events (Heddle et al., 2012; Vetter 
et al., 2014) or general apprehension about receiving a transfusion (Luby et 
al., 2001) resulted in reported concern or worry in patients and HCPs. Some 
patients did not report concerns about receiving transfusions (Moxey et al., 
2005) or reported that their mood improved post transfusion (Ryblom et al., 
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2015). Some physicians reported that they would be concerned if new viral 
or bacterial threats emerged, and therefore would reduce their level of blood 
product use (Amin et al., 2004). Some HCPs reported concerns about 
watching and waiting instead of transfusing, but others reported no concerns 
(e.g. regarding potential complications of transfusions for patients) (Francis 
et al., 2009a; Islam et al., 2012).    
Alternatives: Some surgical patients, surgeons, GPs and anaesthetists 
reported preferring alternatives in order to reduce perceived risk associated 
with transfusion (Ferguson et al., 2001; Graham et al., 1999; Lowe et al., 
2001; Moxey et al., 2005). Willingness to pay for autologous transfusion 
(PAD) was also high for patients reporting dread of receiving an allogeneic 
transfusion (Lee et al., 1998; Lee et al., 1997). HCPs’ perceptions of 
considering alternatives for their patients were mixed, and influenced by 
evidence, technique complexity, patient demand, the patient’s condition and 
perceptions of free and safe blood supplies (Francis et al., 2009a; Graham et 
al., 2002; Islam et al., 2012; Torella et al., 2001; Treloar et al., 2001).  
Health benefits: Patients receiving transfusions monthly for Myelodysplastic 
syndromes (MDS) reported that transfusions restored their physical and 
mental strength and eased symptoms such as breathlessness, fatigue and 
headaches (Ryblom et al., 2015) and there was evidence of benefits 
outweighing risk for some patients (Fitzgerald et al., 1999). However, some 
hospice and hospital inpatients also found it difficult to perceive the benefit 
of the transfusion (Orme et al., 2013), in some cases due to ill health 
associated with their medical conditions (Fitzgerald et al., 1999). For HCPs, 
while some HCPs perceived transfusion to be beneficial (Lee et al., 2003) 
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others reported that not transfusing, and instead monitoring the patient’s 
condition may reduce transfusion risks (Francis et al., 2009a; Islam et al., 
2012).  
Necessity: Patients reported understanding why their transfusions were 
necessary, such as due to blood loss or low blood counts (Davis et al., 2012b; 
Murphy et al., 1997b). Patients with MDS reported recognising when their 
transfusions were needed through exacerbation of symptoms, such as walking 
difficulties, poor concentration, heart palpitations and nausea (Ryblom et al., 
2015). HCPs considered transfusions necessary when there was an acute or 
risk of bleeding, functional deterioration and anaemia (from chemo-and/or 
radiotherapy or preoperative) (Ddungu et al., 2018; Hartford et al., 2015; 
Leibovitz et al., 2004; Manzini et al., 2018; Soares et al., 2017). For patients, 
reasons for transfusing were reported to be generalized weakness, trauma and 
surgery (Luby et al., 2001). 
Decision making: HCPs reported making transfusion decisions on a case-by-
case basis (Francis et al., 2009a; Islam et al., 2012; Leibovitz et al., 2004), 
with a shift from blood being considered as ‘good for everybody’ (Treloar et 
al., 2001). Decisions were reportedly influenced by cost, the patient’s age and 
health condition (e.g. coronary artery disease) or the availability of blood 
(Ddungu et al., 2018; Leibovitz et al., 2004; Salem-Schatz et al., 1990; von 
Babo et al., 2018). Haemoglobin levels, pallor and the safety of the blood 
(disease free) influenced transfusion decisions (Adusei et al., 2018; Ddungu 
et al., 2018; Hartford et al., 2015; Leibovitz et al., 2004; Manzini et al., 2018; 
Müller et al., 2014; Soares et al., 2017; von Babo et al., 2018). Physicians in 
one study reported that they were confident to carry out the transfusion 
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process (Tavares et al., 2015) and widely explained the risks and benefits of 
transfusion to patients (Al-Riyami et al., 2016). Some patients reported, 
however, that physicians often made the transfusion decisions (Adams et al., 
2011) and in one study patients after transfusion counselling reported that 
doctors relied too much on transfusion (Khan et al., 2012). Some patients in 
a low-income country would not consent to transfusion due to infection risk 
(Shah et al., 2012).  
2.4.2 Changes in perceptions over time 
Figure 5 displays the distribution of themes for broadly each 5-year period of 
study publication. This shows that all themes have been sporadically 
investigated since 1984 with less publications on this topic pre-1996 and 
during 2006-2010. Topics within the theme of ‘Safety/Risk’ are the most 
consistently investigated, with a surge of research into ‘Decision making’ and 
‘Necessity’ post 2011. ‘Negative emotions’, ‘Alternatives’ and perceptions of 
‘Health benefits’ have had some investigation during the middle to late 20-
year period of this timeline, but this has declined most recently since 2016.  
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Figure 5 Systematic review reported themes of perceptions by publication 
years 
2.4.3 Relationship between themes 
Relationships between the themes were identified (synthesis stage 4) and 
represented in a conceptual model of blood transfusion perceptions (Figure 
6) to portray the relationship between the themes. The themes were 
recognised as constructs in the model that are either cognitive or emotional, 
with the behavioural ‘Decision making’ construct positioned to the right of 
the model.  
The arrows connecting the cognitive or emotional constructs depict 
relationships; ‘Alternatives’ and ‘Safety/risk’ share relationships with 
‘Negative emotions’ due to patients and HCPs holding negative emotions 
about potential transfusion risks and this influences their preferences for 
alternatives, which are considered in terms of their safety. ‘Health benefit’ 
and ‘Safety/ risk’ are directly connected as the benefit of transfusion often 
also outweighed risk concerns (Fitzgerald et al., 1999). All of the cognitive 
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represented by the central arrow. For example, ‘Negative emotions’ 
influences ‘Decision making’ through ‘Safety/risk’, with concerns about the 
safety of blood influencing decision making for HCPs (Amin et al., 2004) and 
patients also directly accepting blood due to the potential benefits (Davis et 
al., 2012b), creating an association between ‘Health benefits’ and ‘Decision 
making’. ‘Alternatives’ and ‘Necessity’ also naturally link to ‘Decision 
making’ due to the consideration of alternatives and transfusion necessity 
based on patients’ clinical conditions.
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Figure 6 Conceptual model of blood transfusion perceptions 
Constructs linked with single headed arrows indicating a causal relationship, double headed dashed arrows indicate a bi-directional relationship. Themes adjacent to the construct are shaded as 
indicated in key.
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 Discussion 
This systematic review included 41 studies reporting adult patients’ and 
HCPs’ perceptions of blood transfusion. The studies in this review were 
generally of moderate to high quality methodologically and included a range 
of theories, mostly related to ‘risk’ in parallel with the consistent reportage of 
‘risk’ related perceptions across the timelines of papers. The synthesis of the 
reported perceptions highlighted that patients and HCPs viewed transfusion 
with low to moderate risk, but that some perceptions of transfusion-associated 
risk, or negative emotions, were associated with the use or consideration of 
transfusion alternatives. Some patients perceived benefit from transfusion 
(Davis et al., 2012b; Murphy et al., 1997a; Ryblom et al., 2015), however, 
other patients found the benefit difficult to discern due to the impact of their 
illness (Fitzgerald et al., 1999; Orme et al., 2013). It was also reported that 
HCPs led the decision making (Adams et al., 2011), yet as reported in one 
paper, involved patients to provide information about the benefits, risks and 
alternatives associated with transfusion (Al-Riyami et al., 2016). The 
emergent over-arching themes about blood transfusion perceptions were 
organised into a conceptual model of blood transfusion perceptions with five 
cognitive or emotional constructs antecedent to the construct of ‘Decision 
making’.  
The context of studies in the review bears consideration due to its likely 
influence on the findings. Most studies investigated the perceptions of 
patients receiving or being prepared for transfusions in relation to surgery. 
Transfusion recipients commonly had their perceptions investigated post 
transfusion, and studies with HCPs most often included mixed groups. As 
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more transfusions are reportedly used in medical contexts, such as emergency 
and haematology compared to surgical, (64% medical vs. 29.4% surgical; red 
blood cell transfusion use in North England, 2004) (Wallis et al., 2006) some 
patient and HCP groups may have been under-represented. For example, 
emergency transfusion patients were identified in only two studies (Fitzgerald 
et al., 1999; Luby et al., 2001), and haematology patients in five studies (n=3 
studies with mixed patient samples: (Adams et al., 2011; Cheung et al., 2014; 
Davis et al., 2012b) and two studies either conducted in a day hospice setting 
(Orme et al., 2013) or in Sweden, with findings only codable to the themes of 
‘Health benefits’ and ‘Necessity’ (Ryblom et al., 2015) ). Thus, there is a gap 
in a more detailed investigation of perceptions from specific patient and HCP 
groups, including emergency or regular recipients of transfusion.  
This review also failed to identify papers reporting demographic data of 
patients’ religions, making it unclear whether patients who oppose transfusion 
based on their religious beliefs, such as Jehovah’s Witnesses, were involved 
in included studies. In addition, whether patients and HCPs held different 
perceptions of transfusion per blood component or for alternatives was 
difficult to determine as the blood component being investigated was not 
specified in 24 studies. For these studies, HCPs may have been considering 
different blood components than their colleagues when reporting their 
perceptions, or patients may not have been aware of the blood component 
being transfused. If patients lacked information about the risks or reasons for 
the transfusion or specific blood component being offered, this would impact 
their ability to fully evaluate the treatment’s efficacy compared to any 
alternatives (Horne, 2003). Lack of understanding of a proposed treatment’s 
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necessity, alongside patients’ concerns being unaddressed could impact 
treatment uptake (Horne et al., 2013).  
Theories containing risk constructs were most frequently cited in this 
literature, however, the most recent study citing a theoretical underpinning 
was in 2012 (Islam et al., 2012). Whilst blood transfusion is a treatment 
associated with risk (Eder et al., 2013; Llewelyn et al., 2004), patients and 
HCPs perceived the risk of contracting an illness from a blood transfusion as 
low (Graham et al., 2002; Lee et al., 1997; Lowe et al., 2001). Yet, when 
surveyed, patients’ and HCPs’ perceptions of blood transfusion risks (e.g. 
infection contraction or adverse events) were associated with negative 
emotions (Moxey et al., 2005; Vetter et al., 2014). The systematic review 
identified by the search (Ngo, 2013) focussed on identifying studies that 
‘measured or discussed’ transfusion risk perceptions with a broader range of 
‘stakeholders’ beyond patients and HCPs (e.g. blood donors, journalists) 
(N=15 studies included). Whilst this was inclusive to broader groups, 
focusing on ‘risk’ alone ignores the balance and careful risk vs benefit trade 
off that patients and HCPs have to make when encountering real transfusion 
scenarios (Fitzgerald et al., 1999). Risk and benefit, for example, are also 
elements of transfusions informed consent discussions, per UK guidance 
(JPAC, 2019; SaBTO, 2011), alongside discussing ‘possible alternatives to 
transfusion’. Therefore, this current review went beyond the (Ngo, 2013) 
review and sought to inductively identify a broader range of transfusion 
perception themes from a larger amount of studies across a 35-year 
timeframe, considering the relationship between themes.  
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Strengths of this review include the development of a conceptual model of 
blood transfusion perceptions, which makes the themes of perceptions 
potentially more accessible, through visual presentation where key 
relationships between constructs can be portrayed. Half of the six constructs 
in the model were ‘shared’ and included both patients’ and HCPs’ 
perceptions. This highlights a moderate level of similarity in how patients and 
HCPs perceive transfusion, (e.g. a level of correspondence in broad thematic 
areas, such as safety/risk), although some patients’ concerns related to disease 
or infection risk from blood transfusion (Adams et al., 2011; Moxey et al., 
2005) were elevated in comparison to reported HCP concerns, which were 
more linked to the possibility of adverse events, such as allergic reactions 
(Vetter et al., 2014). Gaps in a shared understanding of all themes identified 
by this review support further joint investigation of both groups’ perceptions, 
strengthening patient-HCP collaboration, such as when executing shared 
decision-making (Toledo, 2014).  
Some methodological considerations are potential limitations of this review. 
There is debate in the literature about the feasibility of conducting syntheses 
of qualitative evidence (Dixon-Woods et al., 2005). Conversion of 
quantitative evidence to qualitative themes is similarly somewhat 
controversial (Dixon-Woods et al., 2005). In this review, an approach was 
taken whereby quantitative data, usually descriptive frequency data, were 
used during the interpretation of the results, for example, when considering 
how prevalent, thus important, a perception was. Themes were then 
summarised with these data in mind, for example, that transfusion was 
perceived with ‘low to intermediate risk’.  
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These review findings could be used to inform clinical practice and future 
research. For clinical practice, the findings of this review can be used by 
HCPs when discussing transfusion decisions with their patients in 
consultations, with the identified themes converging with UK transfusion 
guidance (e.g., discussing transfusion risks, benefits and possible alternatives 
with patients) (JPAC, 2019; SaBTO, 2011). This guidance stipulates that 
patients should be aware of the indication for transfusion and type of blood 
component to be used, all being advocated by this programme of research and 
a key data extraction item of the included studies in this review. Beyond UK 
guidance, some low- and middle-income countries were also represented in 
the results, with these countries having lower resources and differing levels 
of risk exposures. However, this review identified similar perceptions across 
countries; that some patients in a low-income country held concerns about 
transfusion because of perceived risks (Shah et al., 2012), indicating that 
greater discussion of these themes would be widely beneficial. Studies from 
low- (Uganda) and middle-income countries (Ghana) in this review 
recommended physician transfusion training to be added to their medical 
institution training, with a specific focus on transfusion decision making 
(Adusei et al., 2018; Ddungu et al., 2018). Such in-service training could 
address culturally specific practices and norms and highlight specific 
perceptions to be investigated further.  
In terms of the development of future research, a key gap in the review was 
the extent to which theory was used. Subsequent studies in this programme 
of research were informed by theory, beginning with an exploration of the 
extent to which themes identified in this inductive synthesis corresponded 
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with constructs of treatment perceptions in the broader treatment perceptions 
literature (Chapter 3). This provided a basis for qualitatively exploring blood 
transfusion perceptions from an under-researched clinical area where 
knowledge gaps exist (e.g. perceptions from haematology care settings) 
(Study 2/ Chapter 4). Haematology settings administer transfusions to 
patients on a routine basis, with patients often receiving repeated transfusions 
for cancer-related diagnoses or long-term blood disorders. Qualitative 
research is often used to investigate in detail peoples' perceptions of their 
health issues and has been minimally used in blood transfusion perception 
research to date (n=11 of 41 studies). Greater use of qualitative research is 
advocated in transfusion medicine to generate findings that can enhance the 
safety and quality of the blood system (Whittaker, 2002). The final study in 
this programme of research (Study 3) built on its preceding Study 2 to 
investigate transfusion healthcare delivery further, in view of optimising 
patients’ transfusion services (Study 3/ Chapter 5).   
In conclusion, this systematic review identified cognitive, emotional and 
behavioural themes of blood transfusion perceptions, themes that were shared 
by a wide range of patients and HCPs. Represented as a conceptual model, 
the complete set of ‘Cognitive and emotional’ constructs may be associated 
with observable behaviours resulting from ‘Decision making’ in clinical 
practice. This may signal areas for discussion or consideration in relation to 
transfusion decision making, consistent with recommended UK guidance 
(JPAC, 2019; SaBTO, 2011).  The blood transfusion constructs are discussed 
further in the following Chapter 3, in relation to their link to the treatment 
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perceptions literature and gaps from this review will be addressed in Study 2 
(Chapter 4). 
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3 Mapping of blood transfusion perceptions constructs with 
treatment perceptions frameworks.  
This chapter presents a comparison of constructs from the conceptual model 
of blood transfusion perceptions developed in the systematic review (Chapter 
2) and constructs from key treatment perceptions frameworks. This 
comparison was undertaken to evaluate how the inductively developed 
constructs comprising the blood-transfusion conceptual model align with the 
broader treatment perceptions literature. 
 Background 
In the early 1960s psychologists began investigating fearful disease 
communication and responses to health threats. This led to the identification 
of cognitive representations of danger (e.g., disease threat), distinguished 
from plans that people in turn form as protective responses (Leventhal, 1970; 
Leventhal et al., 1997). As people seek to apply common-sense to threats they 
face, they construct detailed representations of their health threats (illnesses 
and symptoms) to generate goal directed behaviours for self-management 
(such as taking treatments), goal attainment and response efficacy (Leventhal 
et al., 2003). As described in Chapter 1, the five core dimensions of illness 
representations (illness identity, cause, time-line, consequence or cost and 
cure/control) have been integrated into a five-component measure to assess 
peoples’ underlying cognitive illness representations; The Illness Perceptions 
Questionnaire (IPQ) (Weinman et al., 1996). The IPQ and its revised version 
(IPQ-R) (Moss-Morris et al., 2002) have been widely applied to investigate 
perceptions across a range of illness populations, such as for patients with 
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cancer, endocrine, nutritional and metabolic diseases and mental and 
behavioural disorders etc., (Broadbent et al., 2015). It is argued, however, that 
the five dimensions of illness representations can also be used to 
conceptualise treatments; identity (e.g., label of how to use / take), cause (e.g., 
how it works), time-line (till benefits apparent), consequence or cost (e.g., 
side effects) and cure/control (i.e. potential to cure illness) (Leventhal et al., 
1997; Leventhal et al., 2010). Thus, instead of viewing treatments as a means 
of ‘curing’ or ‘controlling’ a condition, a broader range of perceptions could 
be considered, e.g., perceptions of treatment benefits and side effects. This 
would help to acknowledge these factors and the role that these perceptions 
may have in treatment selection and adherence.  
Researchers continuously seek to investigate patients’ treatment perceptions, 
understanding that these perceptions have an influence on health outcomes, 
such as adherence (Horne, 1999). There are numerous models and measures 
available to investigate patients’ treatment perceptions, one of which is the 
widely used Beliefs about Medicines Questionnaire (BMQ) (Horne et al., 
1999b). The BMQ is of interest in the current context, as although not a 
‘medicine’, such as drugs taken in tablet form, transfusions are prescribed by 
healthcare professionals (HCPs) with the intention to treat ill or injured 
patients. Transfusions should be prescribed, as with medicines, in line with 
the patient’s clinical need and consideration of risks and alternative 
treatments. Patient informed consent is also sought prior to or retrospectively 
when transfusions are administered (JPAC, 2019). Thus, their beliefs about 
transfusions are key to decision making.  
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The BMQ was constructed using a factor analysis of themes related to 
patients’ medicine-related beliefs identified in published studies and 
qualitative interviews with chronically ill patients. The BMQ assesses beliefs 
related to specific medicines, in particular of the ‘Necessity’ of prescribed 
medicines: ‘Beliefs about the necessity of the medicines for maintaining 
health’, ‘The perceived role of medication in protecting against deterioration 
of the present and future health status of the patient’ and of ‘Concern’ about 
prescribed medicines: ‘having to take my medicines worries me; my 
medicines are a mystery to me’ (Horne et al., 1999b). A separate section 
covers medicine beliefs in general: General-Harm: ‘Themes relating to the 
nature of medicines’ and General-Overuse: ‘How medicines are used by 
doctors’ (Horne et al., 1999b). ‘Necessity’ and ‘Concern’ beliefs about 
specific medicines provide evidence for a Necessity-Concerns framework, 
where higher adherence is associated with stronger perceptions of the 
necessity of the treatment and fewer concerns about treatment (Horne et al., 
2013).  
Studies conducted using the BMQ have been able to identify strong 
associations between medication beliefs and adherence, with patients less 
likely to take their medicines as prescribed if they hold concerns about them 
(Pound et al., 2005). In a study of stroke patients, non-adherent patients 
scored lower on positive beliefs about medicines and higher on negative 
beliefs (Sjölander et al., 2013). Thus, the BMQ can be considered as a useful 
instrument to assess patients’ beliefs, which can then be discussed in 
consultations, such as concerns about adverse effects (Neame et al., 2005). 
Other researchers have used the BMQ as a framework for adapting surveys 
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to asses beliefs about specific treatments and clinical interventions, such as: 
beliefs about surgery (Francis et al., 2009c), beliefs about deferoxamine 
(chelation therapy with a slow pump infusion) versus oral iron chelators 
(Trachtenberg et al., 2012) and as identified in the preceding systematic 
review (Chapter 2), to develop a Beliefs about Transfusion Questionnaire 
(Khan et al., 2012). 
Whilst there appears to be value in adapting the BMQ, there are also other 
instruments and frameworks that have been developed to investigate 
treatment perceptions in specific patient populations. The Treatment 
Representations Inventory (TRI) was developed to explore treatment 
representations in a coronary artery disease (CAD) population (Hirani et al., 
2008). The TRI explores patients’ emotional concerns of managing 
treatments, decision satisfaction and cure. During validation of the TRI, 
correlations between treatment concerns and the remaining subscales were 
not found; indicating that whilst patients may be worried about their 
treatment, they may also value it and hold optimistic outcome expectancies 
(Hirani et al., 2008).  
The range of subscales in the BMQ and TRI indicate that a variety of 
treatment beliefs could be held by patients, including beliefs covering 
‘decision-making’ related domains (‘decision satisfaction’ from the TRI). 
The medicine taking literature also presents the broad range of potential 
decision-making beliefs. Literature from this field profiles medicine users as 
active or passive accepters of medicines, either consciously deciding to take 
their medicines as prescribed or relinquishing control over medicine taking 
(Dowell et al., 1997; Johnson et al., 1999) . It is also noted that people may 
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modify or reject their treatment regimens, often after a period of testing 
(Johnson et al., 1999).  
Some patients may conclude that complementary alternatives and alternative 
medicines are more suitable to treat their conditions. The complementary and 
alternative medicine beliefs inventory (CAMBI) was developed to assess 
patients’ beliefs in natural treatments, participation in treatment and holistic 
health (Bishop et al., 2005). For instance, ‘Beliefs in natural treatments’ 
examines patients’ beliefs about treatments being non-toxic, using natural 
ingredients and having no negative side effects. The ‘participation in 
treatment’ scale is used to assess patients’ views on the extent that HCPs 
should solely make treatment decisions or seek to involve their patients 
(Bishop et al., 2005). The CAMBI may be relevant for blood transfusion, due 
to blood being derived from human donors, yet donor blood is processed, and 
transfusions are known to be associated in some cases with negative side 
effects (e.g., infections and reactions).  
Taken together, the different instruments offer a broad range of frameworks 
for conceptualising and assessing treatment perceptions. It is important to 
consider how the six blood transfusion perception constructs from the 
systematic review conceptual model (Chapter 2) align to the broader 
treatment perceptions literature. A comparison of the transfusion constructs 
with constructs from frameworks and items from published measures in the 
broader literature would help establish the extent to which the blood 
transfusion constructs correspond with constructs and items from other 
treatment perceptions  frameworks and measures.   
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Considering how the transfusion conceptual model constructs relate to the 
broader treatment perceptions literature would help to establish which 
frameworks may provide explanatory value to the understanding of blood 
transfusion perceptions. Key constructs to explore going forward when 
investigating transfusion perceptions may come to light, as well as unique or 
specific perceptions, relevant only to the transfusion context.  
If the blood transfusion perceptions constructs hold convergence with the 
broader literature, this would support ongoing use of the conceptual model as 
a structure to consider blood transfusion perceptions within (i.e. that key 
‘treatment perceptions constructs’ are not being missed by utilising the blood 
transfusion conceptual model going forward). This would maintain use of the 
transfusion constructs, which profile specific perceptions of transfusion from 
a range of studies, potentially worthwhile to explore further and not abandon. 
Items from published measures may also add value for ongoing qualitative 
research. Learning can be taken from the description of quantitative item and 
applied to the transfusion context, preventing quantitative items being purely 
translated into qualitative questions without recourse to earlier literature.  
3.1.1 Chapter objective and methods 
This chapter aimed to map the blood transfusion conceptual model constructs 
to constructs from broader treatment perceptions frameworks and items from 
published measures to explore potential comparisons.  
The researcher (BV) conducted this process by mapping the extent that each 
blood transfusion conceptual model construct corresponded with treatment 
perceptions constructs and items in recognised treatment perceptions 
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frameworks and published measures, either fully, partially or ‘no-match’. Full 
mapping indicates that the constructs / items aligned (e.g. ‘Health benefits’ 
and a construct named ‘Benefits’, which is inclusive of considering health 
related benefits). Partial mapping indicates that some similarity between the 
constructs / items exists, however, the construct definitions do not fully match 
(e.g. ‘Alternatives’ and a construct / items largely covering perceptions of 
‘holistic health and wellness’). No match indicates that the constructs / items 
do not correspond in that instance and that they are conceptually unique (e.g. 
‘Decision making’ and ‘Risk’). Descriptions of treatment perceptions 
constructs or items aided the researcher to make mapping decisions. For 
example, if two constructs held some similarity, in that part of the description 
from the treatment perceptions construct held similarity to the blood 
transfusion construct, the overall mapping for the constructs would be 
considered ‘partially’ matched. The mapping decisions were reviewed by an 
additional team of two Health Psychologists and discussed until full 
agreement was reached.  
The researcher identified five frameworks and published measures for 
comparison based on their relevancy to the treatment perceptions literature: 
1) the Beliefs about Medicines Questionnaire (BMQ) (Horne et al., 2004; 
Horne et al., 1999b) supported with the available items from the Khan, 
Watson and Dombrowski (2012) Beliefs about Transfusion Questionnaire 
(Khan et al., 2012); 2) the complementary and alternative medicine beliefs 
inventory (CAMBI) (Bishop et al., 2005); 3) the treatment representations 
framework (Leventhal et al., 1997; Leventhal et al., 2010); 4) the Treatment 
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Representations Inventory (TRI) (Hirani et al., 2008) and 5) a model of 
medicine taking (Pound et al., 2005).  
 Results 
Table 4 presents the mapping results, with green cells indicating full mapping 
between the constructs and items, orange cells indicating partial mapping and 
blank to indicate no match. A confirmatory tick mark is displayed in the full 
and partially mapped cells. Summaries of the mapping per framework are 
provided subsequent to the table.  
Following the table, there will be a more detailed description of each 
framework or measures’ overlap with the transfusion constructs followed by 
a section summarising the overlaps and discussing patterns across the models. 
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Table 4 Mapping of treatment perceptions and blood transfusion perceptions constructs 
 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Beliefs about Medicines Questionnaire items (Horne et al., 1999b) (Beliefs about transfusion questionnaire (BTQ) (Khan et al., 2012) constructs added to relevant 
domains by researcher, no guidance available in publication) 
 indicates correspondence 
General-Harm 
Themes relating to the nature of 
medicines: 
• Most medicines are addictive 
• Medicines do more harm 
than good 
• People who take medicines 
should stop their treatment for 
a while every now and again 
• All medicines are poison 
 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
• Blood Transfusion 
Questionnaire (BTQ): Blood 
transfusion can result in new 
health problems / Transfusions 
should only be a last resort 
 
      
General-Benefit 
Individuals’ beliefs about the 
potential benefits of medicines 
(Horne et al., 2004) 
• In most cases the benefits of 
medicines outweigh the risks 
• Medicines help many people 
to live better lives 
 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
General-Overuse 
How medicines are used by 
doctors: 
• If doctors had more time with 
patients they would prescribe 
fewer medicines 
• Doctors use too many 
medicines / place too much 
trust on medicines 
• Natural remedies are safer 
than medicines 
      
BTQ: Doctors rely too much on 
transfusion / Doctors are too 
quick to suggest transfusion / 
People are not always told there 
are alternatives to transfusion 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Specific-Concerns: 
Concerns about the medicine 
(emotional: having to take my 
medicines worries me; 
cognitive: my medicines are a 
mystery to me) 
• I sometimes worry about the 
long-term effects of my 
medicines 
• I sometimes worry about 
becoming too dependent on 
my medicines 
• My medicines disrupt my life 
 
 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Specific-Necessity: 
Beliefs about the necessity of 
the medicines for maintaining 
health 
The perceived role of 
medication in protecting against 
deterioration of the present and 
future health status of the patient 
• My health at present / in the 
future, depends on my 
medicines 
• My life would be impossible 
without my medicines 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
• Without medicines I would be 
very ill 
• My medicines protect me from 
becoming worse 
      
Treatment representations dimensions (Leventhal et al., 1997; Leventhal et al., 2010) 
 indicates correspondence 
• Identity (e.g., label of how to 
use / take it: my treatment will 
return me to my normal life) 
      
• Cause (e.g., works by 
removing, killing or 
neutralising pathogenic 
material: my treatment is a 
very technical procedure) 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
• Time-line (e.g., when and for 
how long to take: the benefits 
of my treatment take a while 
to become apparent) 
      
• Consequence or cost (e.g., 
symptoms or side effects, 
physical damage, addiction, 
financial costs etc., my 
treatment produces many side 
effects) 
      
• Cure/control (e.g. cure and 
control of symptoms and 
objective indicators of disease: 
my treatment will cure my 
illness) 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Treatment Representations Inventory (TRI) (Hirani et al., 2008) 
 indicates correspondence 
• Treatment value (benefit of 
treatment in controlling or 
arresting CAD (e.g. My 
treatment will bring my illness 
under control, my treatment 
will increase my lifespan / 
longevity) 
      
• Treatment concerns (anxiety 
and worry about the treatment 
(e.g. when I think of my 
treatment I feel anxious, My 
treatment may lead to many 
medical complications) 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
• Decision satisfaction 
(satisfaction with and 
suitability of treatment chosen 
(e.g. I fully understand what 
the treatment entails, the 
discomfort and effects of my 
treatment will be worthwhile 
given the benefits I am going 
to receive from it). 
      
• Cure (ability of treatment to 
remove the disease (e.g. I 
believe my treatment will 
return me to a normal life, my 
treatment will last a short 
time) 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
The complementary and alternative medicine beliefs inventory (CAMBI) (Bishop et al., 2005) 
 indicates correspondence 
Beliefs in holistic health 
E.g., 
• Health is about harmonizing 
your body, mind and spirit 
• Imbalances in a person’s life 
are a major cause of illness 
• Treatments should focus on 
people’s overall well-being 
      
Beliefs in holistic treatments 
• It is important for treatments 
to boost my immune system 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
• Treatments should enable my 
body to heal itself 
• Treatments should increase 
my natural ability to stay 
healthy 
• I think my body has a natural 
ability to heal itself 
Beliefs of natural treatments 
• Treatments should have no 
negative side effects 
• It is important to me that 
treatments are non-toxic 
• Treatments should only use 
natural ingredients 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Beliefs in participation in 
treatment e.g.,  
• Treatment providers should … 
treat patients as equal 
partners / help patients make 
their own decisions about 
treatment 
• Patients should take an active 
role in their treatment 
      
Model of medicine taking (Pound et al., 2005) 
 indicates correspondence 
Passive Accepters: Passive 
Users ‘These people relinquish 
control over medicine taking’ 
(Dowell et al., 1997) 
      
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 Constructs of blood transfusion perceptions from the systematic review conceptual model 
 Safety/risk Health benefits Alternatives Negative 
emotions 
Necessity Decision making 
Constructs below from other 
treatment perception 




safety measures or 
risks associated 
with transfusion, 
such as infections, 
adverse reactions 
The physical or 
psychological 




















Reasons when to/not 
to transfuse, how the 
transfusion decision 
was made or 
communicated, and 
the patients' role in 
that process. 
Active Accepters: Purposeful 
adherence ‘A conscious decision 
to take drugs as prescribed’ 
(Johnson et al., 1999) 
      
Rejecters: Rejecters/ skeptics or 
purposeful non-adherence e.g. 
‘A conscious decision not to 
take the drugs, possibly 
following a period of testing 
(Johnson et al., 1999) 
      
Modifiers: e.g. ‘Active users’ 
consciously decide to modify 
the regimen, following 
deliberation and testing. 
      
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3.2.1 Mapping summary: 
3.2.1.1 The Beliefs about Medicines Questionnaire (BMQ)  
The BMQ items (Horne et al., 2004; Horne et al., 1999b) mapped fully in 
seven instances and partially in five instances to all six of the systematic 
review (Chapter 2) conceptual model constructs. The BMQ ‘Harm’ item 
mapped fully to the blood transfusion ‘Safety/risk’ construct as patients and 
HCPs in the included review studies identified risks (potential harms) 
associated with transfusion, such as ‘adverse reactions’ and ‘illness 
contraction’. The BMQ ‘Benefit’ item mapped fully with the ‘Health 
benefits’ construct with patients in systematic review studies recognising 
benefits of their transfusion, such as improved strength, reduced headaches 
and fatigue (Ryblom et al., 2015). Due to risks and benefits being evaluated 
and discussed between patients and HCPs, BMQ ‘Benefit’ was also 
considered to fully map with the conceptual model ‘Decision making’ 
construct.  
BMQ ‘Overuse’ mapped fully to the transfusion constructs of ‘Alternatives’ 
and ‘Decision making’, and partially to ‘Safety/risk’. This was because some 
patients and HCPs reported perceptions in the systematic review studies in 
favour of alternatives being considered, such as to avoid potential risks 
associated with the use of transfusion (Moxey et al., 2005). BMQ ‘Overuse’ 
mapped fully to ‘Decision making’ due to patients perceiving that HCPs led 
the transfusion decisions with limited patient involvement, where patients 
may be less informed of other potential alternatives (Adams et al., 2011). In 
the BMQ ’Overuse’ item, natural remedies are conceptualised as being safer 
than medicines, this partially maps to ‘Safety/risk’ as alternatives to 
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transfusions may be considered as safer than transfusion in some cases. This 
received a partial rating as there is was less evidence in the systematic review 
of a natural alternative, except possibly ‘watching and waiting’ in certain 
circumstances being viewed as the safer option by HCPs than transfusing 
(Francis et al., 2009b; Islam et al., 2012).  
The BMQ subscale ‘Necessity’ was mapped fully with the construct of 
‘Necessity’ and partially with ‘Health benefits’ and ‘Decision making’ from 
the systematic review. Patients reported understanding why their transfusions 
were necessary and their symptoms signalled to them their upcoming 
transfusion need, with transfusion providing patients with health benefits, 
such as alleviating their symptoms (Davis et al., 2012a; Murphy et al., 1997b; 
Ryblom et al., 2015). The BMQ-Necessity questionnaire items signal that 
medicines for specific conditions may be conceptualised in relation to 
protecting current and future health. This may extend scope in future studies 
to explore perceptions of current and future transfusion necessity to protect 
health, possibly identifying nuanced views between the two.  
BMQ items ‘Necessity’ and ‘Concern’ were judged to partially map onto the 
transfusion ‘Decision making’ construct. This is due to evidence from the 
Necessity-Concerns framework signalling that ‘Necessity’ and ‘Concern’ are 
factors that can underpin judgements about whether to accept prescribed 
medicines (i.e. a decision-making process); implying a consequent 
relationship between the constructs and/or items (Horne et al., 2007). BMQ 
‘Concern’ has also been fully mapped to ‘Negative emotions’, although 
‘Concern’ arguably covers ‘concern’ related emotions, with the addition of 
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‘worry’, whereas ‘Negative emotions’ encompasses broader emotions, such 
as ‘fear’ and ‘apprehension’ as identified in review studies.  
3.2.1.2 The Beliefs about Transfusion Questionnaire (BTQ) 
Item definitions were provided for BTQ items ‘Harm’ and ‘Overuse’ only 
(Khan et al., 2012). These two items mapped fully to three constructs from 
the blood transfusion conceptual model (‘Safety/risk’, ‘Alternatives’ and 
‘Decision making’) and partially to one construct (‘Necessity’). BTQ ‘Harm’ 
was fully mapped to blood transfusion constructs ‘Safety/risk’ and also 
partially to ‘Necessity’, with the BTQ ‘Harm’ item used to also explore 
whether medicines should be used as a last resort, similar to the exploration 
of transfusion as being a ‘necessity’. BTQ ‘Overuse’ mapped fully to 
‘Alternatives’ and Decision making’ from the transfusion conceptual model, 
due to HCPs often making the transfusion decisions, where alternatives may 
not be explained in detail (Adams et al., 2011).  
3.2.1.3 The treatment representations framework 
Each of the five treatment representation domains (Leventhal et al., 1997; 
Leventhal et al., 2010) mapped either fully in two instances and partially in 
three instances to two blood transfusion constructs: ‘Safety/risk’ and ‘Health 
benefits’. ‘Consequence / cost’ and partially the ‘Cause’ domain mapped to 
‘Safety/risk’ due to transfusions being recognised as having potential side-
effects, which are managed by technical procedures put into place to provide 
safe transfusions (Graham et al., 2002; Heddle et al., 2012). The ‘Cure’ 
domain was mapped fully against ‘Health benefits’ due to transfusions 
controlling and minimising patients’ symptoms. ‘Identity’ and ‘time-line’ 
were also partially mapped to ‘Health benefits’ as some patients were specific 
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about when the transfusions may help them, having formed an identity of the 
expected benefit of transfusion with an expected time-line to recognise such 
effects “... you know I feel better after, sometimes the next day I feel very 
lively.” (P8) (Orme et al., 2013).  
3.2.1.4 The Treatment Representations Inventory (TRI) 
The four TRI (Hirani et al., 2008) domains mapped in six instances to four of 
the six transfusion conceptual model constructs. ‘Treatment value’, ‘Decision 
satisfaction’ and ‘Cure’ all mapped fully with ‘Health benefits’ as patients 
report that their transfusions improve their health and there is evidence of 
patients outweighing potential transfusion risks over benefit (Davis et al., 
2012b; Fitzgerald et al., 1999; Murphy et al., 1997b; Ryblom et al., 2015). 
‘Decision satisfaction’ also mapped fully to ‘Decision making’, however, in 
the direction of potential ‘dissatisfaction’ as some patients in the review 
studies felt that they had a lack of choice or involvement in transfusion 
decisions (Adams et al., 2011). Although developed for a different patient 
population, ‘Treatment concerns’ in the TRI (anxiety and worry) mapped to 
some patients’ blood transfusion perceptions incorporated into the ‘Negative 
emotions’ construct (e.g., ‘Apprehension about receiving a transfusion), and 
‘Safety/risk’ with transfusions leading to possible complications.  
3.2.1.5 Complementary and alternative medicine beliefs inventory (CAMBI) 
The CAMBI (Bishop et al., 2005) mapped partially in seven instances to five 
of the six blood transfusion conceptual model constructs. The ‘holistic 
treatments’ and ‘natural treatments’ dimensions partially map onto the 
‘Alternatives’ construct from the blood transfusion conceptual model, due to 
patients and HCPs holding preferences towards alternatives (discussed for the 
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BMQ ‘Overuse’ and ‘Alternatives’ theme mapping). There is some evidence 
to support a partial mapping between ‘Beliefs in holistic health and holistic 
treatments’ and ‘Health benefits’ and ‘Negative emotions’ from the blood 
transfusion conceptual model; with some patients reporting general improved 
strength post transfusion and mood improvements (Ryblom et al., 2015). 
‘Participation in treatment’ from the CAMBI and ‘Decision making’ from the 
blood transfusion model are partially mapped; with HCPs reported as 
providing patients with information to make a decision (Al-Riyami et al., 
2016), yet evidence supporting full mapping to the ‘participation in treatment’ 
items is not currently found in the transfusion literature. ‘Natural treatments’ 
from the CAMBI has been partially mapped with ‘Safety/risk’ due to the 
question of whether blood components that are transfused are regarded as a 
‘natural’ treatment.  Blood components are produced by the body rather than 
generated from chemical compounds and are in that sense natural. However, 
transfused blood is medically processed (i.e. separated and treated) and 
prescribed in turn as a healthcare intervention, with links to ‘Safety/risk’ and 
possible side effects. This may lead some to not perceive blood components 
and transfusions as strictly natural.  
3.2.1.6 Model of medicine taking 
The blood transfusion conceptual model construct of ‘Decision making’ 
partially maps to perceptions associated with treatment acceptance and 
rejection from the medicine taking literature (Pound et al., 2005). In the 
systematic review, there was some evidence that patients passively accepted 
transfusion and that HCPs led the decision making (Adams et al., 2011). 
Patients were also reported to be willing, in one low income country, to reject 
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transfusions due to infection risk (Shah et al., 2012). The mappings were rated 
as partial, however, because perceptions of active accepters or modifiers 
appeared to be less present in the systematic review studies to date.  
3.2.1.7 Summary of mapping 
Overall, the Beliefs about Medicines Questionnaire (Horne et al., 2004; 
Horne et al., 1999b) items mapped to all six blood transfusion constructs from 
the conceptual model, with 12 full and partial mappings evident. The Beliefs 
about Transfusion Questionnaire (Khan et al., 2012) items supported the 
BMQ ‘Harm’ and ‘Overuse’ mapping but also provided some mapping to the 
blood transfusion construct of ‘Necessity’ ‘Transfusion should only be a last 
resort’ (Khan et al., 2012).  The remaining four frameworks mapped only 
partially to between two and four constructs from the blood transfusion 
conceptual model, with the constructs of ‘Necessity’ and ‘Alternatives’ being 
less mapped to constructs from the remaining four frameworks and measures.  
 Discussion 
The results of this mapping process have provided evidence of how the blood 
transfusion conceptual model constructs correspond widely with other 
prominent treatment perception frameworks and measures in the broader 
literature. The Beliefs about Medicines Questionnaire (BMQ) (Horne et al., 
2004; Horne et al., 1999b) items mapped most closely with the conceptual 
model constructs, with the Treatment Representations Inventory (TRI) 
(Hirani et al., 2008) and the Complementary and Alternative Medicine Beliefs 
Inventory (CAMBI) (Bishop et al., 2005) mapping to four blood transfusion 
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constructs, although in both cases failing to map to the construct of 
‘Necessity’.  
As confirmed by this mapping exercise, the constructs from the conceptual 
model provide a coherent framework, aligned to the broader treatment 
perceptions literature, to be considered in ongoing investigations of patients’ 
and HCPs’ transfusion perceptions. As presented through this mapping, the 
conceptual model constructs map broadly to the treatment perceptions 
literature, therefore the conceptual model from the systematic review can be 
contextualised in the broader literature, and although transfusion is not a 
medicine per se, it is broadly considered using the same domains as other 
medicines (BMQ) or treatments for specific conditions, such as coronary 
artery disease (TRI).  
The blood transfusion conceptual model containing the six constructs mapped 
to multiple constructs and/or items from almost all of the treatment 
perceptions frameworks and measures except the model of medicine taking 
(Pound et al., 2005). This indicates that the constructs and/or items operate 
cohesively, for example, that constructs such as ‘Safety/risk’ and ‘Health 
benefits’ are key sets of constructs to consider, jointly appearing in the other 
treatment perceptions frameworks and measures. The transfusion construct of 
‘Alternatives’, however, may be more transfusion specific as for transfusion 
there are often a number of alternative treatments which could be tried, to 
reduce risks or the requirement for a transfusion. This may not be the case for 
other conditions addressed by the models. The CAMBI (Bishop et al., 2005) 
literature, however, considers alternatives more broadly in scope of 
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alternative medicines, which may be non-toxic and promotive of a body’s 
natural healing abilities.  
Of significance to this mapping exercise was also that the construct of 
‘Decision making’ appeared in other treatment perception frameworks and 
measures. This reinforced the need for a ‘Decision making’ type construct or 
question as when considering treatments, patients and HCPs face key 
considerations about treatment choice prior to treatment initiation. Patients 
are often encouraged to be a part of their treatment choice (Malhotra et al., 
2015), making it useful to explore decision-making alongside other treatment 
perceptions. For blood transfusion, in particular, some evidence shows that 
patients may not always be involved in their transfusion decisions (Adams et 
al., 2011), making this construct essential to explore in order to ascertain 
patients’ experiences and views towards decision-making involvement. This 
mapping exercise has also revealed the possibility that some patients may 
actively accept or modify their treatments, which would be essential to 
understand due to implications this could have on a patient’s health. The 
literature indicates that patients who reject their treatments do so based on 
their ‘common sense’ implicit appraisals guiding their treatment perceptions 
and behaviours (Horne et al., 2013). 
Implications for investigating transfusion perceptions are evident following 
this mapping exercise. As the blood transfusion conceptual model construct 
of ‘Necessity’ was only mapped fully against BMQ ‘Necessity’ and BTQ 
‘Harm’ items there is value in retaining this going forward as ‘Necessity’ 
related questions can be used to elicit perceptions of treatments protecting 
present and future health. This may be a relevant construct especially for 
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repeatedly transfused patients who may arrive for their transfusions with an 
imminent need for their blood, but as a means to control a longer-term health 
condition.  
Similar to the blood transfusion construct of ‘Alternatives’, ongoing 
transfusion perceptions research would benefit from retaining broader blood 
transfusion constructs, namely ‘Negative emotions’ and ‘Safety/risk’ rather 
than reducing these to focusing on ‘Concern’ or ‘Harm’ only. Possibly 
questioning patients and HCPs broadly about their ‘downsides’ to transfusion 
would expand the exploration and incorporate any risk considerations as well 
as perceived harms. Likewise, addressing broader emotions during data 
coding would enable ‘concerns’ and other emotions, such as fear or 
apprehensions to become evident and distinguished in the analysis.   
In conclusion, the conceptual model of blood transfusion perceptions 
encompasses constructs that are consistent with treatment perception 
constructs and items in the literature. Transfusion can be largely perceived in 
the same way as other treatments, even though different in ‘nature’ from 
traditionally considered treatments (medicines, surgery etc.). This connection 
provides strength to apply this model in future blood transfusion perceptions 
studies. 
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4 Exploring perceptions of blood transfusion in haematology 
This chapter describes Study 2 of the programme of research, a qualitative 
interview study with adult patients and healthcare professionals (HCPs) 
receiving and providing transfusions in UK haematology day care units. 
Transfusions in this context are often provided on a repeated basis to patients 
with blood disorders, cancer or long-term conditions. As identified in the 
previous Chapter 3, the conceptual model of blood transfusion perceptions 
constructs align to the broader treatment perceptions literature. Therefore, the 
conceptual model constructs will be the over-arching framework of 
investigation for this study, applied to interview data collection and analysis. 
 Introduction  
4.1.1 Background 
Study 1 of this programme of research is presented in Chapter 2 and reports 
a systematic review of patients’ and HCPs’ perceptions of blood transfusion 
(Abdul-Aziz et al., 2018) (Appendix 1), where two key research gaps were 
identified. For the first gap, the review identified a limited number of studies 
that explored the perceptions of specific patient and HCP groups, such as 
patients and HCPs in emergency or haematology settings. For haematology, 
the systematic review identified two studies investigating perceptions in 
specific haematology patient sub-groups; hospice transfusion patients (Orme 
et al., 2013) and a Swedish study including patients with Myelodysplastic 
conditions only (Ryblom et al., 2015), with perceptions codable to the ‘Health 
benefits’ and ‘Negative emotions’ constructs.  
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It is important to investigate the blood transfusion perceptions of patients’ and 
HCPs’ from haematology, as this patient group receive transfusions on a 
repeated basis. This is to manage anaemia (lack of red blood cells), or 
conditions affecting red blood cells, such as Thalassaemia or types of cancer 
affecting blood cells (e.g. Leukaemia, Lymphoma and multiple myeloma) 
(NHS Choices, 2018). Patients may be enrolled onto a chronic transfusion 
programme to treat ongoing anaemia, and between 45-90% of patients with 
blood cancers such as Myeloma or non-Hodgkin’s lymphoma will require 
repeat transfusions during treatment (European Hematology Association, 
2012).  
Patients receiving transfusions on a repeated basis form a very different 
transfusion patient group to emergency one/off transfusion recipients, who 
will interact with and perceive transfusion very differently. Repeat 
transfusion patients may receive transfusions alongside other treatments and 
the transfusion may be anxiety provoking due to the persistent regularity that 
the transfusions are required (as often weekly to six weekly for many patients) 
(Trachtenberg et al., 2012). It could be argued that patients may fall into 
habitual routines with receiving repeated treatments, such as transfusions, but 
when first diagnosed many haematology cancer patients face initial concerns 
with their treatment, holding treatment expectations that are often worse than 
reality and finding it harder to come to terms with non-curative treatments 
(Randall et al., 2005).  
There is limited evidence as to how patients attending for repeated 
transfusions perceive transfusion overall as a healthcare intervention. If repeat 
transfusion patients do hold any negative perceptions of their transfusions, 
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this may influence decision making, (Abdul-Aziz et al., 2018) and adherence. 
Emergency and one/off transfusion patients will not be required to adhere to 
any transfusion schedule and form adaptive coping responses in order to do 
this. Repeat transfusion patients may disengage with their transfusion 
regimen over time with transfusions becoming less acceptable to patients, 
particularly if negative perceptions are not resolved. This is supported 
through the broader literature that treatments are accepted when patients view 
a high ‘Necessity’ of the treatment, whilst holding fewer ‘Concerns’ (Horne 
et al., 2013). In the haematology context there may be limited or no alternative 
options to the transfusion available, so patients may benefit from learning to 
cope with their concerns. This is the case for patients with Thalassemia, for 
whom transfusions are a necessity, who have been found to experience higher 
quality of life when ‘concerns’ about their general treatment are lower 
(Trachtenberg et al., 2012).  
As some haematology patients will be receiving transfusions on a long-term 
basis, some patients may have ‘accepted’ their conditions and transfusion as 
a part of their treatment regimen. Acceptance can be viewed as a part of 
coping, being important to how patients adjust to chronic illnesses (Sharpe et 
al., 2006). Active acceptance (an adaptive response to unchangeable 
circumstances) is distinguished from resigned acceptance (maladaptive 
coping associated with negative psychological outcomes) (Nakamura et al., 
2005). Patients receiving transfusions for long-term conditions in the 
haematology unit may actively accept their transfusions or accept them on a 
resigned basis.  
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Clinical health-related factors may also influence patients’ perceptions. Many 
haematology patients have cancer and/or anaemia, which result in patients 
experiencing high levels of fatigue, diminished quality of life, lethargy, 
decreased mental alertness, physical weakness and poor concentration 
(Jansen et al., 2003). Transfusions for this patient group may lead to negative 
health outcomes, such as iron overload (Hershko & Hoffbrand, 2000) and 
mortality, for example, if patients have organ dysfunction (Vincent, 2008) or 
cardiac surgery (Murphy et al., 2007). Therefore, it is important to ascertain 
the benefits and potential downsides of transfusions for this patient group, 
gathering particular insight into how transfusions might improve or further 
impact on patients’ lives.  
Patients facing health threats will attempt to self-regulate the threatening 
situation by engaging with ways to improve their health, which may be 
considering how transfusion could help to ‘control’ their condition (Leventhal 
et al., 1980; Leventhal et al., 1984).  What patients think about transfusion is 
therefore important and if transfusions help patients to improve their health, 
patients will form updated treatment perceptions of their health threat (e.g. 
improved and stable anaemia through transfusions). If patients are able to 
manage their conditions on an ongoing basis with the aid of transfusions, it 
will become important for patients to adhere to their transfusion schedule to 
cope with their condition. The outcome of such coping strategies will re-
inform patients’ illness perceptions, as indicated by the Common Sense Self-
Regulation Model (CS-SRM) (Leventhal et al., 1980; Leventhal et al., 1984).  
Alongside exploring patients’ transfusion perceptions, it is equally important 
to explore the perceptions that HCPs hold about transfusion. The second 
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identified research gap uncovered by the preceding systematic review was 
that no studies were identified where both transfusion patients’ and HCPs’ 
perceptions were jointly investigated. In shared decision-making encounters, 
patients with cancer often defer complex decision-making to HCPs. Elderly 
patients, in particular, may require support at the point of decision-making, 
with cancer schema linked to mortality often being activated at this stage 
(Swainston et al., 2012). If patients’ and HCPs’ perceptions are aligned or 
mutually understood, treatment goals may be more readily established, with 
more open discussion of perceptions and fewer misunderstandings occurring 
(Barry et al., 2000; Mead et al., 2000).  
Whilst shared-decision making is central to patient-centred practice, 
investigating HCPs’ perceptions can also provide insight on factors 
influencing HCP prescribing practices. This is particularly important given 
previously discussed evidence of transfusion overuse and misuse by HCPs. 
For haematology in particular, audits of UK haematology practice have 
identified gaps in the appropriate provision of blood transfusion (red blood 
cells 75% appropriately prescribed in 96% of UK participating hospitals in 
January 2016 (National Health Service Blood and Transplant, 2016). 
Alternatives to transfusion that are available for some haematology patients, 
such as iron tablets, may not be routinely offered or considered. Some 
transfusions, such as platelet transfusions are also ordered at high levels and 
there is evidence that transfusion provision in haematology could be further 
reduced (Estcourt et al., 2012).  
Qualitative research methods are frequently used to explore perceptions, with 
in depth interviews enabling researchers to respond to the individual way in 
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which respondents interpret and answer questions (Fitzpatrick et al., 1994). 
Semi-structured interviews allow the investigator to have a fixed set of topics 
to discuss (Fitzpatrick et al., 1994), with interview questions able to be 
structured around an existing theory or framework to enable exploration of 
the different components. Qualitative methods have been advocated for use 
in transfusion medicine to generate answers to research questions that are rich 
in description, such as through the exploration of issues from transfusion 
recipients’ perspectives (Arnold et al., 2011).  
4.1.2 Aims of the current study 
The current study aimed to address gaps in the literature by exploring 
patients’ and HCPs’ perceptions of blood transfusion from the under-
researched haematology context. This study aimed to investigate both groups’ 
perceptions concurrently using qualitative research methods based on the 
systematic review (Chapter 2) conceptual model of blood transfusion 
perceptions and patients’ and HCPs’ perceptions were compared using 
triangulation methods.  
4.1.3 Objective 
1. To explore adult blood transfusion patients’ and HCPs’ perceptions of 
blood transfusion.  
4.1.4 Research questions 
1. What are haematology patients’ and HCPs’ perceptions of blood 
transfusion? 
2. How closely do patients’ and HCPs’ perceptions align to the 
constructs of the blood transfusion conceptual model? 
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3. Which perceptions are identified as being most important to 
haematology patients and HCPs? 
4. How comparable are patients’ and HCPs’ perceptions? 
 Methods 
4.2.1 Study design 
Semi-structured qualitative interviews based on the conceptual model of 
blood transfusion perceptions from the systematic review (Chapter 2). 
4.2.2 Ethical approval 
Ethical approval was granted from South Central – Hampshire B Research 
Ethics Committee (15/SC/0757) (Appendix 6: Study 2 ethics approval letter). 
4.2.3 Setting and participants 
This study was conducted in the context of UK based National Health Service 
(NHS) haematology day treatment units. Two units were involved in the 
study, one unit was based in London in a large hospital trust. The second was 
in South-west England, being the larger outpatient blood transfusion centre 
for the region.  
4.2.4 Sampling 
Patients and HCPs were recruited using purposive sampling methods. 
Thirteen patients and 13 HCPs were selected as the minimum target sample 
size following published qualitative sample size guidance based on the 
principles of thematic data saturation (Francis et al., 2010). Data saturation 
was assessed during coding of the interview transcripts using a data saturation 
table (Appendix 7: Data saturation table for haematology interview Study 2) 
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to assess that the final three interviews from each group produced no new 
data, which would lead to new emergent themes.  
4.2.4.1 Patient inclusion criteria 
1. Adult patients (aged 18+) attending the haematology day unit for a 
blood transfusion with a non-acute haematological disorder.  
2. Patients deemed by HCPs working in the haematology unit as 
clinically stable enough to participate (i.e., alert and oriented, with 
stable vital signs and without acute respiratory or cardiac difficulty or 
uncontrolled pain) (Adams et al., 2011).  
4.2.4.2 Patient exclusion criteria 
1. Patients who are unable to understand spoken English and respond 
verbally to interview questions in English. 
2. Patients deemed by HCPs to be unable to consent, and participation 
would not be advised per clinical advice. 
3. Patients considered by HCPs to have a cognitive impairment (i.e. 
problems with cognitive functioning like thinking, knowing and 
remembering) (Alzheimer's Society, 2009). 
4.2.4.3 HCP inclusion criteria 
1. HCPs, including consultants, physicians, junior medical staff and 
haematology specialist nurses currently working in the targeted 
haematology day unit(s) who interact with patients, for example to 
discuss with patients their haematological disorder and its treatment, 
or to administer blood products to patients (Galloway, 2013).  
There were no HCP exclusion criteria.  
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4.2.5 Recruitment 
4.2.5.1 Participant recruitment 
Patient recruitment was facilitated by a local collaborator working in the 
blood transfusion suite and having direct patient-contact. This was typically 
a Staff Nurse responsible for providing transfusions in the unit on that day. 
The collaborator assisted the researcher (BV) by completing the recruitment 
log (Appendix 8: Study 2 patient recruitment log) on the recruitment days and 
screening all patients attending for a transfusion against the inclusion and 
exclusion criteria and documenting the screening outcomes. Each patient 
attending for a transfusion on the recruitment days meeting all inclusion and 
no exclusion criteria was invited to take part in the study. The local 
collaborator informed patients about the study and provided a Participant 
information sheet (PIS) (Appendix 9: Study 2 participant information sheet 
(patients)). After patients read the PIS, the researcher approached the patient 
to discuss the study further and gain informed consent, if they were willing to 
participate straight away.  
4.2.5.2 HCP recruitment 
HCPs were informed about the study by the clinical collaborator supporting 
the research or by the researcher directly during opportunities to speak to 
groups or individual HCPs in the units whilst recruiting patients and 
conducting patient interviews at the site. Opportunities to speak to HCPs as a 
group occurred, for example, during early morning staff handovers. Interested 
HCPs were provided with a HCP-specific PIS (Appendix 10: Study 2 
participant information sheet (HCPs)). The researcher aimed to purposively 
recruit a broad range of HCP roles into the study and kept track of the 
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diversity of sampling during recruitment. Informed consent was documented 
on an informed consent form for all participants (Appendix 11: Study 2 
consent form).  
4.2.6 Materials 
4.2.6.1 Interview topic guide development 
Methods to investigate patients’ and HCPs’ perceptions concurrently include 
the use of comparable versions of patient and HCP data collection instruments 
(Légaré et al., 2007). For this study, patient and HCP specific topic guides 
were developed. To enhance comparability, both topic guides were structured 
around the constructs of the blood transfusion conceptual model. The topic 
guides began with general opening questions: e.g., ‘Could you talk to me 
about your experience of receiving blood transfusions?’ [patients], ‘How 
often do you receive / prescribe transfusions?’ [HCPs]. Subsequent questions 
were based on the conceptual model of blood transfusion perceptions from 
the systematic review (Chapter 2); with at least one question asked per 
construct (Table 5). Potential ways of phrasing these questions to assess the 
constructs were guided by the phrasing of items in the BMQ (Horne et al., 
1999b) and other frameworks discussed in Chapter 3. Constructs with full and 
partial mapping were reviewed for suitable question wording to help inform 
the topic guide questions. 
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Table 5 Study 2 interview topic guide questions 
Conceptual model 
construct 
Patient topic guide question HCP topic guide question 
Health Benefit  
 
‘What are the benefits of transfusion for 
you?’ 
* Probe: distinctions between expected 
benefits vs. instant and later benefits? 
‘What are the benefits of transfusion for 
haematology patients?’ 
* Probe: distinctions between expected benefits vs. 
instant and later benefits? 
Safety/risk: 
 
‘Are there any downsides for you in 
receiving transfusions?’ 
‘Are there any downsides for haematology patients 
in receiving transfusions?’ 
Negative emotions: 
 
‘How concerned or worried are you about 
[these] downsides to transfusion?’ 
‘How concerned or worried are you about [these] 
downsides to transfusion?’ 
Alternatives ‘Have you ever been offered any 
alternatives to transfusion?’ 
* Prompt: what are your thoughts about 
this? 
‘How much are transfusion alternatives considered 
for haematology patients?’ 
*Prompt: are there some reasons that transfusions 




‘How much would you say you need 
transfusions to protect your health? 
*Probe distinction between protecting 
health presently or long-term 
‘How much would you say haematology patients 
need transfusions to protect their health? 
*Probe distinction between protecting health 
presently or long-term 
Decision making ‘How involved were you in making 
decisions about your transfusion(s)?’  
‘Can you describe any other ways that you 
might like to be more involved in your 
transfusions?’ 
‘How greatly do you involve patients in making 
decisions about their transfusion(s)?’ 
‘Can you describe any other ways that patients might 
like to be more involved in their transfusions?’ 
* Inserted after interviews at site 1 
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The interviews were also an opportunity to ask patients and HCPs 
respectively how they thought the other group might perceive transfusion 
(e.g. ‘What do you think are your doctors’ or nurses’ / patients’ views of 
transfusion?’). HCPs were asked about the extent to which their perceptions 
may have changed over the course of their practice and patients were asked 
whether their experiences of transfusions have changed over time. These 
questions were asked due to the long-term and repeated nature of transfusions 
in this context.  
A Consultant Haematologist collaborator (SS) and Patient and Public 
Involvement Representative (PA) reviewed all consent forms and study 
information sheets. These materials were revised in light of their feedback to 
enhance clarity and question flow. Four pilot interviews were also conducted 
by the researcher with HCPs and a blood transfusion recipient. This was to 
ensure that the questions asked were clear, logically ordered and 
comprehensive relating to the theoretical underpinning. The topic guides were 
additionally updated following the first set of interviews at the first site to 
include further prompts and probes based on what participants at this site were 
recalling. For example, to probe more closely to the BMQ subscale of 
‘Necessity’; distinguishing present and future health need (Horne et al., 
1999b).  
4.2.7 Procedure 
All patient and HCP interviews were conducted by the trained researcher 
(BV) using the semi-structured interview topic guides (Table 5). All 
participants were interviewed individually, face to face in the haematology 
unit or by telephone if preferred. Interviews were expected to last around 30 
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– 45 minutes and were audio-recorded. For face to face interviews, patients 
were offered the chance to be interviewed before, during or after their 
transfusions in the haematology unit, with before or during data collection 
identified as a gap in the previous systematic review (Chapter 2). Patients 
may provide more vivid accounts of their perceptions as close to the 
transfusion episode as possible rather than providing a retrospective account. 
HCPs were informed that interviews could be arranged flexibly around their 
availability and conducted in the haematology unit. 
A demographic questionnaire was provided to each participant at the end of 
the interview to collect details for patients such as gender, age, ethnicity, 
religion, haematological condition and blood products received (Appendix 
12: Study 2 Demographic questionnaire (patients)). For HCPs, gender, 
clinical role, experience in haematological units and types of interaction with 
patients were collected (Appendix 13: Study 2 HCP demographic 
questionnaire). For the latter two questions, HCPs reported the length of their 
experience working in haematology units and their involvement in 
transfusion in terms of the frequency with which they administer transfusions 
and/or engage in decision-making with patients.  
Interview audio-recordings were transcribed verbatim by the researcher (BV) 
and anonymised to remove any potentially indefinable information (i.e. 
names of individuals, colleagues, hospitals etc.). The researcher also 
preserved participant anonymity by removing any non-essential information 
from any accounts that included characteristics of rare or specified (and thus 
potentially identifiable) clinical cases. All data were stored and managed in 
accordance with the Data Protection Act 1998.   
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4.2.8 Analysis 
Analysis was conducted using a combined deductive approach (Hsieh et al., 
2005) using the conceptual model of blood transfusion perceptions as the 
analytical framework and an inductive thematic analysis approach (Braun et 
al., 2006), described in detail below.  
4.2.8.1 Patients’ and HCPs’ perceptions of blood transfusion 
Analysis was conducted using NVivo 11. Patient and HCP interviews were 
analysed separately using first a deductive approach that allowed for data to 
be coded into a pre-selected analytical framework, in this case, the conceptual 
model of blood transfusion perceptions (Chapter 2). Participants’ responses 
were first coded to the construct from the model (‘Safety/risk’, ‘Alternatives’, 
Health benefits’, Negative emotions’, ‘Necessity’ and ‘Decision making’) 
they were judged to best represent. For example, a quote of ‘patients benefit 
from transfusions to restore their energy’ was coded according to the model 
construct ‘Health benefits’. If appropriate, a response was coded to more than 
one construct, for example ‘I do worry less about how risky the blood is 
nowadays’, which was coded to ‘Negative emotions’ and ‘Safety/risk’. To 
make the construct labels more descriptive, ‘Safety/Risk’ and ‘Decision 
Making’ from the systematic review conceptual model were re-titled into 
‘Awareness of Risk / Safety’ and ‘Involvement in Decision Making’ 
respectively. 
At this stage, inter-rated reliability was assessed to compare the deductive 
coding decisions using one patient and one HCP anonymised transcript (7% 
of total transcripts) with two additional coders who were postgraduate 
researchers with experience in qualitative research. Coders were made 
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familiar with the study and research questions. Inter-rater reliability was 
conducted to assess how reliable the researcher’s (BV) initial allocation of 
responses to the model constructs was. Percent agreement was used to assess 
reliability (total number of cases coded the same way by two independent 
raters divided by total number of cases) (Stemler, 2001). A coding book was 
developed for this process, which provided a summary of each deductive 
construct and an example of codable data (Appendix 14: Coding book for 
Study 2 haematology interview transcripts). Disagreements were discussed 
by the researcher (BV) and the rater until 100% reliability was reached and 
the coding book was iteratively updated during this process.  
The deductive coding was followed by an inductive thematic analysis 
approach where themes are generated through open coding, followed by the 
refinement of themes (Gale et al., 2013). Similar participant responses coded 
to each construct were grouped together and an inductive summary label 
theme generated. A six-step thematic analysis approach was used: 1) 
familiarisation (data transcription, re-reading transcripts and noting initial 
ideas); 2) generating initial codes (coding interesting features of the data in a 
systematic fashion); 3) collating codes to potential themes; gathering all 
relevant data to potential themes (e.g. iron- overload related risks as a part of 
the ‘Safety/risk’ theme); 4) reviewing themes (e.g. checking if themes work 
and are coherent with ‘thematic map’ of the analysis, 5) defining and naming 
themes and 6) producing the report (Braun et al., 2006).  
Inductive analysis was also performed on data that could not be initially coded 
deductively into any of the existing constructs from the model (e.g. quotes 
relating to transfusions as ‘part of a patient’s life’ or the ‘burden’ of 
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transfusion). These responses were subsequently analysed using thematic 
analysis as described above.  
4.2.8.2 Perceptions identified as most important to patients and HCPs 
Perceptions that are important to patients may need to be given further 
consideration in clinical practice, possibly through patient-centred service 
reforms being considered or changes to practice guidelines (Armstrong et al., 
2018; Brocklehurst et al., 2018; Tsianakas et al., 2012a). One method of 
determining importance, which is often used in qualitative research, is by 
using frequency counts of how frequently a theme occurred /is referred to 
(Marks et al., 2004). For example, how many patients or HCPs reported 
perceptions coded to the construct of ‘Health benefits’, with consideration 
given to how elaborate a construct is, through frequency of themes. These 
approaches are often used in other hybrid deductive framework and inductive 
thematic analysis interview studies, incorporating theoretical frameworks, 
such as the Theoretical Domains Framework (Atkins et al., 2017; Patey et al., 
2012). For this study, importance of perceptions was assessed on two criteria: 
frequency counts of participants (patients and HCPs) reporting data into each 
construct / theme and secondly on how elaborate each construct or theme was, 
assessed by frequency counts of themes.  
4.2.8.3 Conceptual models of patients’ and HCPs’ perceptions of 
transfusion for haematology 
BV adapted the existing conceptual model of blood transfusion perceptions, 
from Chapter 2, to include new constructs of patients’ and HCPs’ transfusion 
perceptions for the haematology context. Once the inductive themes were 
generated from the patient and HCP analysis, the themes were mapped to the 
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existing conceptual model structure. The aim was to illustrate how the 
different components from the generic model were present or absent in the 
haematology specific groups, and how the constructs inter-related. New 
themes specific for this group were added to the model as constructs and 
presented using a unique colour code compared to the original deductive 
constructs.  
4.2.8.4 Triangulation of patients’ and HCPs’ perceptions 
One way to compare findings from different data sources is to tabulate the 
findings from each source and identify areas of overlap, disagreement, or 
silence/absence (Tonkin-Crine et al., 2015). Different data sources can 
include different participant groups. This approach was applied to compare 
patients’ and HCPs’ perceptions of transfusion using qualitative triangulation 
protocols (Farmer et al., 2006; Hopf et al., 2016). This involved creating a 
convergence matrix, in which themes generated from analysis of patients’ and 
HCPs’ transcripts were tabulated as either: ‘agreement’ indicating that a 
comparable theme was present for both groups (e.g. ‘Transfusion has become 
a part of patient's routine life’ (HCPs) and ‘Transfusion part of routine life’ 
(patients)); ‘partial agreement’ meaning that the theme is partially 
comparable across the two groups (e.g. ‘Need for transfusion apparent 
through symptoms’ (patients) and ‘Patient reliance and expressed need for 
transfusion’ (HCPs)); ‘disagreement’ indicating a contradictory finding in 
each participant group (e.g. ‘Patient anxiety and upset with receiving regular 
transfusions’ (HCPs) and ‘Relaxed during transfusion appointments’ 
(patients)); and ‘silent’ indicating that no comparison could be recognised 
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(e.g. patient theme but not HCP theme) (Farmer et al., 2006; Hopf et al., 
2016).  
 Results 
4.3.1 Participants recruited 
Recruitment at site 1 took place on six working days over a continuous two-
week period, and all eligible patients who attended for blood transfusions in 
this time period (n=24) were screened to be invited into the study. 
Approximately 18 HCPs including Haematology Consultants, one 
Transfusion Practitioner, Haematology Nurse Specialists, Registrars, Staff 
and Registered Nurses were informed about the study by the site Principle 
Investigator or Researcher. This covered approximately all of the HCPs 
treating blood transfusion patients during this time period.  
Recruitment at Site 2 was conducted over eight working days across two 
consecutive weeks. Thirty-five patients attending for blood transfusions were 
screened for eligibility. Approximately 10 HCPs (as per site 1 but including 
Senior House Officers and a Clinical Health Psychologist and excluding any 
Transfusion Practitioners) were directly approached and informed about the 
study by the researcher. The researcher also briefly introduced the study at a 
nurses’ briefing at the start of a morning shift on the first day of the 
researcher’s recruitment days. Around 15 attendees were at this briefing 
including Nurse Managers. These recruitment strategies notified potentially 
all eligible HCPs in the unit about the study.    
Appendix 15: Reasons for patient exclusion from study 2 lists the detailed 
reasons for exclusions for 45 screened patients per site. The majority of 
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patients were not eligible due to insufficient English (n=6), previously 
screened or interviewed (e.g. patient returning for a weekly transfusion) 
(n=6), advised by screening personnel not to invite (n=4), no transfusion 
needed on the day; patient sent home (n=4) or on patient list but transferred 
to ward for transfusion or since deceased (n=3). In terms of participating, 
some HCPs were reluctant to participate in the study, expressing that they 
would have limited worthwhile perceptions to share, or due to lack of time. 
The final sample consisted of 14 patients (eight from Site 1, six from site 2) 
and 14 HCPs (seven from site 1, seven from site 2). 
4.3.1.1 Participant characteristics 
Table 6 displays patient participant characteristics from both sites. Male 
patients consisted of 43% of the patient sample with the median age of 68. 
The majority of patients classified themselves as White British (71%) and 
Christian religion (79%). Patients had a range of educational backgrounds and 
haematological disorders. The majority of patients interviewed were in the 
haematology unit to receive red blood cell transfusions (93%) with 50% of 
patients also having experience of receiving platelets in the past. Thirteen 
patients were interviewed during their transfusions, with one patient 
interviewed before an upcoming transfusion.  
Table 6 Study 2 patient participant characteristics 
Patients included: N=14  
Gender  
Male 6 (43%) 
Female 8 (57%) 
Age  
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<45 1 (7%) 
45-65 4 (29%) 
>65 9 (64%) 




Any other White background 1 (7%) 
Asian/Asian British 1 (7%) 
African 1 (7%) 
Any other ethnic group 1 (7%) 
Religion  
Christian (including Church of England, 
Catholic, Protestant and all other Christian 
denominations) 
11 (79%) 
No religion 1 (7%) 
Prefer not to provide 2 (14%) 
Highest level of education completed  
No formal education 3 (21%) 
GCSE / O’Levels 4 (29%) 
A Levels / college certificate 2 (14%) 
University level 3 (21%) 
Graduate / professional 2 (14%) 
Haematological condition(s)  
Myelodysplasia 3 (21%) 
Myeloma 1 (7%) 
Myelofibrosis 1 (7%) 
Lymphoma (CLL) and a second 
haematological condition 
1 (7%) 
Acquired haemolytic anaemia 1 (7%) 
Inherited anaemia, including Thalassemia 2 (14%) 
Aplastic Anaemia 3 (21%) 
Other Anaemia  2 (14%) 
Blood products currently receiving  
Red blood cells 10 (71%) 
Red blood cells & platelets 3 (21%) 
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Platelets 1 (7%) 
Other blood products received  
Red blood cells 5 (36%) 
Red blood cells & platelets 7 (50%) 
Unknown 2 (14%) 
 
The patients involved in this study had multiple health conditions and 
reported taking many other medicines, vitamins and supplements. These were 
taken for haematological or other health conditions, including asthma, high 
blood pressure, diabetes, dermatological conditions or following hip 
replacements or transplants.  
Table 7 displays the HCP participant characteristics from both sites. HCPs 
were mainly female (64%) from a range of roles but mostly Haematologists, 
specialists or senior role HCPs. Years of experience in the HCP’s current 
clinical role was between 1 and 30 years (M = 10.5 years, SD = 8) and the 
range for experience in haematology day units was between a few months to 
24 years (M = 8 years, SD = 8). The majority of HCPs interacted with 
haematology patients receiving transfusions in the unit daily or at least 
weekly (86%).  
Table 7 Study 2 healthcare professional participant characteristics 
Healthcare professionals included: N=14 
Gender  
Male 5 (36%) 
Female 9 (64%) 
Clinical role  
Consultant Haematologist 3 (21%) 
Specialty doctor (Haematology) 1 (7%) 
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Specialist Registrar 2 (14%) 
Specialist House Officer 1 (7%) 
Senior Charge Nurse 1 (7%) 
Haematology Specialist Nurse 2 (14%) 
Nurse (other) 2 (14%) 
Transfusion Practitioner 1 (7%) 
Clinical Psychologist 1 (7%) 
Interaction with patients in the haematology 
unit 
 
Daily (discussion and blood product 
administration) 
2 (14%) 
Weekly (discussion and blood product 
administration) 
3 (21%) 
Daily discussion 4 (29%) 
Weekly discussion 3 (21%) 
Monthly discussion 2 (14%) 
 
4.3.1.2 Reliability results and data saturation 
Inter-rater agreement for coding decisions based on patient transcripts was 
67%. For the HCP transcripts, inter-rater reliability on the coding decisions 
was highest at 60%. This was considered under the advised 75-90% 
acceptable level of agreement (Stemler, 2004). Full consensus was, however, 
reached on all disagreements. 
Data saturation was reached by the time the 13th patient and HCP interview 
was analysed, as no new themes were identified at this stage (Appendix 7: 
Data saturation table for haematology interview Study 2).  
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4.3.2 Perceptions of blood transfusion  
4.3.2.1 Patients’ perceptions 
Table 8 provides a full list existing constructs from the deductive analysis: 
‘Awareness of risk / Safety’, ‘Health benefits’, ‘Necessity’, ’Negative 
emotions’, ‘Alternatives’ and ‘Involvement in decision making’ and the 
themes inductively generated for each construct of the conceptual model of 
blood transfusion perceptions. These are presented alongside frequency 
counts (i.e. number of participants that reported a perception contributing to 
that theme) and supporting illustrative quotes. Each construct from the model 
is summarised in turn below.  
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Table 8 Study 2 constructs from the blood transfusion conceptual model (patients) with themes, frequency counts and supporting quotes listed 
Construct header Frequency 
(n patients) 
Patient quotations 
Awareness of risk / safety   
Discomfort and illness during or post-transfusion 
7 “there's always situations that I was here hours waiting for blood and I ended up 
receiving it, but the following day I was in bed all day” (Patient 12, Aplastic Anaemia, 
Site 2) 
Potential infection or reaction risk 
5 “basically, you kind of just think, you know, 'is this gonna be the transfusion that might 
cause me to have a reaction?' or, 'is this the unit that's going to cause something in 
the future?' but you can't really live like that, so you don't really think about it too much 
really, it doesn't stop me having them” (Patient 8, other Anaemia, Site 1) 
No experienced negative consequences 5 “I feel quite good really, I’m not having any side-effects or anything like that which is 
very good” (Patient 6, Myelofibrosis female, Site 1) 
Health risks from high iron levels 4 “because the more blood I receive, the more the iron level in my blood goes up” 
(Patient 12, Aplastic Anaemia, Site 2) 
Caution needed, blood should be used appropriately 
2 “there's many, many, many issues of blood, you know, if the haemoglobin's dropped 
or loss of blood, or that sort of thing, but er, I think people need to be a bit more 
careful” (Patient 8, other Anaemia, Site 1) 
Health benefits   
Boosting blood levels 8 
“well normally it/ well, it depends, erm, how low the haemoglobin is, the lower it is 
then the benefit is quicker because you're being topped up but” (Patient 14, Inherited 
Anaemia, inc Thalassemia, Site 2) 
Keep going with daily life 7 
“well I wouldn't be able to get about, I'd be fighting for breath and all that if I didn't 
have it, you know, I wouldn't be able to do anything I do now. I can walk about” 
(Patient 7, Myelodysplasia, Site 1) 
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Construct header Frequency 
(n patients) 
Patient quotations 
Relief of symptoms such as tiredness 7 “when I received blood transfusion after that, I rest a bit and then I feel strong but before I feel weak” (Patient 10, other Anaemia, Site 2) 
Anticipated benefits 6 “I just feel as though that if I got a transfusion with fresh blood, surely I’ve got to feel better from it, I think so” (Patient 1, Myeloma, Site 1) 
Patient convinced of benefit by significant others 3 “everyone was telling me I looked better and that in itself made me feel better as well I suppose” (Patient 1, Myeloma, Site 1) 
Can take time to feel benefit of transfusion 2 
“this is a benefit, the blood, but sometimes it takes a while to kick in, it's like if you're 
taking medication from the doctor, sometimes it takes, erm, a while to kick in” (Patient 
11, Lymphoma (CLL) and a second haematological condition, Site 2) 
Necessity   
Transfusion prolonging life and aiding survival 11 “oh yes, it just seems to me as being essential, erm, as much as say needing oxygen 
in the air is an essential, without the transfusions I wouldn’t be here” (Patient 4, 
Aplastic Anaemia, Site 1) 
Transfusions required as a current and long-term 
supportive treatment 10 
“they gave me two courses of ATG, it's an immunogloubulin … the second time, I 
didn't have any response. Since then, since, … I've been receiving transfusions” 
(Patient 12, Aplastic Anaemia, Site 2) 
Need established by HCPs and clinical indicators 8 
“if it is lower than 80, they said I need a blood transfusion … sometimes it depends, 
they keep seeing the blood test, decided if I need to have a blood transfusion” (Patient 
10, other Anaemia, Site 2) 
 
Need apparent through symptoms 8 
“yeah, when it drops, I feel a bit tired, but/ you feel it, dizzy, a little bit dizzy, tiredness, 
shortness of breath, sometimes/ I try to manage it, but/” (Patient 9, Acquired 
Haemolytic Anaemia, Site 2) 
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Construct header Frequency 
(n patients) 
Patient quotations 
Speculation and doubt over pending transfusion 
prescription 7 
“Erm, last week I had two units of blood ∙ but this week ∙ it’s only like the platelets, so 
possibly next week it’ll just be platelets and one unit of blood” (Patient 2, Aplastic 
Anaemia, Site 1) 
Negative emotions   
No concerns or worries with transfusion 10 “no [concerns or worries], cause there's no point worrying about something I can't 
really do anything about” (Patient 8, other Anaemia, Site 1) 
Attempts to manage worries and fears 9 
“so, it doesn't look, it looks ok for you for a minute, and then you start to think about 
something else but that one you have to be on the positive side all the time, maybe 
not keep saying 'that's not good'” (Patient 9, Acquired Haemolytic Anaemia, Site 2) 
Relaxed during transfusion appointments 5 “I come regularly, erm, to be honest it's a nice, this sounds really weird but, you know, 
it's a day where, I, I fully relax because I'm just having my blood and I'm not thinking 
of anything else” (Patient 14, Inherited Anaemia, inc Thalassemia, Site 2) 
Gratitude that transfusions possible 5 “I'm very grateful that there is blood available for me and other patients, erm, and I 
appreciate that hugely” (Patient 14, Inherited Anaemia, inc Thalassemia, Site 2) 
Receiving transfusions unpleasant 4 “everybody hates having them, they all hate the cannula’s in” (Patient 2, Aplastic Anaemia, Site 1) 
Concern of transfusion dependency 4 “sometimes, erm, I feel scared … of course if you see blood, you think, you think to yourself that it's bad” (Patient 10, other Anaemia, Site 2) 
Positive emotions of not needing transfusion 2 
“there was a wonderful telephone message and it said [Mr/Mrs surname], we don’t 
want to see you today and so everyone cheered you know. I, I didn’t come in, which 
was brilliant” (Patient 4, Aplastic Anaemia, Site 1) 
Perception that doctors dislike prescribing 
transfusions 1 
“no, most of the doctors like, they, they always hate giving transfusions to someone 
…” (Patient 9, Acquired Haemolytic Anaemia, Site 2) 
Chapter 4 Haematology interview study 
142  
Construct header Frequency 
(n patients) 
Patient quotations 
Alternatives   
Alternatives considered or already in use 7 
“I was offered the main treatment for this condition, is the bone marrow transplant, 
but I, I'm not really keen to do that, cause it's, I've, erm, you know, the side effects of 
treatment …” (Patient 12, Aplastic Anaemia, Site 2) 
No alternatives, transfusion only option 5 “yeah, I would just fade away, yeah, cause there's nothing else that can help me” (Patient 8, other Anaemia, Site 1) 
Patient's body can correct depleted cells 3 “hopefully, erm, with erm, not needing platelets, might just be my body saying ‘I’ll have a go now’” (Patient 4, Aplastic Anaemia, Site 1) 
Patient preference for alternatives 3 
“I wish they'd/ sometimes I wish that I didn't have to have it done. I wish they could 
just give you like a tablet and something like that” (Patient 11, Lymphoma (CLL) and 
a second haematological condition, Site 2) 
Involvement in decision making   
Transfusion offered with patient involvement in 
choice 7 
“yeah I had choice, I had a choice, yes I will go along with it, or no I won’t bother. She 
gave me that choice as well, ∙ but I was led by her professional advice” (Patient 1, 
Myeloma, Site 1) 
Deferral of decision making to HCPs 7 “I just take it for granted that what they’re asking me to do, or what they’re doing is the correct thing to do” (Patient 5, Myelodysplasia, Site 1) 
Willing acceptance of transfusions 7 
“I suppose I sort of took it in my stride really, think well if they’re gonna help me, then 
you’ve gotta go along with it, haven’t you really, that’s how I feel” (Patient 6, 
Myelofibrosis female, Site 1) 
Confronted with limited or no choice 6 
“They're the experts and they say so, and, like they said 'if you don't want it, you just 
die', 'you choose to die', they said, 'don't bother coming in'” (Patient 7, 
Myelodysplasia, Site 1) 
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Construct header Frequency 
(n patients) 
Patient quotations 
Decision making discussion positive 5 
“[the consultant] does try to explain in simple terms, er, what [he/she] thinks, and the, 
the whole thing has been optimistic and upbeat … there’s never been any pessimism 
at all, which has been terribly encouraging” (Patient 4, Aplastic Anaemia, Site 1) 
Routine 'automatic' treatment 3 “with it being, you know, a chronic condition, so very long-term, so it's almost automatic regular treatment” (Patient 14, Inherited Anaemia, inc Thalassemia, Site 2) 
More frequent transfusions would be resisted 2 “I try to avoid as well because the more blood I receive, the more the iron level in my blood goes up” (Patient 12, Aplastic Anaemia, Site 2) 
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Awareness of risk/safety: Patients recounted negative consequences that they 
experienced during and post-transfusion, mainly from painful cannulisation 
and beliefs about adverse effects, most notably from high iron levels needing 
to be controlled to prevent damage to major organs. Some patients reported 
that reactions were only likely at the start of the transfusion or had no negative 
consequences to report on.  
Health benefits: Transfusions aided patients to keep going with their daily 
lives with patients acknowledging benefits such as reduced tiredness and 
improvements in blood levels, wellbeing and transfusions helping to manage 
their conditions. Many patients thought that other similar patients must also 
perceive transfusion as beneficial, and some patients were convinced and 
persuaded of the benefits by HCPs or significant others. Two patients felt that 
the benefit was variable and can take time to be felt, or that they often felt 
drained post-transfusion as if no transfusion was given.  
Necessity: Patients reported receiving transfusions as a supportive treatment 
for their immediate health needs (e.g. to support chemotherapy) or for 
management of a long-term condition, being necessary to prolong patients’ 
lives. Some patients recalled that the need for transfusion became apparent 
through symptoms they experienced (e.g. lethargy) (n=8). For other patients 
they relied on HCPs and clinical indicators to determine the necessity for 
transfusion, yet this often made it problematic for patients to establish a 
routine with their transfusions.  
 Negative emotions: Some patients reported worries, fears and frustrations 
with receiving transfusions or found being cannulated unpleasant, 
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transfusions time-consuming or initially hard to deal with at first. In spite of 
this, more patients talked about having no concerns or worries with 
transfusion or that they have found ways to manage negative emotions. For 
example, communicating with HCPs or keeping a hopeful and positive 
outlook. Some patients liked attending for transfusion, expressing gratitude 
that blood was available.   
Alternatives: Patients discussed alternative treatments, such as unspecified 
tablets that they were taking to try to reduce their transfusion requirement, or 
treatments that were previously unsuccessful or not feasible (e.g. bone 
marrow transplant). Some patients felt that they would prefer an alternative, 
for example, to relieve the burden of the transfusion time-length, but that there 
were none available for them. Other patients commented that the functioning 
of their body may influence how much blood they would need or how 
frequently they would need transfusions, for example if their body worked to 
reinstate depleted blood cells.   
Involvement in decision making: Patients reported either being involved in 
the initial transfusion decision making, or that they deferred decisions to 
HCPs, or that HCPs solely made the decisions. Many patients accepted HCPs’ 
decisions, finding transfusion discussions positive or had limited or no choice 
but to accept the transfusion. For some patients, transfusions were almost an 
‘automatically’ prescribed treatment.  
4.3.2.2 New haematology constructs: patients 
Three new themes were developed from interview data that could not be 
initially coded into any pre-existing construct of the conceptual model. These 
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three themes were recognised as new constructs to add to the conceptual 
model: ‘Social connection’ was the largest new construct (13 patients 
reporting data for this construct and five themes), ‘Burden’ the second largest 
construct (12 patients and six themes) and ‘Distinguishing between blood 
products’ (four patients, three themes). Table 9 provides a full list of themes 
with participant frequencies and example quotations per subtheme. Each 
construct is discussed in turn following the table, including illustrative quotes.  
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Table 9 New haematology patient constructs, with themes, frequencies and quotes per theme listed 




Patient involvement generally positive  6 “I think I’m quite involved in everything that does go on, erm, they do keep 
you ∙ up to date and everything” (Patient 2, Aplastic Anaemia, Site 1) 
Interaction with other patients 6 “we know a lot of people here so we have chats, things like that – so it’s like 
a little family really” (Patient 6, Myelofibrosis, Site 1) 
Lack of interaction or activity during transfusions 5 “Well except in my case because being partially sighted, I can't read, can't 
see peoples' faces, so er, I'm just sat here for about eight to ten hours, just 
looking at the wall more or less” (Patient 5, Myelodysplasia, Site 1) 
Curiosity and appreciation for blood donors  3 “you know ‘what do you think about the blood?’ and erm, I think, I think 
about the blood, that it came from somebody, just curious to know a little bit 
more about the person” (Patient 4, Aplastic Anaemia, Site 1) 
Support from family or primary care HCPs 2 “when we approach the doctor, my family member: 'ask this one, ask this 
one', he/she is like/ so, which is a big help, but like me, I don't know what to 
ask” (Patient 10, other Anaemia, Site 2) 
Burden   
Transfusion part of routine life  7 “I carry on completely normal, normal life with the, you know, the odd 
transfusion every now and again, yeah” (Patient 8, other Anaemia, Site 1) 
Transfusions are inconvenient  5 “I think it's too often because being in hospital twice a week, minimum twice 
a week/ cause the week I receive blood, I have to come three times, and 
it's exhausting” (Patient 12, Aplastic Anaemia, Site 2) 
Chapter 4 Haematology interview study 
148  
Construct header Frequency 
(n patients) 
Patient quotations 
Life restrictions, travel 4 “it stops you from, if you ever wanted to go to another country, make a life 
in another country, it's a downside of it, the whole thing, be very difficult to 
do that” (Patient 13, Inherited Anaemia, inc Thalassemia, Site 2)  
Attendance not a great burden  4 “it’s not a burden to me, I don’t live too far away” (Patient 4, Aplastic 
Anaemia, Site 1) 
Distinguishing between blood products 
Knowledge gaps for platelets  2 “I don’t really understand what platelets do, I know, I know that they, that 
they repair the damage in the body, and works like that erm, ∙∙ well I am not 
a doctor am I” (Patient 5, Myelodysplasia, Site 1) 
Positive perception of platelets  2 “it’s just that one’s shorter than the other. The erm, platelets only take about 
20 minutes to half an hour” (Patient 2, Aplastic Anaemia, Site 1) 
Distinction between non irradiated and irradiated blood  1 “all blood transfusions are different, but this is irradiated blood transfusion” 
(Patient 11, Lymphoma (CLL) and a second haematological condition, Site 
2) 
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Social connection: Six of the 14 patients reported that they interacted with 
other patients in the unit, and six patients were also positively and fully 
involved in their transfusions, such as through interacting with HCPs (who 
they found to be approachable) to ask them general questions or to discuss 
their transfusion regimens. Some patients reflected on wider family, or GP 
support, or talked of a curiosity or connection to the blood donors. Yet, other 
patients felt that they lacked or held limited interaction with other patients, 
especially patients with different health conditions or to respect their privacy 
(n=5), or that further involvement was complex. 
“I’ve met, half a dozen people over the course of the time and er, but they all 
have/ they either have/ they’ve all got some sort of cancer treatment or some 
sort of deficiency, but it’s not the same as my own, but even if it were, I’m not 
sure that would take me very far, er, swapping notes with someone else whose 
got erm … wouldn’t really give me any great comfort or distress” (Patient 4, 
Aplastic Anaemia, Site 1).  
Burden: Half of the patients interviewed reported that transfusions were a 
part of their routine life, that attendance was not a great burden and that the 
experience was consistent over time and easy (switching between red cell and 
platelet transfusions). Around an equal number of patients (n=8) reported, 
however, that transfusions were inconvenient, involving lengthy 
appointments, frequent hospital trips and restriction to activities such as 
travelling away. 
“… we come here for blood and platelets very often, you know, our life is like 
attached to the, the hospital, we live like in a probation, you know, I feel like 
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we live in a probation because, er, it's kind of a prison, we feel, I feel like I'm 
a prisoner, you know, yeah, because I can't go, er, very far for very long” 
(Patient 12, Aplastic Anaemia, Site 2).  
Distinguishing between blood products: Four patients shared perceptions 
about specific blood products, mostly platelets. These patients perceived 
platelets quite positively (e.g. quicker to infuse) and had less curiosity over 
their donor origin. However, there were some knowledge gaps about platelets 
(e.g., what platelets did and where they were harvested from), and a one 
patient specifically reported that he/she was receiving irradiated blood, with 
no greater elaboration provided on what was different about this.  
“it's irradiated blood like I told you … it's just blood really” (Patient 11, 
Lymphoma (CLL) and a second haematological condition, Site 1).  
4.3.2.3 Importance of perceptions: patients 
Table 10 reports the importance ranking of constructs from the conceptual 
model, alongside newly identified constructs, according to frequency and 
thematic elaboration (i.e. number of themes per construct). The most frequent 
patient construct, that all patients reported perceptions for was ‘Involvement 
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Table 10 Frequencies and elaboration of patients’ responses per construct  
 
4.3.2.4 Patients’ blood transfusion perceptions conceptual model for 
haematology  
In the patient’s conceptual model (Figure 7), the six construct structure from 
the conceptual model of blood transfusion perceptions presented in the 
systematic review (Chapter 2) is supported with the addition of three new 
haematology-specific constructs. The constructs of ‘Burden’ and 
‘Safety/risk’ are proposed to be linked with ‘Negative emotions’ due to some 
patients reporting their transfusions to be time-consuming or involving risk. 
‘Health benefits’, ‘Social connection’ and ‘Negative emotions’ are associated 
with perceptions in the ‘Safety/risk construct, due to patients often 
deliberating transfusion risk vs. benefit and efforts made to have positive 
social interactions (e.g. with HCPs) reportedly eased some patients concerns 
(‘Negative emotions’) or information needs. These five constructs as well as 
three ‘clinical’ constructs influence ‘Decision making’, such as the 
availability of ‘Alternatives’, differences in perceptions depending 
Construct Frequency (number of 
patients reporting 
perceptions related to the 
construct) 
Elaboration (number 
of themes inductively 
generated for the 
constructs) 
Negative emotions 14 8 
Involvement in decision 
making 
14 7 
Health benefits 14 6 
Necessity 14 5 
Social Connection 13 5 
Awareness of risk / safety 12 5 
Burden 12 4 
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potentially on the blood product being transfused (‘Distinguishing between 
the blood products’) and the transfusion ‘Necessity’ (determined by HCPs or 
clinical indicators).
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Figure 7 Conceptual model of patients’ blood transfusion perceptions in haematology 
Single headed arrows indicate a direct one-way relationship, double headed dashed arrows indicate a bi-directional relationship between constructs. Influences on 'Decision making' are shown 
using the arrows.   
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4.3.2.5 HCPs’ perceptions 
Table 11 provides a full list constructs from the deductive analysis and newly 
generated HCPs’ themes of blood transfusion perceptions for each construct. 
Frequency counts (i.e. number of participants that reported a perception 
contributing to that theme) are also presented, supported with illustrative 
quotes and explanations for each construct below.  
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Table 11 Study 2 constructs from the blood transfusion conceptual model (HCPs) with themes, frequency counts and supporting quotes listed 
Construct header Frequency 
(n HCPs) 
HCP quotations 
Awareness of risk / safety   
Risks mitigated by safe transfusion practices 12 “…it's all quite safe, erm, in terms of, em, getting the right blood product for the patient, 
cause it's different steps in safeguarding steps to do that” (HCP 10, Senior House 
Office, Site 2) 
Risks and benefits established with patients 9 “so you just try to reassure it's a rarity, for you to obviously get anything from 
transfusion, and erm, reactions is the one that commonly comes up as well, they worry 
about reacting to, cause, 'does it have any side effects?' is the common question I get 
asked” (HCP 8, Nurse, Site 2) 
Iron overload considered a key risk 7 “the downside is if they continue to have lots and lots and lots of blood transfusions 
they will become / have high iron levels … so then you have the problem of the liver 
being affected because high ferritin, so that’s the downside of it” (HCP 2, Nurse, Site 
1) 
Infections, antibodies and reactions risks 7 “um, long-term wise I think it is probably not good for them because the more you get 
transfusion, the more becomes/ they develop the risk of having antibodies, er, and that 
can be very bad for them in the long run because you are/ every time we cross-match 
their blood products, it becomes rarer and rarer” (HCP 9, Senior Charge Nurse, Site 2) 
Short and long term medical and psychological impact 6 “they're also concerned about getting addicted to blood transfusions” (HCP 12, Clinical 
Psychologist, Site 2) 
Risk of not providing a transfusion 5 “they've got Leukaemia or MDS (Myelodysplasia Syndromes) and they just, and they 
know that this is all you can do, they just need to have their transfusion every how ever 
many weeks, and if you're not providing a chair for them, then they could end up on 
our medical assessment unit” (HCP 2, Nurse, Site 1) 
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Construct header Frequency 
(n HCPs) 
HCP quotations 
Health benefits   
Symptom improvement, making patients feel better 11 “Yeah, so largely it erm, taking away the tiredness and lethargy, which is, er, a symptom 
of patients that are anaemic, er, and for some of them improving their symptoms of 
shortness of breath on exertion” (HCP 7, Specialist Registrar, Site 1) 
Supportive care to carry on with normal daily living 10 “it's about trying to give them a quality of life, so trying to work out what's the best, you 
know, what's the best, amount of blood to give them if you like” (HCP 2, Nurse, Site 1) 
Benefits last a limited time only 8 “… it's really tricky to say to that person, or to their relatives 'right, we don't think you're 
benefitting from blood anymore' because they know if they don't have the blood they 
will die” (HCP 3, Specialty doctor (Haematology), Site 1) 
Shared HCP agreement of transfusion benefits 5 “yeah I think generally we all share the same view that actually it's benefiting the 
patient” (HCP 9, Senior Charge Nurse, Site 2) 
Patient questioned on benefits to provide / continue 
transfusions 
5 “…when we see them in clinic or when we see them in the day unit, um, and if we find 
they're having symptomatic benefit from it, you know then we carry on with it” (HCP 3, 
Specialty doctor, Site 1) 
Some risk-benefit for patients questionable 3 “I think quite, some of my patients who've maybe only got a slight anaemia, sort of eight 
to nine, haven't felt any better on transfusions, I think they'd rather have the slightly low 
count, so I think it really depends how low their haemoglobin goes” (HCP 13, 
Consultant Haematologist, Site 2) 
Necessity   
Transfusions support chemotherapy or used to treat 
anaemia 
12 “as I've said, it's the only way, with a lot of these people, it's the only thing that's keeping 
them alive, or it's the thing that's allowing them to have treatment, that's hopefully going 
to keep them alive” (HCP 8, Nurse, Site 2) 
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Construct header Frequency 
(n HCPs) 
HCP quotations 
Transfusions are vital, aiding survival 10 “it is palliative technically, it is because we are keeping them alive cause if we didn't 
transfuse them, they will die” (HCP 5, Consultant Haematologist, Site 1) 
Transfusions given to protect health 8 “if somebody has got a really low haemoglobin, they need the blood, cause obviously 
they’re struggling, sometimes they’re breathless, it puts a strain on the heart” (HCP 4, 
Transfusion Practitioner, Site 1) 
Necessity established using clinical and patient factors 8 “it (frequency of the transfusions) depends on their haemoglobin, the clinical 
symptoms, and the data, I mean, the blood results” (HCP 11, Haematology Specialist 
Nurse, Site 2) 
Patients rely on and express need for transfusion 5 “but other patients are so fixated by it, and it is keeping them going, that I think 
sometime it’s, I think, they really rely on it” (HCP 1, Haematology Specialist Nurse, Site 
1) 
Negative emotions   
Patients' unexpressed potential negative emotions 12 “Erm, I'm not quite sure though, how they exactly feel about their specific transfusion 
going in at the time, whether they're anxious, or? whether they feel happy, or? I dunno” 
(HCP 10, Senior House Office, Site 2) 
Patient anxiety and upset with receiving regular 
transfusions 
10 “they do get really worried if they come in and their haemoglobin's low, they 
immediately start thinking something bad's happening or worrying that they're going to 
have to start coming in every week” (HCP 8, Nurse, Site 2) 
Concern about downsides of transfusions for patients 10 “it is worrying, I mean people, if they've got cardiac problems, they can get chest pain, 
just really really unwell” (HCP 2, Nurse, Site 1) 
Practice concerns and frustrations 9 “I do worry here that we don't have enough capacity to get patients who are becoming 
acutely unwell and there isn't a space for them, and that really frightens me” (HCP 4, 
Transfusion Practitioner, Site 1) 
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Construct header Frequency 
(n HCPs) 
HCP quotations 
HCPs’ strategies to reduce patient anxiety 6 “[transfusion] is not treating the underlying cause and therefore their transfusion 
requirement will go up and at some point, we will stop. Because we warn them early 
that that's gonna happen; when that does happen they're less shocked” (HCP 7, 
Specialist Registrar, Site 1) 
Patients perceiving transfusion positively, as a lifeline 5 “I think people tend to be positive about it cause I think they get the fact that, you know, 
this is, this is all we've got for you, but actually it does work, you know” (HCP 3, 
Specialty doctor, Site 1) 
Upset in witnessing patients' worsening health or 
death 
3 “yeah, it’s quite distressing, it’s quite distressing, especially when you’ve known 
somebody for a number of years and then it gets to that point, you do sort of kind of 
think ‘oh why are they coming in’” (HCP 5, Consultant Haematologist, Site 1) 
Alternatives   
Alternatives considered or already in use 10 “most of these patients that are on such regular transfusion programmes are on EPO 
(erythropoietin) are on iron, are on all the other kind of alternatives to blood that they 
can be on and despite that are still requiring a blood transfusion” (HCP 10, Senior 
House Office, Site 2) 
No alternatives, transfusion only option 7 “I think as clinicians, people always weight that up and I think it's very difficult because 
I think there genuinely isn't an alternative … I just think there really isn't an alternative 
unfortunately” (HCP 4, Transfusion Practitioner, Site 1) 
Support for greater consideration and use of 
alternatives 
6 “in terms of the patients who require regular top up transfusions, it doesn't seem like 
there's much research done into alternative therapies and things and so we just readily 
assume 'oh we'll do bloods' as that's all we know, that's all we're readily exposed to” 
(HCP 9, Senior Charge Nurse, Site 2) 
Committed to giving regular transfusions once started 3 “So once you get someone in to having transfusion, you can't, if you could/ you switch 
the on switch, but you can't flick it off again and it usually ends up with that person 
being admitted to the main hospital with some infection…” (HCP 2, Nurse, Site 1) 
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Construct header Frequency 
(n HCPs) 
HCP quotations 
Involvement in decision making    
HCPs advocate and involve patients in decisions 13 “… other patients want to take control of it and not be told what to do, so you have to 
be, erm, I think you have to be flexible about that” (HCP 7, Specialist Registrar, Site 1) 
Team decision on transfusion prescription 13 “the nursing staff had reviewed the bloods and felt that they needed a blood transfusion, 
but then also/ ultimately the decision is with, um, with the doctor” (HCP 1, Haematology 
Specialist Nurse, Site 1) 
Patient autonomy in their own transfusion decisions 11 “I think he/she pushes it quite far, so he/she might avoid coming out for a transfusion 
to see if his/her haemoglobin gets better” (HCP 3, Specialty doctor, Site 1) 
Individual transfusion regime for each patient 11 “we try and individualise transfusion practice per patient, so if you have a patient whose 
haemoglobin drops down to below, I don't know, 70, on every two weeks, that's how 
often you give them their blood, so it is individualised” (HCP 5, Consultant 
Haematologist, Site 1) 
Transfusions prescribed appropriately using 
guidelines 
12 “to actually have something like that to say 'well I am following NICE guidance, 
therefore, I've got this huge! weight of evidence behind me, so I feel confident to make 
that decision'” (HCP 4, Transfusion Practitioner, Site 1) 
Deferral of decision making to HCPs 6 “I think a lot of patients rightly so place their trust in the medical team, the nurses and 
the doctors, so if somebody said they need a transfusion, I think it's very few and far 
between patients that say no” (HCP 14, Specialist Registrar, Site 2) 
Barriers to discussing transfusion or obtaining consent 5 “it is not always possible (obtaining and documenting verbal consent), especially in 
patients who are either unable to give consent or, you know, patients who are not in a 
state, because of the physical condition to give consent” (HCP 3, Specialty doctor, Site 
1) 
Tendency towards providing transfusion 4 “if they're very symptomatic with it, and even if the level is slightly off the baseline but 
they're very symptomatic then we like to give it” (HCP 10, Senior House Office, Site 2) 
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Awareness of risk/safety: Fifty percent of HCPs reported iron overload as the 
key risk for this patient group and more HCPs spoke about risks being 
mitigated as much as possible through safe transfusion and blood testing 
practices. Patients were made aware of risks such as iron overload, antibody 
build up, infections, reactions or risks associated with not being transfused 
through discussion with HCPs. A few HCPs reported other medical and 
psychological risks with transfusions, such as bone marrow damage, the 
requirement of venesections, nausea or patient dependency on transfusions.  
Health benefits: HCPs reported that transfusions improved patients’ 
symptoms and helped them to feel better to maintain their quality of life and 
daily activities. HCPs reported that they questioned patients about how 
beneficial they found their transfusions to be, in order to continue their 
transfusion prescriptions, yet HCPs knew that at some point for many patients 
the transfusion benefits experienced would end. Although a number of HCPs 
were convinced of the benefits and felt that their colleagues held a shared 
view of transfusion being beneficial (n=5), some risk-benefit considerations 
in particular patient cases were questionable (n=3).  
Necessity: HCPs reported that transfusions aided patients to survive and 
protected their health and that transfusions widely support haematology 
patients who receive chemotherapy or suffer from anaemia due to their 
illnesses. HCPs reported judging transfusions to be necessary based on 
clinical factors, such as the patients’ haemoglobin level and their physical 
functioning. HCPs reflected on patients who became dependent on their 
transfusions, feeling that they were necessary, with patients experiencing 
anguish when transfusions are deferred or delayed.  
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Negative emotions: Overwhelmingly, HCPs were concerned about the 
burden and physical impact of transfusion for their patients and were 
concerned and frustrated with capacity pressures and the difficulties of 
providing patients with more effective care (e.g. worries about patients being 
reviewed enough, lack of time to interact with patients). HCPs were aware of 
a large amount of patients’ anxieties, reasons for their distress or of the 
challenges that patients faced with receiving repeated transfusions (e.g. 
needing transfusion and its regularity, delays). HCPs reported using strategies 
such as offering reassurance or copies of blood counts, for example, to try to 
reduce patients’ anxieties. Some HCPs reported that patients’ fears may 
inhibit their involvement in transfusion discussions and that some patients 
expressed positive emotions when they did not need a transfusion, or for other 
patients, transfusions were viewed positively, as a lifeline. Clinical safety 
procedures being in place reduced some HCPs’ concerns.  
Involvement in decision making: The majority of HCPs advocated and 
involved patients in transfusion decision-making, despite some accounts of 
decisions being made away from the patients (n=6), without informed consent 
(n=3) or being deferred to them by the patients to make (n=5). Many HCPs 
reported making patient-tailored transfusion decisions as a team, consulting 
with laboratory departments and guidelines. There was a slight tendency 
towards providing transfusion if symptoms indicated towards this, and 
accounts of patients questioning or resisting their transfusion were present. 
Transfusions were also seen as a part of a treatment plan discussed to a lesser 
extent when primary treatments took precedent: 
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Alternatives: HCPs supported greater consideration into the use of 
alternatives and consulted patients who may request alternatives. Many 
alternatives, however, were either being tried to some benefit (Erythropoietin 
injections) (n=4) or alternatives generally were not an option for this patient 
group (n=4). Some HCPs understood that patients may prefer alternatives, but 
opted for transfusion due to symptoms, clinical indicators or the evidence 
base.  
4.3.2.6 New haematology themes: HCPs 
Four new themes were developed from HCP data that could not be coded into 
the pre-existing conceptual model constructs. These four themes were 
recognised as new constructs added to the conceptual model: ‘Burden’ (14 
HCPs reporting data for this construct and 2 themes), ‘Organisational factors’ 
(13 HCPs and 5 themes), ‘Stability/ Variability of transfusion perceptions’ 
(11 HCPs and 3 themes) and ‘Supportive relationships’ (9 HCPs and 2 
themes). Table 12 provides a full list of themes with participant frequencies 
and example quotations, followed by a discussion of each construct, with an 
elaborative quotation in turn.  
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Table 12 New haematology HCP constructs and themes, frequencies and quotes per theme listed 




Anticipated attendance burden for patients 11 “if they’re really regular I suppose it’s the fact they’re having blood test and 
they’re here, and they’re seeing the doctors, and you do, it must be quite hard, 
patients must feel they’re like here all the time almost” (HCP 1, Haematology 
Specialist Nurse, Site 1) 
Transfusion’s become a part of patient's routine life 7 “I think for some, it's just like a way of life for them, em, it's just something that 
they do and they know other patients who are on a similar sort of path and then 
they're quite pally with them…” (HCP 9, Senior Charge Nurse, Site 2) 
Organisational factors 
Solutions needed to improve processes and ease 
capacity strain 
7 “… we're trying to organise transfusions, at short notice, for our patients at 
short notice on the day unit and ˆ they've got no capacity to deliver the 
transfusion” (HCP 6, Consultant Haematologist, Site 1) 
Constraints to greater discussion of patients’ views 6 “there's only one of you, and seven patients, it's not always easy to sit with the 
patient, discuss any concerns or issues or just have a general conversation” 
(HCP 8, Nurse, Site 2) 
Solutions needed to enhance communication 6 “I think there's the other side about educating staff as well about blood 
transfusion, you know, and how to define risks and you know, encouraging 
them to discuss with the patients” (HCP 2, Nurse, Site 1) 
High and costly blood use for hospital 6 “I mean blood transfusion can work, but, um, it is quite a bit more costly both 
for the hospital and for the patient's time” (HCP 12, Clinical Psychologist, Site 
2) 
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Theme header Frequency 
(n HCPs) 
HCP quotations 
Complicated management of transfusion slots 5 “so they send me a letter or an e-mail or something saying 'this person is going 
to need blood product support and then we're like 'well, where are we gonna 
put them in then?” (HCP 3, Specialty Doctor, Site 1) 
Stability and variability of transfusion perceptions 
Views consistent and similar to colleagues 7 “I think there's a general agreement about the use of transfusions for this 
patient group… yeah, I'd say we pretty much all have the same view” (HCP 10, 
Senior House Office, Site 2) 
Views broadened through haematology exposure 7 “before blood transfusions were a one-off sort of thing … since being here, it’s 
actual haematology conditions that require regular blood transfusions, so I see 
a different side now, and I see, erm how reliant people are on them” (HCP 5, 
Consultant Haematologist, Site 1) 
Patients' transfusion perceptions variable 2 “I think it's very variable, I don't think there's like one general consensus across 
the patients definitely” (HCP 14, Specialist Registrar, Site 2) 
Supportive relationships   
HCPs approachable and bond with patients 5 “… one of our regulars died in, in the week on the ward, and it's upsetting 
because you know, we get to know them so well and all about them, they talk 
to you a lot and erm, and it gets quite personal” (HCP 3, Specialty Doctor, Site 
1) 
Efforts to increase patient comfort in unit 4 “they are often coming in with someone, erm, that you know, they bring 
someone with them … just to ensure that they've got relatives, or they've got 
people involved” (HCP 8, Nurse, Site 2) 
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Burden: HCPs’ perceptions for this theme reported that frequent and lengthy 
appointments must be burdensome for patients (n=11), and that transfusions 
have become a part of patients’ routine lives (n=7). One HCP commented that 
patients could maintain some quality of life despite frequent hospital visits: 
“because these patients if they don't have their transfusions, they aren't able 
to get up and be, have that level of activity that they would have without that 
transfusion, so despite having to come in and have a cross-match one day, 
blood the following day and then only really have one day out of hospital a 
week, they still manage to maintain some quality of life” (HCP 14, Specialist 
Registrar, Site 2).  
Organisational factors: Many HCPs from both sites acknowledged 
constraints that they faced to more greatly discuss their patients’ transfusion 
perceptions, such as the haematology units being busy or the lack of routine 
questioning of patients’ perceptions. HCPs explained in detail the complexity 
of managing the limited transfusion slots, as blood was highly used at a cost, 
and felt that solutions were needed to improve processes and ease capacity 
strain. Patient- or HCP-education was signalled as necessary to enhance 
patient and HCP communication.  
In relation to the complexity of managing the slots: “we'll sit down and we'll 
look and 'well if I have to cancel this person this week, if they needed a 
transfusion in three weeks’ time, are we going to be able to have a slot?' you 
know, that sort of thought behind it, so it's quite complicated … we try and 
stretch it because of the lack of availability of slots, we try and stretch it to 
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the absolute maximum, so we/ and we try not to prescribe if we don't have to 
prescribe” (HCP 3, Specialty Doctor, Site 1).  
Stability and variability of transfusion perceptions: Many HCPs reported 
that their own views about transfusion were either stable over time and similar 
to their colleagues or inconsistent with their own past views or with their 
colleagues’ views. For example, HCPs reported that their views had often 
broadened since working in haematology units, proving exposure to medical 
and long-term transfusion use. Or that their perceptions and behaviours have 
changed over time, such as having greater tolerance of lower haemoglobin 
levels in patients before transfusing. One nurse specifically reported how a 
patient changed their perceptions based on a discussion with them:  
“I don’t think those people think oh yeah it is a blood transfusion, and it’s 
somebody else’s blood you’re receiving, it is a transplant … erm, they / I 
think it makes some of them stop and think, some of them, or other people say 
“Oh yes, yes I know that” or “oh yeah, I’ve never really thought of it that 
way” so it is interesting” (HCP 2, Staff Nurse, Site 1). 
Supportive relationships: HCPs discussed their efforts to be approachable 
for patients and how they developed a bond with many patients, such as by 
listening to them and providing information like blood counts. This was felt 
to be important to enhance patients’ feelings of control. HCPs reported ways 
in which they aimed to increase their patients’ level of comfort during the 
transfusions, or that other patients or patients’ acquaintances whom patients 
attend with may be supportive. 
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“Erm, some of them might get some benefit out of that [lengthy appointments] 
cause it gives them an opportunity to have a chat with patients who are going 
through a similar experience and see that they're not alone” (HCP 6, 
Consultant Haematologist, Site 1).  
4.3.2.7 Importance of perceptions: HCPs 
Table 13 reports the importance ranking of constructs from the conceptual 
model, alongside newly identified constructs, according to frequency and 
thematic elaboration (i.e. themes per construct). The most frequent HCP 
theme was ‘Involvement in decision making’, followed by ‘Health benefits’ 
and ‘Necessity’.  
Table 13 Frequencies and elaboration of HCPs’ responses per construct  
 
 
Construct Frequency (number 
of HCPs reporting 
perceptions related to 
the construct) 
Elaboration (number of 
themes inductively 
generated for the 
constructs) 
Involvement in decision 
making 
14 8 
Negative emotions 14 7 
Health benefits 14 6 
Necessity 14 5 
Burden 14 2 
Organisational factors 13 5 
Alternatives 13 4 
Awareness of risk / safety 12 6 
Stability/ Variability of 
transfusion perceptions 
11 3 
Supportive relationships 9 2 
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4.3.2.8 HCPs’ blood transfusion perceptions conceptual model for 
haematology  
In the HCP haematology conceptual model, the six construct structure is also 
supported (Figure 8), with the addition of four haematology-specific 
constructs. Three constructs are proposed to link directly with ‘Negative 
emotions’: transfusion ‘Burden’, ‘Safety/risk’ concerns and ‘Supportive 
relationships’, which could help ease patients’ concerns or worries. 
‘Supportive relationships’ such as positive contact with HCPs and other 
supportive contacts, whilst patients receive their transfusions may also ease 
perceptions of transfusion ‘Burden’.  
‘Safety/risk’ vs. ‘Health benefits’ decisions are associated, being routinely 
considered and discussed with patients and the model also displays ‘clinical 
factors’ which influence ‘Decision making’. This is transfusion ‘Necessity’, 
the suitability of ‘Alternatives’ and ‘Organisational factors’; appointment 
availability etc. Prior to decision making, the ‘Stability or variability of 
HCPs’ transfusion perceptions may influence tolerance of (lower) 
haemoglobin levels, practice consistency, transfusion acceptability and team 
decision making agreement.  
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Figure 8 Conceptual model of HCPs’ blood transfusion perceptions in haematology 
Single headed arrows indicate a one-way relationship and double headed dashed arrows indicate a bi-directional relationship between constructs. Influences on 'Decision making' are shown using 
the arrows. 
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4.3.2.9 Triangulation of patient and HCP perceptions  
To assess convergence and divergence of perceptions, the 95 patient and HCP 
themes generated during inductive analysis were tabulated (Table 14) and 
compared using the aforementioned triangulation protocol. There was 
moderate convergence (42%) between patients’ and HCPs’ perceptions. Full 
agreement between patients’ and HCPs’ themes was recognised on 24 
occasions (35%), partial agreement on seven occasions (8%), disagreement 
on four occasions (5%) and silence on 39 occasions (52%). Table 14 lists all 
themes with their agreement ratings. 
Agreement was greatest for the ‘Health benefits’, ‘Alternatives’ and 
‘Involvement in decision making’ constructs. For ‘Health benefits’, for 
example, HCPs reported similar benefits of blood transfusion as patients, 
mainly that transfusions aided patient survival and improved patients’ 
symptoms. Partial ratings occurred, for example, with HCPs reporting that 
they involved patients in their transfusion decisions, whereas for patients, 
they commented that involvement was generally positive and that they were 
offered transfusions with an element of choice.  
Disagreement was recognised for example, for ‘Burden’ where patients 
expressed often having ‘Life restrictions’ in respect to travel, due to needing 
to stay close to the haematology unit, whereas some HCPs reported that 
transfusions can become a part of a patient’s routine life “it's very individual, 
some patients, erm, have been in the system a long time, especially 
haematology patients and they just take it as part and parcel of the course 
and they don't really have, they kind of got so use to it they don't really have 
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any qualms in having the blood transfusion” (HCP 14, Specialist Registrar, 
Site 2).  
Silence occurred for themes, in which patients or HCPs expressed their 
particular patient / HCP role experiences (e.g. no negative consequences from 
transfusion or that patients are reviewed and consulted with when transfusions 
may need to end). 






Theme label Agreement 
rating  
Burden 




P Attendance not a great burden  
HCP Anticipated attendance burden 
for patients 
Burden 




P Life restrictions, travel 
HCP Transfusion has become a part 
of patient's routine life 
Distinguishing 
blood products 
P Knowledge gaps for platelets  Silent 
Distinguishing 
blood products 
P Positive perception of platelets  Silent 
Distinguishing 
blood products 











P Transfusion offered with patient 
involvement in choice 
HCP HCP advocates and involves 
patients in decisions 
Social 
connection 
P Interaction with other patients Silent 
Social 
Connection 
P Lack of interaction or activity 
during transfusions 
Silent 











P Curiosity and appreciation for 














HCP Efforts to increase patient 




HCP Solutions needed to improve 





HCP Constraints to greater discussion 




HCP Solutions needed to enhance 

















HCP Views on transfusion broadened 















risk / Safety 
P Discomfort and illness during or 
post-transfusion 
1 Agreement  
1 
Disagreement 
P No experienced negative 
consequences 
HCP Short and long term medical and 
psychological impact 
Awareness of 
risk / Safety 
P Health risks from high iron 
levels  1 Agreement 







Theme label Agreement 
rating  
HCP Iron overload considered a key 
risk 
Awareness of 
risk / Safety 
P Potential infection or reaction 
risk  
1 Agreement 
HCP Infections, antibodies and 
reactions risks 
Awareness of 




P Caution needed, blood should be 
used appropriately 
1 Agreement HCP Transfusions prescribed 
appropriately using guidelines 
Awareness of 
risk / Safety 




risk / Safety 




risk / Safety 




P Transfusions used as a current 




HCP Transfusions support 
chemotherapy or used to treat 
anaemia 
Necessity 
P Transfusion prolonging life and 
aiding survival  
2 Agreement HCP Transfusions are vital, aiding survival 
HCP Transfusions given to protect 
health 
Necessity 
P Need for transfusion apparent 
through symptoms  1 Partial 
agreement HCP Patient reliance and expressed 
need for transfusion 
Necessity P Speculation and doubt over 




P Need established by HCPs and 
clinical indicators 2 Agreement 











HCP Team decision on transfusions 
prescription 
HCP Necessity of transfusion 
established in balance with 
clinical and patient factors 
Health benefits 
P Keep going with daily life 
1 Agreement HCP Supportive care to carry on with 
normal daily living 
Health benefits 
P Boosting blood levels* 
1 Agreement  
1 Partial 
agreement* 
P Relief of symptoms such as 
tiredness 
HCP Symptom improvement, making 
patients feel better 
Health benefits 
P Can take time to feel benefit of 
transfusion 1 Agreement 
HCP Benefits last a limited time only 
Health benefits P Anticipated benefits Silent 
Health benefits P Patient convinced of benefit by 
significant others 
Silent 
Health benefits HCP Shared HCP agreement of 
transfusion benefits 
Silent 





P No concerns or worries with 
transfusions 
2 Agreement P Gratitude that transfusions possible 
HCP Patients perceiving transfusion 
positively, as a lifeline 
Negative 
emotions 






P Relaxed during transfusion 
appointments* 
P Concern of transfusion 
dependency 
HCP Patient anxiety and upset with 
receiving regular transfusions 



















P Perception that doctors dislike 
prescribing transfusions 1 Partial 
agreement HCP Concern about downsides of 
transfusions for patients 
Negative 
emotions 















HCP Upset in witnessing patients' 
worsening health or death 
Silent 
Alternatives 
P Alternatives considered or 
already in use 
1 Agreement 
HCP Alternatives considered or 





P No alternatives, transfusion the 
only option 
2 Agreement P Confronted with limited or no choice 
HCP No alternatives, transfusion the 
only option 
Alternatives P Patient preference for 
alternatives 
1 Agreement 
HCP Support for greater consideration 
and use of alternatives 
Alternatives P Patient's body can correct 
depleted cells 
Silent 
Alternatives HCP Committed to giving regular 





P Willing acceptance of 
transfusions 2 Agreement  
1 Partial 
agreement* HCP Patient autonomy in their own 
transfusion decisions 











HCP Patient reliance and expressed 
need for transfusion 
HCP Patient questioned on health 





P Deferral of decision making to 
HCPs 
1 Agreement 

















P More frequent transfusions 











HCP Barriers to discussing 










This chapter reports an interview study conducted across two haematology 
day units that aimed to investigate haematology patients’ and HCPs’ 
perceptions of blood transfusions. This study found that patients and HCPs 
considered transfusions beneficial for managing patients’ haematological 
disorders and symptoms. HCPs largely worked together with their colleagues 
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and patients to discuss transfusion decisions, risks and blood-sparing 
alternatives. Both patients and HCPs experienced negative emotions, linked 
to the downsides of transfusion for patients. HCPs also held concerns directed 
towards constraints with the transfusion service that they can provide. 
Patients and HCPs reported strategies to manage their negative emotions, 
such as remaining positive and hopeful (patients) or offering reassurance to 
patients (HCPs) or holding trust in their clinical safety measures (HCPs).  
From the inductively generated constructs, ‘Burden’ was an emergent 
construct for both patients and HCPs where there was a clear distinction 
between transfusions being time-consuming and frequent, yet also for some 
patients, a part of their ‘routine’ lives. New constructs for patients covered 
their cognitive understanding and experience with the different blood 
products they receive (‘Distinguishing between blood products’) and their 
perceptions of support that may be available for them, such as from other 
patients (‘Social Connection’). HCPs’ perceptions led to constructs being 
generated that profiled a considerable level of compassionate patient care: 
(‘Supportive relationships’), within a busy and pressurised environment: 
(‘Organisational factors’). HCPs in this study had the opportunity to reflect 
on the ‘stability’ and ‘variability’ of their own transfusion perceptions, 
remarking their perceptions to remain largely stable after working in the field 
of haematology and that their perceptions were comparable with their 
colleagues. Overall, there was moderate convergence between patients’ and 
HCPs’ themes of perceptions despite both groups holding different roles 
(patients vs. providers).  
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The constructs generated from this study extended on the conceptual model 
of blood transfusion perceptions, from the preceding systematic review. This 
suggests that specific patient and HCP groups receiving transfusions in 
different contexts will hold unique perceptions, supporting the requirement to 
explore transfusion patient and HCP groups within their specific contexts, 
rather than treating transfusion patients and HCPs homogenously. This is 
supported in the treatment perceptions literature, that context will inform 
treatment perceptions (Horne, 2003). The conceptual models in this chapter 
portrayed how context linked to key emotional perceptions, for example, 
organisational pressures causing concern for HCPs and through holding 
strong relationships with HCPs (‘Social connection’) patients were exposed 
to collaborative patient-HCP practices (e.g. ad hoc discussion of the 
transfusion regimen and asking questions). Collaborative practices found in 
this context may have positive outcomes for patients. Patients who engage 
with HCPs in more collaborative practices have a higher level of decisional 
control and decisions matching their preferences, resulting in better health 
outcomes for the patient (Ghane et al., 2014). 
For the current study, perceptions of ‘risk’ related to patients’ clinical 
vulnerability and transfusions raising patients’ iron levels. HCPs were 
empathetic to and aware of these health threats and treatment needs facing 
patients. Findings also highlighted synchrony in perceptions between patients 
and HCPs, in particular for the ‘Health Benefits’, ‘Alternatives’ and ‘Burden’ 
constructs. Although, the triangulation analysis detected that HCPs may 
perceive that transfusions cause less patient disruption once they are in an 
established routine, whereas patients discussed ongoing challenges, such as 
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travel restrictions. There was also alignment into the report of patients being 
involved in the decision-making, yet many patients faced limited treatment 
options beside transfusion and irrespective of this held some knowledge gaps. 
Therefore, there are some areas where HCPs could have had a more accurate 
understanding of patients’ perceptions, which may have implications for 
practice and ongoing scheduling of transfusions (e.g. if patients have ‘burden’ 
related or ‘knowledge’ related barriers or uncertainties).  
The findings from this study align with and advance on the broader literature. 
Patients in this study did not find their transfusions to be overly anxiety 
provoking or hard to come to terms with (Randall et al., 2005). Instead they 
remained hopeful, keeping a positive outlook, as had been reported elsewhere 
in the cancer treatment literature, with haematology patients reporting 
acceptance of their conditions, changing life’s priorities, and increasing 
engagement with HCPs and significant others as a way to cope with their 
conditions (Bulsara et al., 2004) (Prip et al., 2017). Patients may have used 
appraisal-focussed coping to accept the reality of their situation, redefining it 
as acceptable (Moos et al., 1984). Patients receiving dialysis treatment have 
been reported to find acceptance, perceiving dialysis as a life-sustaining gift 
(Reid et al., 2016).  
Some patients in this study reported that they enjoyed attending for their 
transfusions and that their acceptance of transfusion improved over time. 
Patients are likely to have developed ways that they cope with their 
transfusion, such as occupying themselves during their transfusions and 
engaging with the wider patient and healthcare team, which they reutilise each 
time their appointment occurs. The positive outcomes of such strategies 
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inform the development of new perceptions (Leventhal et al., 1980; Leventhal 
et al., 1984), which is evidenced with patients discussing long-held and 
consistent perceptions towards the transfusions, such as that it ‘keeps them 
going with daily life’ etc.  
HCPs treating cancer patients have, however, been reported to experience a 
high level of emotional exhaustion (Trufelli et al., 2008). For HCPs in this 
study, the findings signalled many aspects of their compassionate care. 
However, if not well supported, many HCPs may be exposed to a potential 
risk of ‘burnout’, defined as ‘a breakdown of the psychological defences that 
a worker uses to cope with intense job-related stress’ (Brohl, 2006). This is 
due to HCPs aiming to increase patients’ comfort and meet their information 
needs whilst working in a pressurised service. HCPs also reported holding 
some negative emotions of the downsides of transfusion for many of their 
patients.  
Strengths of this study include the methodological approach taken to reduce 
bias by inviting all eligible transfusion patients to take part in the study, 
alongside interviewing consenting transfusion HCPs at the same sites within 
the same study time-frame. All patients were interviewed whilst in their 
transfusion chair, during or just prior to their transfusion, minimising recall 
bias and potentially heightening the vivid and actual account of their beliefs 
and experiences. Although the ‘in context’ investigation of patients’ and 
HCPs’ perceptions minimised recall bias, a limitation of this could be that 
patients, especially, may have provided more positively framed perceptions 
as the interviews were conducted in the unit with other patients and often 
HCPs within hearing distance. This may have enhanced participants 
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providing more socially desirable responses that listeners would have more 
highly endorsed (Edwards, 1957). The researcher reflected on this, aiming to 
conduct the interviews in quiet sections of the haematology unit to allow the 
participants to freely share their views as openly as possible. The researcher 
also clarified that the research was being collected independently for her PhD 
qualification and that the interviews were confidential, holding no bearing on 
the HCP’s role or the patient’s care.  
Understanding participants’ own interpretation of their issues is in line with 
the theoretical Realism stance, which the researcher is aligned to. Critical 
Realism (Willig, 1999), for example, acknowledges ways in which 
individuals make meaning of their experience (Braun et al., 2006). Therefore, 
it was important that the interviews were semi-structured, allowing 
participants to fully express how they experience delivering or receiving 
transfusions in the real haematology context.  
To facilitate meaningful comparisons of patient and HCP data to be drawn, 
patients and HCPs were also asked comparable topic guide questions, with 
the deductive constructs aligned to the broader treatment perceptions 
literature, as discussed in Chapter 3. As a limitation to this, however, HCPs 
were asked a translated version of a patient-centred questions (e.g. ‘What are 
the benefits of transfusion for haematology patients?’ instead of ‘What are 
the benefits of transfusion for you?’). Although HCPs’ own perceptions did 
emerge through the interviews, of challenges they faced, etc., there may have 
been value in asking HCPs a slightly alternate set of questions, addressing 
their potential needs. A further limitation to the study was that the researcher 
solely completed the triangulation ratings alone, without a second rater to 
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assess inter-rater reliability. This leaves the rating results open to subjective 
bias, where the researcher may have interpreted no links, e.g., a higher level 
of ‘silent’ or ‘agreement’ themes, which scored the most highly without a 
secondary objective rater providing their opinions.  
Future research could build on this study by utilising the applicable patient or 
HCP conceptual model to consider whether other patient and HCP groups 
hold similar beliefs about transfusion. Sickle-cell patients receiving 
exchange-transfusions, for example, often have to manage their pain in the 
community and face mistrust and stigmatization from HCPs when attending 
hospital, in that they do not wish to attend or disclose information for fear of 
not receiving adequate treatment for pain (Maxwell et al., 1999). Further 
research with acute transfusion patients remains warranted; as an under-
represented transfusion patient group, as well as research with other patient 
groups who also receive routine treatments, such as dialysis patients. This 
may prove beneficial to identify patients’ and their treating HCPs’ 
perceptions. Further research may also wish to explore patients’ perceptions 
about ‘Organisational factors’, whether this impacts on their experiences of 
receiving transfusions, or whether their ‘Supportive relationships’ are 
adequate. 
There are some key implications for practice suggested from this study. HCPs 
showed motivation for the transfusion service to be enhanced, or potentially 
better resourced and organised. Services were reportedly stretched in terms 
of capacity (i.e. full transfusion appointment slots) and HCPs provided a high 
level of goodwill and gave great efforts to ensure patients’ wellbeing. When 
asked directly, there was some lack of clarity from HCPs about how patients 
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perceive transfusion. This indicates that some patients may benefit from a 
greater amount of support, for example, newly transfused patients who are 
yet to build sustainable coping strategies. Patients may thus welcome service 
enhancements, for example education into specific blood products, such as 
platelets, which do hold the greatest transmission risk (Goodnough et al., 
2003) or greater involvement in transfusion decision-making, specifically in 
how to manage any negative emotions, at least at the time of diagnosis, when 
engaging in decision-making discussions. If patients are not as involved in 
their transfusions as they wish to be, or lack understanding of parts of the 
process or blood products, patients may form misperceptions and face 
challenges of coping with unnecessary fears. Possibly less relevant for 
transfusion dependent patients, but patients having knowledge gaps about 
their treatment, exacerbated through not being involved in decision-making 
discussions, may have a lower level of treatment adherence, being less able 
to weigh up the risks and benefits of treatment (Horne et al., 1999a).  
In conclusion, this study addressed a gap in the evidence base of haematology 
transfusion patients’ and HCPs’ perceptions of blood transfusions. The 
findings of this study revealed that transfusions are perceived to be necessary 
and beneficial for haematology patients and that patients were largely 
involved in their transfusion decision making, but experienced negative 
emotions in relation to the burden of the repeated transfusions, and health 
consequences, such as iron overload. HCPs shared these concerns with their 
patients and the challenges of providing a high volume of repeated 
transfusions with stretched capacity weighed heavily. Further research could 
utilise the haematology conceptual models with several alternate patient and 
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HCP groups and seek to investigate within the haematology service 
recommendations for practice change arising from these findings. If patients’ 
experiences of receiving transfusions in haematology units were enhanced, 
patients may feel more supported to deal with negative emotions. Improving 
the transfusion service for patients may also enhance HCPs’ negative 
emotions and potentially alleviate some service pressures.  
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5 BOOST: Building Optimised Outpatient Services in 
Transfusion: A focus group study 
Study 2 (Chapter 4) of this thesis qualitatively explored haematology patients’ 
and healthcare professionals’ (HCPs’) perceptions of blood transfusion. The 
results showed that HCPs found transfusions to be beneficial and necessary 
for haematology patients, but that perceptions of transfusion ‘burden’ and 
delivering transfusions in pressurised services existed. This chapter describes 
Study 3 of this programme of research, which involved focus groups with 
blood transfusion HCPs that aimed to build on Study 2 by investigating 
HCPs’ views of patients’ reported perceptions of blood transfusions and 
identify opportunities for service improvement to address these.  
 Introduction 
Implementing change in healthcare, such as introducing new or modified 
innovations, is complex and particularly challenging if alterations in clinical 
practice are required, or if better collaboration between disciplines, changes 
in patient behaviour or in the organisation of care are sought (Grol et al., 
2013). Interventions have been initiated to improve blood transfusion clinical 
practice by changing HCPs’ prescribing behaviour. For example audit and 
feedback interventions, guideline changes or introducing transfusion forms 
that outlined criteria for transfusion (Tinmouth et al., 2005; Wilson et al., 
2002). Interventions have also been launched to conserve blood use coherent 
with Patient Blood Management initiatives (Oliver et al., 2014), supporting 
optimised care delivery for patients, who are placed central to the care they 
receive. 
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It is important to design services with patients in mind, to provide patients 
with the best experience and to reduce any negative cognitive or emotional 
perceptions that can arise when patients face health threats and seek treatment 
(Leventhal et al., 1980). Policy makers advocate patient participation in their 
healthcare, suggesting that this improves quality, efficiency and health 
outcomes (Coulter et al., 2007). Involving patients and considering their 
treatment perceptions is especially important for designing patient-centred 
changes, impacting patients who could then after face alterations to how they 
are offered their treatments and services.  
Identifying patients’ perceptions has been central to help drive change in 
healthcare practice. Experience based co-design (EBCD) is one approach to 
access user experiences and to use the knowledge of the users encountering 
the service to design better services (Bate et al., 2006; Brocklehurst et al., 
2018). EBCD has been effectively applied in secondary care settings placing 
patients as active partners with HCPs in quality improvement for breast and 
lung cancer (Tsianakas et al., 2012b; Tsianakas et al., 2015). Patient inspired 
changes have also been recognised for older-aged patients attending hospital 
outpatient clinics (Wolstenholme et al., 2010) or through focus group style 
methodologies being used, in which patients and HCPs worked together to 
stimulate ideas for service improvements, which were subsequently 
prototyped and tested (Thomson et al., 2015).  
These studies show that patients can be considered as joint experts in their 
care, holding perceptions that are vital to service re-design. The haematology 
interview study reported in Chapter 4 identified scope and potential need for 
implementing change in haematology transfusion service structure and 
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delivery. The theme ‘Organisational factors’ identified from HCP interviews 
related to the need for haematology transfusion services to be altered to 
improve processes and ease capacity strain. Some HCPs reported that they 
did not spend time exploring their patients’ views on transfusion, with some 
HCPs unsure about how haematology patients felt about their transfusions. 
Addressing this could help to bridge patient and HCP communication around 
transfusion, which is fundamental to patient-centred healthcare delivery and 
underpins the ethos of patient involvement in co-designing the services they 
receive (Bate et al., 2006; Brocklehurst et al., 2018).  
Patients communicating their perceptions to HCPs is fundamental and 
underpins patient-centred approaches such as shared decision-making 
(Charles et al., 1999). Some HCPs may be unaware of the types of perceptions 
reported by haematology patients in the preceding interview study (Chapter 
4). Some patients reported their transfusions to be burdensome, requiring 
frequent hospital visits, and although beneficial and necessary, very few other 
alternatives were possible, and patients faced many risks, such as excessive 
iron levels. It is currently unclear how HCPs might respond to these 
perceptions. HCPs may consider it feasible within haematology outpatient 
services to modify current practices and support change. Alternatively, as 
indicated in the interview results, HCPs may be led by routine and guideline-
led practices, which often over-rule patients’ preferences (Molewijk et al., 
2003).  
This study aimed to present blood transfusion HCPs with haematology 
patients’ perceptions from the preceding interview study and explore their 
responses to these perceptions. This study sought to identify whether HCPs 
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can identify with these views and feel that they are reflective of their daily 
practice and explore what could be done to address the perceptions by altering 
service provision.  
Practice change is often facilitated through the generation of service 
improvement strategies. This encompasses guideline change 
recommendations to address current practice gaps, as well as direct patient 
care initiatives such as new procedures or techniques (Grol, 2013). Change 
may also be initiated through healthcare teams altering how they work and 
clinical leads championing change (Brown et al., 2014). In haematology 
transfusion contexts, joint patient and HCP motivators for service 
enhancement are likely to exist. This is for the benefit of improving patients’ 
experiences but also to create optimised services that relieve pressures on 
HCPs.  
The study aimed to foster collaboration between HCPs of different levels of 
seniority and roles from different transfusion units, to meet and discuss the 
patients’ perceptions and potential service improvement strategies. This 
allows for best practices to be shared and the patients’ perceptions to become 
a ‘catalyst for high-quality innovation’ (McNichol, 2012). It is likely that 
HCPs will identify barriers and enablers to implementing changes to their 
practice. Planning complex practice change requires the nature of the 
innovation; characteristics of the professionals and patients involved, and the 
social, organisational, economic and political context to be considered (Grol 
et al., 2004).  
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Clinical practice is a form of human behaviour, which can be explained, 
understood and predicted by drawing on theories and models of behaviour 
change (Atkins et al., 2017). These models describe the various determinants 
of behaviour and specifies key variables to explain differences that occur 
across situations, contexts and populations (Noar et al., 2005). Healthcare 
practice change that directly involves patients and HCPs changing their 
behaviour benefits from the application of theory and the consideration that 
single behaviours operate within larger systems of behaviours, with their 
being multiple levels of intervention, such as population, community and 
individual levels (Dahlgren et al., 1991; National Institute for Health and Care 
Excellence., 2007, 2014).  
In haematology units, population change may involve service re-organisation 
or changes directed at the whole haematology outpatient population. 
Community changes may involve strengthening team links to consider 
patients’ perceptions and behaviours before and after they attend the unit for 
their transfusions. Individual behaviours may be directed at behaviours HCPs 
or patients could solely do differently, such as HCPs altering their prescribing 
habits or patients reducing the number of missed appointments. As there are 
multiple theories of behaviour change, with little guidance of the best theory 
to select, the Theoretical Domains Framework (TDF) (Michie et al., 2005) 
offers a theoretical framework comprised of 14 domains, which can be used 
to explain cognitive, affective, social and environmental influences on 
behaviour. The 14 domains, which have been validated are: Knowledge, 
Skills, Social professional role and identity, Beliefs about capabilities, 
Optimism, Beliefs about consequences, Reinforcement, Intention, Goals, 
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Memory attention and decision processes, Environmental context and 
resources, Social influences, Emotion, Behavioural regulation (Cane et al., 
2012). These domains contain 84 theoretical constructs, which are concepts 
specifically devised to be part of a theory (Michie et al., 2005) (e.g. within 
‘Knowledge’ is ‘procedural knowledge’ and ‘knowledge of task 
environment’ etc.).  
To facilitate behaviour change, people must face opportunities to change their 
behaviours, as well as being able (capability) and motivated to. These are 
factors underpinning behaviour considered in the COM-B (Capability, 
Opportunity, Motivation – Behaviour) Model, which is a behavioural science 
model used to demonstrate how behaviour is generated through an interaction 
of capabilities, opportunities and motivations (Michie et al., 2011). 
‘Capability’ to influence behaviour change, in the COM-B, is recognised as 
physical strength and psychological skill and knowledge. ‘Opportunity’ is 
conducive of being in the right physical and social environment (e.g., 
physically accessible, affordable, socially acceptable, sufficient time). 
‘Motivation’ equates to reflective and automatic influences of competing 
behaviours (Michie et al., 2011). As presented in Figure 9, the TDF domains 
map onto the six sources of behaviour from the COM-B Model (Figure 9). 
Both models are increasingly applied to explore barriers and enablers to HCP 
practice change (Francis et al., 2012).  
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Figure 9 COM-B Model (Michie et al., 2011) and Theoretical Domains 
Framework (TDF) (Michie et al., 2005) domains linkage  
The COM-B Model and TDF offer frameworks that could be used to identify 
and categorise reported barriers and enablers to service improvements in 
haematology services. The COM-B Model also serves as the hub of the 
Behaviour Change Wheel (BCW) (Michie et al., 2011) which is a synthesis 
of 19 frameworks of behaviour change used to identify intervention options 
(Michie et al., 2011). Figure 10 shows the BCW with the COM-B Model core 
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‘sources of behaviour’ and nine intervention functions related to the COM-B 
dimensions and seven types of policy that can be used to deliver the 
intervention (Michie et al., 2011).  
 
Figure 10 Behaviour Change Wheel (Michie, van Stralen & West, 2011) 
The BCW is applied to an increasing number of intervention development 
studies, for example to increase the frequency of physical activity advice for 
cancer patients (Webb et al., 2016), to develop collaborative medication 
review and decision-making interventions (Sinnott et al., 2015) and for 
antibiotic prescription in long-term care facilities (Fleming et al., 2014). Thus, 
the BCW is worthwhile to utilise when considering the categories of any 
emergent intervention ideas, prior to planning their development further.  
5.1.1 Study aims 
This study aimed to explore the extent that HCPs identified with patients’ 
transfusion perceptions from the previous interview study in their practice 
and explore resultant areas for practice change. 
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5.1.2 Research Questions:  
1. To what extent do HCPs identify with constructs of patients’ reported 
perceptions of blood transfusion? 
2. Which (if any) strategies can be implemented to improve haematology 
transfusion services to better address patients’ perceptions?  
3. What are the potential constraints and enablers to implementing the 
suggested service improvement strategies?  
4. Which intervention options can be proposed to implement the 
strategies into practice? 
5. How do the proposed strategies link back to the constructs of patients’ 
transfusion perceptions? 
 Methods 
5.2.1 Study design 
This mixed-methods study utilising semi-structured focus groups and an 
open-ended questionnaire.  
Focus groups were chosen to enable group discussion and encourage group 
interactions, with the discussion moderated by a facilitator (Plummer-
D'Amato, 2008). A follow-on free-text response questionnaire was used as a 
part of this study due to foreseen time-constraints in the focus groups to 
present and collect responses on the complete set of nine patient blood 
transfusion perceptions constructs.  
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5.2.2 Ethical approval 
Ethical approval was granted from City, University of London, School of 
Health Sciences Research Ethics Committee (PhD/18-19/02 – July 2018) 
(Appendix 16: Study 3 ethics approval letter).  
5.2.3 Study branding  
The study was named BOOST ‘Building Optimised Outpatient Services in 
Transfusion’ for two reasons. In the preceding interview study transfusion 
was described by and presented to patients as a ‘boost’ to their blood levels 
and health. This study also sought to identify ways to improve or ‘boost’ 
transfusion services. The name ‘BOOST’ was therefore used in the branding 
and announcement of the study.  
5.2.4 Participants 
Eligible participants were HCPs, such as Haematologists, Physicians, 
Registrars, Nurses and Transfusion Practitioners attending South Central 
Regional Transfusion Committees (RTC) meetings held on two dates in the 
Autumn of 2018 with around 20 delegates attending the first meeting, and up 
to 80 attending the second meeting. RTCs are responsible for implementing 
actions of the broader National Blood Transfusion Committee in England and 
overseeing activities of the Hospital Transfusion Committees (Joint United 
Kingdom (UK) Blood Transfusion and Tissue Transplantation Services 
Professional Advisory Committee, 2018). Many RTCs meet bi-monthly 
outside of the hospital environment for educational away days, where 
delegates can present and discuss audit findings and share learning practices, 
for example. 
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5.2.5 Recruitment 
Potential participants were notified about the study around one week prior to 
the RTC meeting date by e-mail to all attendees from the Secretary of the 
RTC. A Participant Information Sheet and Recruitment flyer were developed 
(Appendix 17: Study 3 participant information sheet, Appendix 18: Study 3 
recruitment flyer) and attached to the e-mail. On the day of the meeting, 
delegates were introduced to the study in person and during the opening 
introduction at the start of the day. Delegates wishing to take part could sign-
up in advance or attend at the arranged time and designated location. Focus 
groups were planned to include a minimum of two or three participants and a 
maximum of ten participants per focus group. This allows for views to be 
shared on a topic that could be considered highly engaging (i.e. having more 
time in a smaller group or being interactive ‘workshop style’ with a larger 
group) (Ritchie et al., 2014). The focus groups took place in a separate small 
room within the RTC meeting venue with the researcher (who was the focus 
group facilitator) obtaining signed informed consent prior to the focus group 
commencing (Appendix 19: Study 3 consent form). The co-facilitator, who 
was the Secretary of the RTC and a Haematologist involved in the project, 
was also present at some points during the focus group. This was considered 
of benefit, with a well-brief observer often able to validate and establish the 
credibility of focus group data (Jackson, 1998).  
5.2.6 Focus group procedure 
The focus groups were conducted in line Tuckman & Jenson’s (1977) ‘Model 
of group phases’ (Ritchie et al., 2014) (pg. 215) and were planned to last 
around 45 minutes at set time-points during the RTC meeting day. Focus 
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groups were opened by the facilitator with introductions, establishment of the 
ground rules and an introduction to the previous research. Individual 
introductions helped the facilitator to identify each participant and allowed 
each participant the opportunity to introduce themselves and to briefly share 
their views of what they thought the haematology patients’ perceptions might 
be as an ice-breaker exercise. The main body of the focus group followed 
with the facilitator introducing the labels for the top three constructs of 
patients’ perceptions that were identified through the previous patient 
interviews (June 2018): ‘Negative emotions’, Involvement in decision 
making’ and ‘Necessity’ (Table 15). Due to the 45-minute time constraints, 
only the top three ‘priority’ constructs of patients’ perceptions were presented 
for discussion, prioritised in Study 2 (Chapter 4) per frequency counts of 
patients reporting perceptions coded to the construct. Each construct, 
summarised by the researcher, was read aloud to the participants and 
distributed in text on printed laminated cards. Positive and negative aspects 
of the same construct of perception were included in the summary to present 
a balanced view given the diversity of the haematology patient group and the 
bi-polar nature of the findings (Table 15). Ten-minutes was allocated for each 
construct to allow for a semi-structured discussion around the topic guide 
questions below.  





‘Some patients had no concerns about receiving 
repeated transfusions or managed their worries 
by remaining hopeful and positive.  
Some patients enjoyed attending; as a time-out 
and they were grateful for the transfusions. 
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For some patients, having transfusions was seen 
as unpleasant and the frequency and duration 
caused frustrations’.  
2: ‘Involvement in 
decision making’ 
 
‘Some patients recalled being involved in the 
transfusion decision-making, and that they 
willingly accepted the transfusion.  
Other patients reported that they deferred the 
decision making to the doctors or had limited 
involvement, mainly because transfusion was 
their only option’. 
3: ‘Necessity’ 
 
Some patients knew when they needed their 
transfusion as they felt tired, low in energy and 
experienced headaches.  
Overwhelmingly, patients reported that their 
transfusions are essential to prolong their life 
and aid survival.  
Yet, some patients do not know how much 
blood they will receive until they get to the 
hospital or are unable to predict a routine with 
it. 
 
5.2.6.1 Topic guide questions: 
The topic guide questions were developed to address the research questions 
of the study and the questions were referred to by the facilitator to provoke a 
semi-structured discussion after the theme was introduced:  
• Are these perceptions that you also hear about from patients? 
• Is there something that could be done within the health service to 
improve patients’ experiences? 
• Would there be any constraints to this? 
• Are there things that may help change to occur? 
The first topic guide question aimed to elicit the extent that HCPs identified 
with the perceptions in their practice (e.g. that they felt that the perceptions 
were reflective of what they anticipated or experienced patients’ perceptions 
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to be). The second topic guide question addressed research question two, to 
explore any potential service improvement strategies and the latter two topic 
guide questions aimed to elicit HCPs’ perceived constraints and enablers to 
their suggested strategies. The latter two questions were deliberately kept 
open to encourage group discussion.  
During the course of data collection, an additional slide (11) was inserted in 
the researcher’s presentation materials (Appendix 20: BOOST Study 3 
PowerPoint slides) following the first focus group about the different levels 
for intervention (Dahlgren et al., 1991; National Institute for Health and Care 
Excellence., 2007, 2014). This was emphasised to be ‘Population’ 
‘Community’ and ‘Individual’ levels as the Facilitator observed that many 
HCPs proposed ‘population’ and ‘community’ level changes in the first focus 
group. Therefore, this addition aimed to prompt and encourage HCPs in the 
subsequent focus groups to consider multiple levels of change, including 
individual HCP change. 
A summary discussion was initiated by the facilitator in the last 10-minutes 
of the focus group to summarise any service improvement strategies. At the 
end of the focus group the facilitator introduced and distributed the follow-on 
questionnaire (Appendix 21: Study 3 participant ‘follow on’ questionnaire). 
This questionnaire presented summaries of the remaining six constructs 
identified through the previous patient interviews (Chapter 4): ‘Health 
benefits’ ‘Social connection’, ‘Awareness of Safety/risk’, ‘Burden’, 
‘Alternatives’ and ‘Distinguishing between blood products’ with the topic 
guide questions for free text completion. Participants were handed the 
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questionnaires to take away for completion and return using the pre-paid 
envelope provided or via e-mail to the researcher / facilitator.  
5.2.7 Confidentiality 
The importance of confidentiality was emphasised through the Participant 
information sheet (Appendix 17) and at the opening of the focus group. This 
ensured that opinions shared during the focus group were not disclosed 
outside of the group and that details of attendees and mentioned people and 
places were not further circulated. The follow-on questionnaires were also 
confidential, in that the participant’s own name was not required to be 
inserted on the questionnaire.  
5.2.8 Data analysis 
5.2.8.1 Inductive analysis 
Focus groups were audio recorded, transcribed verbatim and fully 
anonymised so that no individual patient, HCP, or hospital / service could be 
identified from the transcripts.  
Focus group data reporting the extent that HCPs identified with patients’ 
reported perceptions were narratively summarised, with the content of the 
focus group discussions analysed using Thematic Analysis (Braun et al., 
2006). This involved the researcher reviewing the focus group transcripts to 
develop labels describing the data (e.g. Staff talking to patients about their 
transfusion worries). The researcher grouped the labels into themes (e.g. 
Support currently offered to patients) which was grouped with similar themes 
and combined into a major theme (e.g. Patient support provision).   
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The free-text responses on the returned follow-on questionnaires were subject 
to analysis using the same methods as the transcribed focus group data.  
5.2.8.2 Service improvement strategies 
The researcher reviewed the transcripts and the questionnaires for service 
improvement strategies, for example, revising transfusion appointment times 
or locations or strategies to improve patient involvement or communication 
etc. Strategies were organised into meaningful groups (e.g. hospital or 
community-based strategy) and coded according to policy and intervention 
functions / categories of the Behaviour change wheel (BCW) (Michie et al., 
2011). Strategies were also mapped back to the nine constructs of patients’ 
transfusion perceptions from Study 2 to obtain an impression of how greatly 
the strategies addressed these constructs.  
Constraints and enablers raised by the participants for each strategy (as 
applicable) were grouped and categorised according to domains from the 
Theoretical Domains Framework (TDF) (Cane et al., 2012; Michie et al., 
2005), for example, a barrier of ‘lack of staff cover’ was coded as 
‘Environmental context and resources’ from the TDF. This was carried out to 
specify the key domains for consideration if strategies were to be developed 
into behaviour change interventions. As the TDF is often applied to the 
context of individual behaviour change, the COM-B component related to the 
applicable TDF domain was also specified in the analysis, this was done to 
highlight broader environment and organisational factors (Michie et al., 
2014).  
Chapter 5 BOOST study 
201  
5.2.8.2.1 Intervention mapping 
The taxonomy of 93 Behaviour change techniques (BCTs) is commonly used 
to identify techniques, which are observable, replicable, and irreducible 
‘active ingredients’ of behaviour change interventions (e.g. behavioural 
counselling, feedback, self-monitoring and reinforcement) (Michie et al., 
2013). For this study, the researcher developed intervention options for each 
strategy, supported by BCTs to be targeted. The selected BCTs were linked 
to the TDF coded constraints and enablers raised by the participants, selected 
by the researcher using ‘The Theory and Techniques Tool’ (Centre for 
Behaviour Change, 2019). The APEASE criteria was used to evaluate the 
intervention options, considering the interventions’ Affordability, 
Practicability, Effectiveness and cost-effectiveness, Acceptability, Side-
effects/safety and Equity (Michie et al., 2011). The researcher imposed that a 
high candidate intervention would satisfy a minimum of four criterion, a 
moderate intervention, three criterion and a low intervention, less than three.  
5.2.9 Reliability 
A second researcher in the team reviewed the inductive coding of the focus 
group themes to verify the main researcher’s coding decisions. This was to 
review all of the quotes and whether the theme and subtheme labels were 
adequately representative of the quotes. Member checking was also used to 
assess a participant’s view of how well the meaning from the focus groups 
was captured and interpreted (Ritchie et al., 2014). This was to ensure clinical 
face validity of the interpretation of the findings. A member of the team with 
experience in TDF/BCW and BCT coding reviewed each proposed strategy 
to assess whether it was classified appropriately according to the domains of 
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the TDF, functions and categories of the BCW and BCT labels from the 
taxonomy. For all coding, disagreements were discussed until full agreement 
was reached.  
 Results  
5.3.1 Focus groups and sample characteristics 
Three focus groups were held in total and the researcher kept a reflective 
diary, updated after each focus group (Appendix 22: Reflective diary from 
study 3 focus groups). One focus group was held at the first RTC meeting 
with six participants at the start of the day and two focus groups held at the 
second meeting two months later with eight participants at the mid-morning 
break and five participants at lunchtime. RTC meeting two provided two 
opportunities for focus groups to be held, being a larger meeting day with a 
higher number of delegates attending (approximately 100 vs. 20 for RTC 
meeting 1). Focus groups lasted between 29 minutes and 43 minutes in 
duration. Table 16 displays the participating HCPs’ roles per focus group. 
Table 16 Focus groups and participants 
RTC meeting 1 RTC meeting 2 
Focus group 1 
(N = 6 participants) 
Focus group 2 
(N = 8 participants)  
Focus group 3 

























Practice Educator  
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 Clinical Scientist  
 Anaesthetist  




5.3.2 Follow on questionnaire response rate 
Each focus group participant received the follow-on questionnaire with the 
same completion instructions. This was to provide their thoughts on the 
additional patient constructs not discussed during the focus groups and to 
return the questionnaire via post using the self-addressed envelope or scan 
and return via email. The follow-on questionnaire response rate from meeting 
one was 50% and meeting two, 23%.  
5.3.3 Inductive analysis of focus group and questionnaire data 
5.3.3.1 Identification of patients’ transfusion perceptions in practice 
The three constructs discussed in the focus groups received in general a high 
level of acknowledgement, with HCPs reporting that they felt the constructs 
were reflective of, and resonated with, their day to day practice and 
interactions with patients in the haematology service. In the final focus group 
3, HCPs did recognise to a greater extent the ‘Necessity’ construct, however, 
the HCPs did not contest the accuracy of the other two constructs presented. 
One HCP expected more perceptions on ‘Burden’ (not presented to the focus 
group) and one HCP reported that they were interested in finding about 
informed consent practices for routinely transfused patients and the 
experiences and thoughts of home transfusion patients.  
The additional six constructs presented in the questionnaires received a 
similarly high level of acknowledgement, with the construct ‘Distinguishing 
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between the blood products’ receiving the lowest acknowledgement in two of 
six returned questionnaires. Two questionnaire respondents commented that 
‘fewer platelets transfusions were provided’ and that ‘patients understood the 
need for them’ (Questionnaires 2 and 6). For the ‘Safety/risk’ construct, three 
respondents agreed that this construct reflected their practice and one 
respondent reported that this construct was not heard from the majority of 
their patients.  
5.3.3.2 Inductive synthesis of focus group data 
Full consensus was reached by the main and second researcher for the 
inductive analysis. A member check also confirmed that the meaning from 
the focus groups was sufficiently captured and interpreted.  
The inductive synthesis of the focus group data led to the development of six 
themes: Practical difficulties for transfusion patients, Patient support 
provision, Service efficiencies, Supporting best practice, Positive 
collaboration with patients and Practice difficulties. These themes are 
presented in Table 17 indicating the HCP roles who contributed to the 
subtheme. When there was wider group support in favour of an argument 
presented, ‘multiple group agreement’ was used to indicate this. Supporting 
quotations are provided in the table and descriptions of the themes content 
provided following the table. 
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Table 17 Themes and subthemes inductively generated from the focus group data 




















“… this is about the patients who are transfusion dependent and 
actually have to take time out on a regular basis, not just to come 
in for transfusions, they’ve gotta go and find somebody to do the 
phlebotomy for the cross match from the day before. You know, 
they still have to come and park at the hospital because they’ve 
got to go to phlebotomy. (FG2, line 85-89, P1, Haematologist) 









“if you do detect that in someone with a bone marrow failure and 
you say actually 'you don't need to transfuse your haemoglobin's 
pretty good' you can sometimes get their wrath!” (FG1, line 80-
82, P2, Haematologist) 
Patient support provision 










“I think it's other things though, it's not just the transfusion, they 
can bring any concerns, any worries they have outside of the 
transfusion in with them and we will do what we can to sort 
things out if we can, so it's a way of getting extra help if they 
need it” (FG1, line 21-24, P4, Lead TP) 
 
• Support from counsellors 1 
Haematologist, BTNP 
 
“I mean, where we are, we do have the option of two counsellors 
all I have to say is that they are two very different characters and 
some patients will see one of them and say 'Oh, it was a waste 
of time' but it may be the wrong one for them” (FG1, line 308-
310, P2, Haematologist) 








“… but if you're a patient there and you've got two/three hours 
and you can't really move, erm, you have got a lot of time to talk 
to the person sat next to you … so that's something on the one 
side of it can make it more pleasant, having more, you know 
community” (FG2, line 150-157, P5, TP) 
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“with the introduction of non-medical authorisation for nurses, 
where you've got the people who are actually taking samples, 
then making the decision, that makes the process much easier 
for the patient because they haven't got to then hang around for 
a doctor, who doesn't know the patient, to review the results, 
and I think better decisions are made quicker” (FG1, line 499-
503, P1, PBMP) 
•  Integrated care pathways 1 
Haematologist, 




“Integrated care pathways, there’s more of a focus now on 
actually putting the money out in the communities and providing 
the services out in the communities again and preventing 
patients from coming into hospital when they don’t need to” 
(FG2, line 234-238, P1, Haematologist) 
• Staff and patient access to test 




Specialty doctor, Nurse, 
TP, PBMP 
“…we have something where it’s actually clerical staff and 
they’re excellent and we have a, a card system we could do it 
electronically, but whereby those on a chronic transfusion 
programme, we roughly guestimate how often they need blood, 
erm, and have a target –“ (FG2, line 257-261, P4, Specialty 
doctor) 
Supporting best practice 
• HCPs transferring their 




Ward Manager, TP 
 
“I go back to the ward and obviously you get feedback with all 
my staff and oh, you know, we just attended and, and been with 
this group which is BOOST, and all your positive, they’re gonna 
pass it on so that they knew that okay, these are the ways in 
what we just had conversation with a very good example of how 
you can treat your patient and then they feel like, you know, 
they’re being empowered with the blood transfusion that they 
have” (FG3, line 397-403, P1, Ward Manager) 
•  Senior HCPs as visible role 






“I learnt from my seniors and I saw, as a junior doctor, I saw my 
registrars running off to do things like get the toast for this patient 
and that patient or a transplant patient, erm, because you see 
your seniors do it, you do it, and hopefully the people following 
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• Patient willingness to engage 
in their care 2 
Haematologists, Lead 
TP, Clinical Services 
Manager, PBMP,  
*multiple speaker 
agreement 
“you have some who want to engage and it's easier to engage 
with them, erm, and to make a plan and if you can make a plan 
and they're engaged, then it's easier to change the plan, as and 
when it needs to be changed” (FG1, line 281-282, P6, Lead TP)  
•  Patient initiated care 2 
Haematologist, Ward 
manager, TP, Lead TP 
“Well I suppose some of our younger patients … they're 
transfused every say four weeks, they know in themselves how 
they feel, so if they don't feel that they need it, they may ring and 
say 'can I delay it two weeks?' or if they're unwell because 
they've got other symptoms that have come on, they'll say 
they're feeling rotten, can they come in? We'll say 'we'll do a 
haemoglobin and see where we go from there', those are the 
proactive ones ... we encourage that” (FG1, line 284-292, P6, 
Lead TP) 




Services Manager,  
“I mean, in a lot of these cases a blood transfusion is the only 
treatment there’s no really other alternative and we say to 
someone, “Well, you can either have the treatment or not have 
it,” and they might say to you, “What’s the alternative?” and you, 
you don’t really have an alternative as such, do you?” (FG2, line 












“… samples are triaged in the laboratory, the importance is 
always given to operations, patients in surgeries and theatres, 
and it’s forgotten actually just because it’s a day care setting and 
there’s a perception that there’s, like, eight hours of transfuse, a 
lot of them can’t be there at 9:00 a.m., some have transport 
issues, some of them have jobs that they need to do and it’s 
difficult” (FG3, line 7-11, P5, TP) 
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• Stretched services 
 1 
Ward Manager, TPs 
*multiple speaker 
agreement 
“I have to say, comparing two different Trusts, going to the day 
care setting that I work in now, it’s like Beirut, it’s so noisy, you 
know, so many patients - and relatives and it’s like a 
thoroughfare, it’s an actual thoroughfare, they are so different” 
(FG3, line 330-335, P4, TP) 











“… so, we have had some patients who because they don't have 
a formal clinic appointment keep turning up for transfusions and 
then you find out when you go down to the lab that they've got 
a very high white cell count” (FG1, line 29-31 P2, Haematologist) 








“…we rely on the GP, now the difficulty is as I mentioned earlier 
is that the patients will not see their GP because processes are 
changing very quickly and to be fair sometimes the GPs, they're 
all, you know, are not getting enough up to date information or 
things are changing or “I don't know enough about this 
condition” and defer it back to us” (FG1, line 312-316, P2, 
Consultant Haematologist) 
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5.3.3.3 Description of focus group derived themes 
Practical difficulties for transfusion patients: HCPs reported on the reality 
that haematology patients will face frequent and lengthy visits to the hospital, 
for example, for blood cross-matching the day before the transfusion, and 
often a six-hour transfusion appointment for two units of blood. Patients may 
need to reschedule personal appointments if there are changes to their planned 
transfusions (e.g., if patients’ blood level improve). This would be to avoid 
unnecessary transfusions, which reportedly occur for some routinely 
attending patients. HCPs in this study discussed patients’ reactions when 
transfusions were refused, which caused anger, further frustrations and 
confusion for patients. 
Patient support provision: HCP discussed support that patients often receive 
in the unit, through forming close and sociable connections with other patients 
and staff in the unit, who provide them with time to off load worries and 
provide practical health assistance. Consistent staff in the units facilitated 
support provisions, with patients often having a specialist nurse to contact if 
becoming unwell. HCPs also discussed that patients often receive support 
from trained hospital counsellors. However, HCPs debated that this was not 
always standard protocol and that mis-matches in patient-counsellor 
personalities may impact patients’ views of the effectiveness of the 
counselling.  
Service efficiencies: HCPs reported a number of practices in place that 
function well. For example, nurses ordering blood transfusions (non-medical 
authorisation), good communication with laboratories and patient tracking 
systems. One HCP presented that in their area, patients can gain access to 
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their blood test results via the GP, helping them to predict the transfusion 
appointment time length. The need to re-establish community services that 
worked well in the past was highlighted, such as integrated community care 
pathways. This was felt to reduce the need for patients to attend the hospital 
and receive healthcare in their community locations, which matches current 
Governmental agendas.  
Supporting best practice: HCPs in one focus group discussed observing and 
sharing best learning practices to improve patients’ experiences. Some HCPs 
were keen to reflect on their own practice on a regular basis and one Ward 
Manager commented that she will use the focus group as an opportunity to 
reflect on and improve her patient-centred practice. A Haematologist and 
Transfusion Practitioner in the same focus group commented that they 
benefitted from witnessing senior staff carrying out additional patient duties 
in an empathetic manner. The senior HCPs would act as role models during 
the Haematologists’ training for how to deliver patient centred care (e.g. 
responding to patients’ food choice preferences).  
Positive collaboration with patients: HCPs discussed positive ways in which 
they interact with patients, such as through shared decision-making, where 
younger patients especially wish to be engaged in their care and make a 
treatment plan. HCPs gave examples of how patients could delay their 
transfusions or if having symptoms attend the unit for an assessment of 
whether a transfusion is needed, which was encouraged. However, when it 
came to transfusion alternatives, this was more challenging. One Anaesthetist 
commented that transfusion was the only option that many patients could be 
offered, and a Haematologist reported that staff can be concerned if Jehovah 
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Witness patients do not consent to transfusions, but that staff have to ‘go 
along with’ patients’ wishes.  
Practice difficulties: Many HCPs in two focus groups reported that 
haematology transfusion receives lower prioritisation (e.g., low recognition 
for funding or laboratory samples processing). Many HCPs referred to their 
services as busy, with a lack of transfusion training for HCPs in other 
departments who may occasionally need to transfuse a haematology patient. 
HCPs sometimes received patient-initiated requests for transfusion outside of 
a pre-arranged appointment, which were sometimes granted (for example, if 
HCPs faced pressure from patients), which can lead to patients being over-
transfused. HCPs reported that they lacked support from community HCPs, 
such as GPs who were unfamiliar with complex haematological conditions, 
patients’ clinical histories or faced their own time pressures. GPs, therefore 
often referred haematology patients back to the unit. Some HCPs noted that 
‘stretched’ services risk the loss of a ‘personal touch’ to patient care. 
5.3.3.4 Inductive synthesis of questionnaire data 
The inductive synthesis of the questionnaire data led to the development of 
four themes: Transfusion acceptance, Practice difficulties, Patients’ 
individual preferences and Patient involvement. Table 18 lists the themes and 
subthemes, with supporting quotations, followed by a text description of each 
theme. 
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Table 18 Themes and subthemes inductively generated from the questionnaire data 





• Appreciation of transfusion 
benefits Q6 
“Most patients who are given transfusions report that the benefits 
outweigh any risks” (Q6 responding to Construct 4 ‘Health benefits’ 
summary)  
• Anticipated physiological 
responses Q1, Q2 
“Occasionally patients don’t notice any initial change” (Q2 
responding to Construct 4 ‘Health benefits’ summary)  
• Patients accepting of 
transfusion as last resort 
Q2, Q6 “our patients have transfusions when all else fails. They understand 
this” (Q6 responding to Construct 8 ‘Alternatives’ summary) 
Practice difficulties 
• HCP time constraints Q1, Q2 “Patients expect very personalised service + extra time which is not 
available” (Q2 responding to Construct 4 ‘Health benefits’ 
summary)  
• Low Palliative Care 
engagement 
Q2 “Ideally this [alternatives to transfusion] should be dealt with by 
palliative care but they often won’t touch patients until dying dead” 
(Q2 responding to Construct 8 ‘Alternatives’ summary)  
• Issues encountered with 
patient attendance 
Q2 “Sometimes patients cancel them [the transfusion] + then turn up 
when symptomatic expecting you to stop what doing + sort them out” 
(Q2 responding to Construct 7 ‘Burden’ summary)  
Patients’ individual 
preferences  
• Diverse patient preferences 
for interaction 
Q2, Q4, Q6 “Those few I’ve spoken to report it as a good catch up time with 
‘friends’. One said that others were happy if they just wanted to sit 
with their eyes closed” (Q4 responding to Construct 5 ‘Social 
connection’ summary)  
• Patients’ personalities and 
cultural beliefs should be 
respected 
Q2, Q4 “I think we need to respect their wishes / cultural beliefs and ensure 
we do everything in our power to make this happen” (Q3 responding 
to Construct 5 ‘Social connection’ summary)  
 • Patient involvement with 
cannulation 
Q4 “The pts I cannulate just say they’re so used to it and some even 
recommend where to go or avoid before I’ve even looked at their 
veins” (Q4 responding to Construct 6 ‘Safety/risk summary) 
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• Lack of patient questioning 
of forgotten information 
Q3 “… though sometimes it [e.g. platelets function] is explained but pts 
forget or are afraid to ask questions as there is no time or afraid to 
look stupid” (Q3 responding to Construct 9 ‘Distinguishing between 
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5.3.3.5 Description of questionnaire derived themes 
Transfusion acceptance: HCPs report in this theme how patients may be 
accepting of transfusion as it has been thoroughly discussed, with patients 
understanding transfusions are provided as a last resort option. Patients may 
become aware of what to expect post-transfusion, such as no initial benefit 
due to experiencing ongoing symptoms post-transfusion where the combined 
biological and psychological effects of the transfusion are ‘draining’. One 
HCP commented, however, that patients are likely to have rationalised the 
need for their transfusion, being aware of potential risks, which are 
outweighed by the transfusion’s benefit.  
Practice difficulties: In the questionnaires, two HCPs commented on similar 
transfusion delivery issues, as raised in the focus groups. HCPs commented 
that patients often expect a personalised service, which they did not have time 
to deliver, or to repeat information already provided. As in the focus groups, 
it was re-iterated that patients often arrive voluntarily when symptomatic for 
transfusions, interrupting HCPs’ work flow. Palliative care was mentioned as 
a further example, of where haematology HCPs lacked wider hospital-wide 
support. 
Patients’ individual preferences: Somewhat opposite to the ‘sense of 
community’ subtheme arising from the focus group discussion, were ideas 
raised about the individuality of transfusion patients in the unit. HCPs 
commented that some patients will spend their time during the transfusion 
relaxing with their eyes closed. Other patients, especially older patients, will 
wish to socially interact with other patients and welcome the support from the 
staff. Although, one HCP reported that patients in their unit were transfused 
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in single rooms, which patients appreciated for the sake of their privacy. 
HCPs commented that patients’ personalities may influence their need for 
greater social interaction in the unit, and that HCPs should respect and be 
supportive of patients’ wishes and cultural beliefs.  
Patient involvement: HCPs used the questionnaires to share examples of how 
their patients may be involved in their transfusions; by suggesting a 
cannulation site to the nurse or sharing their experiences with nursing 
students. Many patients were therefore considered as expert patients, yet 
instances where some patients forgot information that they are told were 
raised, with patients being reluctant to question it again.  
5.3.4 Service improvement strategies 
A total of eight different service improvement strategies were proposed across 
the focus groups, of which five were also mentioned in the questionnaires 
(Table 19). Nine additional strategies were reported in the questionnaires 
(Table 20), which resulted in a total of 17 service improvement strategies 
suggested across both data collection methods. As displayed in Table 19 and 
Table 20, the strategies were grouped into ‘hospital’ and ‘community’ based 
strategies, suggestive of their target implementation location, subdivided 
further into: hospital: ‘transfusion access’, ‘support’ or ‘practices’ and 
community: ‘access’ and ‘support’ related change suggestions. One strategy 
‘screening of patients’ Hb levels’ (Table 19) raised in the focus groups could 
relate to either a ‘hospital’ or ‘community’ practice change, as well as 
‘cannulation improvements’ (Table 20).  
Chapter 5 BOOST study 
216  
Numerous constraints and enablers (N= 34) to the strategies were reported. 
These are listed in Tables 19 and 20 alongside the relevant Theoretical 
Domains Framework (TDF) (Cane et al., 2012) and COM-B (Michie et al., 
2011) domains. Behaviour change wheel mapping (Michie et al., 2011), 
constraints and enablers and intervention mapping will be discussed in more 
detail following the presentation of tables 19 and 20. 
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Table 19 Service improvement strategies from focus groups and questionnaires 
Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
Hospital       
Transfusion access       
1. Development of a transfusing team / unit in 
hospital 
“you also need a transfusing team, don't you? … 
[some group agreement] the one that the patient gets 
transfused to who they can rely on, know, they can 
arrange lines if the access is becoming an issue, they 
can juggle slots accordingly and know the patients 
well enough to know who needs it urgently” (P2, 
focus group 1). 
BCW: Service provision & Environmental 
restructuring 
1 focus group 
& 1 
questionnaire 
a) Relieves pressures on 
























Service managers to 
launch transfusion teams in 
their hospitals (e.g. 
dedicated team in the 
existing unit or 
development of a 
dedicated transfusion unit). 
Transfusion team 
champions to advocate the 
new plans and promote 
how this will relieve 
pressures on other units 
A P E A S E 
?  ?    
 
Support      
2. Standard package of psychological support 
created for repeatedly transfused patients 
“you're going to need the same support [adult 
haematology as paediatrics], just different” (P3, 
focus group 1)  
BCW: Service provision & Enablement 
1 focus group  
None reported N/A N/A N/A N/A 
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
3. Enhancing shared decision-making and 
discussion of blood transfusion with patients 
(e.g. positive, negative aspects) 
“P3: it has to be a negotiation with them rather than 
something you do to them.  
P1: yes, don’t surprise them. 
P4: Yes, you know, it’s, it’s discussion, you know, do 
you think you could sit here for two units if that’s 
needed … cause if you have to go after one unit, 
maybe we could book you in another day. So, that 
sort of discussion allows them a little bit of control 
back” (multiple speakers, focus group 3)  
 
BCW: Environmental restructuring & Enablement 
1 focus group  
a) Consistent staff cover 
with available time 
required 
b) Education for nursing 
staff: “more nurses 
with knowledge of 
blood transfusion” 
(Questionnaire 2) 
c) Improved staff and 
management attitude to 
support changes 
required 













































Encourage managers to 
review staffing capacity 
and facilitate a culture of 
shared decision-making 
where appropriate.  
 
Blood transfusion nurse 
training to present patients’ 
transfusion perceptions 
(e.g. positive and negative 
aspects of transfusion) and 
training workshops could 
allow nurses to practice 
adopting a ‘negotiation’ 
style to transfusion 
conversations.  
 
A P E A S E 
 ?   ?  
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
Practices               
4. Expedite haematology laboratory samples 
“there’s a massive amount of improvement we could 
do within laboratories to actually expedite their 
samples, treat them in way that actually gives that 
patient then the best experience as possible” (P5, 
focus group 3) 
 
BCW: Environmental restructuring  
 
1 focus group 
& 1 
questionnaire 
a) Reduce patient waiting 
time [Enabler] 
“…a lot of them [patients] 
will get delayed cause we 
don’t know what the 
answers are gonna be in 





















management and staff of 
the impact to patients of 
extended waiting times and 
discuss fast-tracking 
haematology samples. If 
supported, co-design new 
processes with lab staff 
(e.g. prompts to alert to 
haematology samples).  
   
A P E A S E 
 ? ? ? ? ? 
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
5. Encourage shared lab, HCP and patient role 
appreciation 
P2:” … and I guess also, it’s role appreciation, isn’t 
it, so it’s knowing what happens with you guys in, in 
the laboratory -  
P5: That’s exactly it, yeah. 
P2: - at some point needs to put all of that 
information together … to say, “Well, actually it is 
because you, you’ve got antibodies and therefore it’s 
gonna take us longer to get that blood,” (multiple 
speakers, focus group 3) 
 
BCW: Education & Persuasion 
 
1 focus group 
& 1 
questionnaire 
a) Patients’ priorities 
different to HCPs’:  
P5: “so it’s almost like 
everyone needs to know, 
what everyone’s actually 
doing, to have a better 
understanding”. 
P2: “But that patient only 
cares about themselves” 
(multiple speakers, focus 
group 3) 
















Provide patients with 
information (verbally, 
leaflets) about safe 
laboratory procedures and 
time-scales.  
 
Consider inviting patients 




A P E A S E 
      
 
6. Improved recording of consultation 
discussions in patients’ notes to enhance 
shared care 
P6: “if you don't know what they discussed last week, 
you don't know if they've got problems, they're not 
mentioning it again this week” 
P3: “it's a shared care sort of thing” 
P6: “so it's nice to know for coordination” (multiple 
speakers, focus group 1) 
 
1 focus group 
a) Distractions and 
provision of 
notes/space to update 
notes 
P2: “… when you get to the 
day ward to see them 
having transfusions you 
don't get the notes out, sit 
down, partly because 
there's not always 


















Unit manager to advise 
administration staff to 
make physical space 
(marked reserved) for 
relevant HCPs to update 
patients’ notes (e.g. in 
back office / side room)  
 
A P E A S E 
      
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
BCW: Enablement P4: “there's not always the 
notes around aren't there, 
so/” (multiple speakers, 




      
Transfusion access              
7. Home transfusion or community transfusion 
sites nearer to patients 
“I think in an ideal world if we had the money and 
the resources, I think transfusion in the home, or in 
hubs nearer to where people live [partial group 
agreement] so if you had a community of villages, 
you had a hub somewhere (P6, focus group 1) 
 






2 focus groups 
& 3 
questionnaires 
a) Resources and funding 
needs for community 
transfusion sites 
b) Medicalisation of the 
home may impact 
family and reduce 
respite  
c) Staff training and 
efficiency to deliver 
home transfusions 
d) Potential blood 
transfer, traceability 
and adverse events 



































Commissioners and unit 
managers to consider 
resourcing local hubs to 
provide patients with 
community transfusions 
and collect patients’ views 
for/ against home 
transfusion.  Alongside 
collecting patients’ views 
assess risks, blood transfer 
and traceability issues and 




A P E A S E 
?  ?  ?  
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
e) May not be every 
patient’s preference 
f) Increased National 
Health Service (NHS) 
focus on community 
integrated care 
pathways [Enabler] 
g) Staff willingness and 
positivity to make 
changes [Enabler] 
h) Utilising existing 
community hubs 
[Enabler]:  
“I think that having 
community places where 
there are already nursing 
staff who can be trained up 
and are transfusion 
competent, you know, erm, 
to, to tap into those” (P1, 








Social / Professional 
Role and Identity (f) 













Practices (hospital or community)       
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
8. Community or hospital screening of patient’s 
haemoglobin (Hb) (red blood cell protein) 
level to provide enhanced communication of 
transfusion requirement and expected duration 
P1: “I think it depends as well when the, 
erm, phlebotomy count is checked, if it's checked on 
the day when the patient is actually in the clinic then 
there may be more likelihood that they might get that 
extra unit that they didn't really need cause they're 
already there, whereas if it was perhaps checked the 
day before, em 
P2: we could give 'em a ring 
P3: yeah exactly, and at least then they're prepped 
P2: and they'll be informed not to come into hospital 
(multiple speakers, focus group 1) 
 
BCW: Service provision & Education 
2 focus groups 
& 2 
questionnaires 
a) May be location 
specific: “I think it 
depends where they 
lived whether they get 
the service or not” (P1, 
focus group 1) 
b) Blood sample transfer 
risks with community 
testing 
c) Equipment expenses 




“…if they can have it 
done in the 
haematology unit … 
they have to come in 
twice and that impacts 
on the quality of life” 
(P5, focus group 1) 
e) Additional burden for 
community HCPs of 
Environmental 
context and 




consequences (b, e, 














Pros and cons 
If community transfusion 
hubs are generated 
(strategy 7), 
commissioners and service 
managers to consider 
adding options for patients 
to remotely visit to screen 
their Hb level and how this 
may reduce hospital 
attendance.  
To offer this service in 
new hubs but to advise 
patients that this may not 
rule out some hospital 
attendance 
 
A P E A S E 
?  ?  ?  
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Service improvement strategies / BCW 
policy category / intervention function 
 
 
Focus group / 
questionnaire 
frequency 
Constraints and enablers 
reported by participants  
 
[Enablers in brackets] 
TDF domain linked 
to constraint / 











 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
providing patients with 
enhanced 
communication 




g) Diagnostic test may not 
rule out patient hospital 
attendance 
h) Provides patients with 
better predictability 
about upcoming 
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Table 20 Service improvement strategies from questionnaires only  
Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 





      
9. Hospital restructuring and physical 
expansion 
“[what can be done … to improve patients’ 
experiences] …restructuring inpatient + 
outpatient …no space to expand hospital …” 
(Questionnaire 2) 
BCW: Environmental restructuring 
3 
a) A complex change due to 
space, financial and staff 
requirements 
b) Leadership decision-































Hospital managers and 
directors to consider options 
to physically expand wards or 
re-organise existing space. To 
include consideration of the 
advantages / disadvantages of 
restructuring for staff and 
patients.  
 
A P E A S E 
 ?  ? ? ? 
 
10. Charging patients for appointment non-
attendance 
“Sometimes patients cancel [transfusions] and 
turn up when symptomatic … need to be charged 
for waste slots + time” (Questionnaire 2) 
 
1 
a) Enhanced patient 
incentives [Enabler]: 
“charging if waste slots 
would give some 















Non-attenders to be verbally 
reminded about wasted 
resources when attending 
with reasons for non-
attendance discussed. A 
shared treatment plan to be 
 
A P E A S E 
   ? ? ? 
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Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 











about health / 
environmental 
consequences 
established, with ongoing 
review and discussion.   
Hospital 
Support 
      
11. Trained volunteers employed to help 
support patients (duties not specified) 
“[what can be done … to improve patients’ 
experiences] …volunteers – trained volunteers” 
(Questionnaire 1) 
 
1 None reported N/A N/A N/A N/A 
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Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
BCW: Service provision & Enablement 
12. Easy to read written information produced 
“[what can be done … to improve patients’ 
experiences] … written information to back up 
verbal appointments” (Questionnaire 4) 
BCW: Education 3 
a) Information would be too 
generic: “info handed to 
patients wouldn’t be 
tailored to the 
individual” 
(Questionnaire 4) 
b) Providing phone call 





















Make pre-existing leaflets 
available to patients (where 
there is low usage). 
Encourage patients to also 
note and raise questions 
during appointments or phone 
calls 
 
A P E A S E 
   ?   
 
13. Informal events and support groups to take 
place in the transfusion unit 
“… patients do value learning from ‘the horse’s 
mouth experiences … maybe from other patients 
(e.g. a voluntary patient self-help group)” 
(Questionnaire 5) 
BCW: Service provision & Enablement 
2 
a) Patient involvement in 
the design of support 
groups [Enabler]: “[no 
constraints, just] asking 
patients what they would 
like” (Questionnaire 4) 
 
b) Patients and their 
families can talk to 




















Set up a coffee morning / 
one-off forum in the unit and 
explore with patients the need 
for events and support groups 
– determine patients who may 
wish to be involved in the 
design of events and groups 
 
A P E A S E 
    ? ? 
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Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
14. Primary transfusion nurses available to 
patients  
“[what can be done … to improve patients’ 
experiences] … have (a) primary nurse(s) that is 
aware of the patient’s history. This will also give 
continuity of care” (Questionnaire 1) 
BCW: Service provision & Environmental 
restructuring 
 
2 a) Financial and staffing 
constraints  
 
b) Culture change 
[Enabler]: “[things that 
may help change to 























Service managers to review 
existing provision of patient-
nurse contact and identify 
patients who may benefit 
from having a specific nurse 
to contact (if not already the 
case).  
 
A P E A S E 




      
15. Contact nurse / team via telephone or 
internet to discuss patients’ transfusion 
queries outside of the hospital 
“[what can be done … to improve patients’ 
experiences] …more out of hospital contact (i.e. a 
named nurse/team who is available at the end of 
telephone” (Questionnaire 3) 
BCW: Service provision & Enablement 
 
2 a) Financial and staffing 
implications: “An initial 
outlay of funding, but 
preventing unnecessary 
blood tests and 
appointments would 
surely cover this cost” 
(Questionnaire 4)  
b) Easy contact method for 
patients who already 
Environmenta



















Service managers when 
reviewing patient-nurse 
contact (strategy 14), to 
review nurses’ capacity to 
deliver direct contact via 
phone / internet. 
 
A P E A S E 
?  ?  ?  
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Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 














16.  Online forums developed for transfusion 
patients to gain support 
“[might patients need more support …] maybe 
from other patients (e.g. a voluntary patient self-
help group). Forums are good for this (online)” 
(Questionnaire 5) 
BCW: Service provision & Enablement 
 
1 Accessibility implications 
for some patients: “… 
[forums] not available to 
those without internet” 
(Questionnaire 5) 
Environmenta























During a one-off coffee 
morning / forum in the unit 
(strategy 13) explore the use 
of online forums with 
patients. Possibly show 
patients existing online 
forums and query their need 
for forums, accessibility 
issues and patients wishing to 
help with the development / 
trialling of a forum.  
 
 
A P E A S E 
    ?  
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Service improvement strategies 





Constraints and enablers 
reported by participants 
















 Effectiveness & 
cost effectiveness 
 Acceptability 
 Side effects/ unwanted 
consequences 
 Equity 
17. Cannulation (tube inserted to vein to 
deliver transfused blood) improvements 
“Not much can be done for pain of cannula 
insertion but numbing cream prior to insertion 
may help” (Questionnaire 6) 
 
BCW: Training 
1 Financial costs: 
“[constraints to this…] 
costs” (Questionnaire 6) 
Environmenta


















Nurse leads to discuss using a 
numbing cream prior to 
cannulation. To review 
evidence and costings for this 
and identify patients to offer 
this to.  
 
A P E A S E 
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5.3.4.1 Widely endorsed strategies 
Two ‘community’ service improvement strategies were mentioned in at least 
two of the three separate focus groups, and were thus considered to be more 
strongly endorsed (7: Home / Community transfusion and 8: Remote Hb 
screening, Table 19). Both strategies involve patients receiving blood level 
screening or transfusions in the community rather than in outpatient 
secondary care (hospital) settings. The remaining strategies focused on 
improving haematology transfusion processes in the hospital site (1: 
Transfusion team / unit, 4: Expedition of lab samples and 6: Improved record 
of consultation discussion in patients’ notes) or communication across teams 
or with patients (2: Psychological support, 3: Enhanced shared decision-
making and 5: Shared lab role appreciation). In the questionnaires, hospital 
and community ‘access’ and ‘support’ strategies were widely endorsed 
(hospital: six strategies, community: three of nine questionnaire strategies in 
total). In particular, strategy nine: ‘Hospital restructuring and physical 
expansion’ and strategy 12 ‘Easy to read written information produced’ were 
both strategies mentioned in three questionnaires of six each (Table 20).  
5.3.4.2 Mapping to BCW, TDF and COM-B 
The total 17 service improvement strategies mapped to one policy category 
(Service provision n=9 strategies, 53%) and six intervention functions 
(Enablement n=7 strategies 41%; Environmental restructuring n= 6, 35%; 
Education n=3 17%; Persuasion, Training and Coercion n=1 each 6%) from 
the Behaviour change wheel (BCW) (Michie et al., 2011) (Table 19). 
Constraints and enablers to implementing the proposed service improvement 
strategies were identified within twelve of the fourteen TDF domains (Figure 
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11). The most frequently coded TDF domains were ‘Environmental Context 
and Resources’ (n= 10 of 34 constraints and enablers, 29%) and ‘Beliefs 
about Consequences’ (n=6, 18%) (Table 19, Table 20 and Figure 11 below). 
These two TDF domains correspond with COM-B domains of Physical-
opportunity and Reflective-motivation, indicating that for the strategies to be 
implemented and successful, there would need to be opportunities afforded 
by the environment (e.g. setting up safe community to laboratory sample 
shipment) and/or plans put into place to enhance people’s motivation (e.g. 
promotion of local blood testing and the benefits of this for patients). 
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Figure 11 Frequency of TDF (Michie et al., 2005) domains and service improvement strategies 
0 1 2 3 4 5 6 7 8 9 10
Goals
Memory, Attention & Decision Processes









Environmental context & resources







1 Transfusion team / unit 2 Psychological support 3 Shared decision-m 4 Lab samples
5 Role appreciation 6 Note recording 7 Home transfusion 8 Pre Hb screening
9. Hospital expansion 10. Charging patients 11. Volunteer support 12. Easy to read info
13. Events in the unit 14. Primary transfusion nurse 15. Contact nurse 16. Online forums
17. Cannulation improvements
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5.3.4.3 Intervention design 
Intervention options for each strategy with reported constraints and enablers 
(n=15) were developed, supported by 28 different Behaviour change 
techniques (BCTs), most frequently ‘Restructuring the physical environment’ 
(utilised for n=9 intervention options, 60%) and ‘Information about the social 
and environmental consequences’ (n=6 options, 40%) (Table 19 and Table 
20). Intervention ideas were evaluated using the APEASE criteria, which 
identified intervention options to be rated highly (5 options, 33%) or 
moderately (7 options, 47%). Three options were rated uncertain or low 
(20%). An intervention, for example, with a moderate APEASE rating was 
for strategy four (enhancing shared decision-making). This would see 
managers facilitating a culture of shared decision-making, by reviewing staff 
capacity to spend more time with patients for longer conversations. HCP 
targeted workshops would be set up to facilitate decision-making being more 
‘negotiated’ with patients, allowing patients more control and choice over 
their transfusions. This may be affordable and effective etc., yet how practical 
it would be may be questionable, based on HCP time-constraints and there 
may be some unwanted side-effects with some patients adopting a greater 
amount of autonomy and disputing clinical advice. A ‘high’ classified 
intervention option was proposed for strategy five (encouraging laboratory, 
HCP and patient role appreciation). Patients may benefit from being 
provided with written information about safe laboratory procedures during 
delays or through organised lab tours. Reciprocally, this intervention option 
could be developed to encourage non patient-facing laboratory staff to more 
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greatly understand patients’ perspectives, with perhaps patients being invited 
to discuss their experiences when meeting laboratory staff.  
5.3.4.4 Mapping of strategies to original patient constructs 
 Of the 17 strategies identified, at least one strategy maps onto all of the 
constructs identified in the patient interviews (Study 2), with most strategies 
addressing perceptions from the constructs of ‘Involvement in decision 
making’ (n=10), ‘Social connection’ (n=8) and ‘Negative emotions’ (n=7) 
(Table 21). Forty-eight mappings were identified; 44 being ‘positive 
associations’ in that the strategy is facilitative and addresses issues relating to 
the perceptions belonging within the construct. Four mappings were, 
however, ‘negatively associated’ in that they are unlikely to work towards 
improving patients’ perceptions associated with the construct. Two strategies 
in particular: ‘Home transfusion’ and ‘Charging patients for wasted 
transfusion slots’ are linked ‘negatively’ with the constructs ‘Social 
connection’ and ‘Negative emotions’. Providing transfusions at home may 
enhance patients’ negative emotions and isolation and charging patients may 
lead to patients feeling reprimanded and disconnected from the units, 
increasing patients’ negative emotions.  
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Table 21 Mapping of strategies to original patient constructs 
  Focus group presented Questionnaire presented 


















Service improvement strategies 
1. Transfusion team / unit                   
2. Psychological support                   
3. Shared decision-m                   
4. Lab samples                   
5. Role appreciation                   
6. Note recording                   
7. Home transfusion                   
8. Pre Hb screening                   
9. Hospital expansion                   
10. Charging patients                   
11. Volunteer support                   
12. Easy to read info                   
13. Events in the unit                   
14. Primary transfusion nurse                   
15. Contact nurse                   
16. Online forums                   
17. Cannulation improvements                   
Colour shading: green cells = positive associations between strategy and theme and red cells = negative associations 
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 Discussion 
This focus group study explored the views of Regional Transfusion 
Committee healthcare professionals (HCPs) about haematology patients’ 
perceptions of blood transfusion and generated potential service improvement 
strategies. Participating HCPs reported that the constructs were reflective of 
their practice and interactions with patients in the haematology units. The 
inductive synthesis of the focus group and questionnaire data produced nine 
themes in total: Practical difficulties for transfusion patients, Patient support 
provision, Service efficiencies, Supporting best practice, Positive 
collaboration with patients, Transfusion acceptance, Patients’ individual 
preferences, Patient involvement and Practice difficulties. HCPs recognised 
that patients commit a large amount of time to receiving their transfusions. 
However, through this study, evidence of patients self-initiating their request 
for transfusions were revealed. HCPs discussed that although there are some 
practices that work well, they suffer the consequences of the lower 
prioritisation of some haematology transfusion services and poor links with 
other wards and the wider community HCPs. HCPs do manage, however, to 
develop close ties with their patients, respecting their individuality and 
largely involve patients in their transfusions and unit activities (e.g., making 
treatment decision plans and suggesting cannulation sites). HCPs reported 
extending their outpatient care activities to provide additional support, such 
as emotional support and authorising prescriptions.  
HCPs were able to propose 17 hospital and community-based service 
improvement strategies in total, which mapped to seven components of the 
Behaviour change wheel (BCW) (Michie et al., 2011), covering ways to 
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improve processes (e.g. developing a transfusion team and expediting 
laboratory samples), ways to enhance patient communication (e.g. 
psychological support, shared-decision making, role appreciation) or 
transfusion-related community provisions (e.g. home transfusion, remote 
blood level screening). Constraints and enablers raised for these strategies 
were able to be mapped to the Theoretical Domains Framework (TDF) (Cane 
et al., 2012; Michie et al., 2005) and behaviour change interventions were 
proposed to develop the strategies further (e.g. to provide HCPs with training 
support to enhance patient decision-making conversations or providing 
written information advising of safe laboratory processes).  
The findings of this study relate with the previous study 2 in Chapter 4, with 
HCPs commenting that haematology transfusion resources are stretched. 
However, this study advances on study 2 by proposing initiatives that would 
lead to patients taking a more central role in their transfusions, such as 
monitoring their own blood levels, or being considered for transfusion in the 
community. There was an impetus too on HCPs needing improved processes, 
improved consideration of the patient’s role (role appreciation) and more 
stable community links. The types of strategies generated map closely to the 
construct of ‘Involvement in decision making’ with HCPs being receptive of 
the need to improve decision making type issues (e.g. information provision, 
notes recording and decision-making discussions). This study reinforced that 
without stable and consistent support systems in place, more problems often 
occur, such as greater patient frustrations and an increasingly disorganised 
service with patients controlling their own transfusion requests or being 
inappropriately transfused and HCP communications breaking down.  
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For this study, individual level change suggestions proved more difficult to 
incite, as opposed to general hospital and community level strategies. HCPs 
may have attributed change as being outside of their control through their 
current experience of responding to a pressured service with often managerial 
top-down changes applied. HCPs also primarily reported constraints to 
change, possibly because HCPs attribute many of the current service 
difficulties to responsibilities outside of themselves (Shaver, 1983). HCPs 
may have learnt to cope with the problems that they face (Schein, 2010), 
feeling that they personally can do little to change large-scale issues.  
For patients, the findings of this study signal that a number of haematology 
patients do require more supportive measures to be put into place. Some 
patients may be willing to consider home transfusion, as found in a French 
study, where there was a preference for home transfusion at a similar 
consistency to preference for home chemotherapy (Havet et al., 2012). A UK 
based intervention of home platelet transfusion and pretransfusion assessment 
reported increases in patients’ preferences for this method and alleviation of 
patients’ concerns about the stress, cost of travel and waiting time at hospital 
(Craig et al., 1999). As long as home transfusion is acceptable to patients, it 
may be an option for localities to begin supporting or continuing if they have 
the resources in place. Home transfusion may be a practical and acceptable 
option for experienced transfusion patients, more ready to receive their 
transfusions away from the unit or patients with less advanced disease stages 
(Havet et al., 2012).  
This focus group study appealed to a selective group of HCPs, being less 
burdensome on their clinical time conducted away from the haematology unit 
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and less time consuming than other consensus methods such as Delphi or 
nominal group technique (Cantrill et al., 1996). HCPs accepted and 
understood the focus group procedure and contributed enthusiastically to the 
group discussions. 
On reflection of the experience of running the focus groups, having active and 
engaged participants made the experience of running the focus groups easier, 
with participants, especially of Consultant level, being engaged in the 
discussion and contributing whole-heartedly. I felt accepted as a researcher at 
each focus group and felt that HCPs gave as honest as possible audio-recorded 
account of the issues that they and their patients face. Each focus group was 
unique, and reflections were documented in the Reflexive log (Appendix 
10.22).  
Overall, groups were easier to facilitate when cohesive and when participants 
gave each other time to talk. Time constraints to the focus groups and groups 
with conversations that deviated away from the topic or where participants 
were left out of the conversation required more active facilitation. This 
required more active problem-solving to steer the group back onto topic and 
the use of more enhanced facilitation, to include all members by, for example, 
personally requesting their thoughts.  
As a cooperative group of HCP participants, there may have been a risk of 
bias, however, in the selected sample of HCPs who volunteered to take part. 
HCPs attending the RCT meetings who routinely engage with transfusion 
committee findings are potentially receptive to considering practice change 
and therefore service-improvements. As time-constraints did  affect the 
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majority of the focus groups, the discussion were also limited to three of the 
nine transfusion constructs identified in Study 2 (Chapter 4). However, the 
use of the questionnaire enabled HCPs to provide their opinions on the full 
set of constructs. The questionnaires produced, however, an even lower 
response rate, but did highlight an equal number of service improvement 
strategies as the focus groups and valuable content related to patient 
involvement, patient transfusion acceptance and individual differences.  
The time-constraints and individual completion of the questionnaire also 
limited service improvement strategies to be debated and possibly organised 
into a prioritised list, with potential pathways (action plans) to 
implementation. In the focus groups, the researcher aimed to overcome this 
by presenting patients’ priority perceptions and summarising with the groups 
strategies that they have mentioned, checking for agreement. Yet, additional 
time and the use of materials such as ‘post-it’ notes to record and prioritise 
ideas or the design of follow on workshops would have potentially increased 
the range of views and the range and specificity of the strategies generated. 
An online version of the follow-on questionnaire may have also been useful 
for respondents to electronically prioritise proposed strategies using ‘drag and 
drop’ options.  
A strength of this study was the application of current behaviour change 
frameworks to help interpret the findings. This provided a structure for 
constraints and enablers to be understood within the TDF (Michie et al., 2005) 
domains, for example, and for interventions to be proposed, taking into 
account constraints and enablers that were raised. Many constraints and 
enablers, however, were based on ‘Environmental context and resources’ 
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issues, which may be more costly and difficult to change, for example, 
hospital expansion or new transfusion units. Such changes would also require 
additional staffing resources. ‘Beliefs about consequences’ may be more 
amenable to change, for example, through further exploration about how 
patients would engage with the new service ideas. The strategies, constraints 
and enablers cited were also speculative and not an exhaustive list. HCPs 
were speculating on hypothetical scenarios (e.g. patients having home 
transfusions) and may have raised constraints that would not materialise, or 
constraints that will become diminished on implementation. Reviewing past 
interventions when formulating the APEASE (Michie et al., 2011) ratings 
would have also been of benefit when formulating intervention options. The 
researcher would have been able to refer to and cite the outcomes of similar 
interventions to build stronger rationales for given APEASE judgements.  
As the process of implementing healthcare change goes through discrete 
stages (Grol, 2013), these strategies are at an early stage, needing to be 
revisited and developed further before being refined into interventions, 
possibly some of those proposed, pilot tested and implemented. Key decision-
makers, such as service leaders, patients, patient representatives, relatives, 
researchers and stakeholders would ideally need to be involved in 
intervention development stages to help a thorough understanding of the exact 
behaviour to be changed to be identified. The next steps would involve 
identifying intervention options (possibly taking further those proposed) and 
specifying the content and implementation options, for example, using 
behaviour change techniques (Michie et al., 2013) and modes of delivery. 
Patient and service user involvement would be consistent with Experienced 
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based co-design methods (Bate et al., 2006; Brocklehurst et al., 2018) and 
researchers would need to be involved to manage the studies and conduct 
ongoing research (e.g. qualitative research to verbally share opinions and 
ideas).   
In conclusion, this study stimulated discussion and debate with transfusion 
HCPs about identified constructs of haematology patients’ blood transfusion 
perceptions, leading to the identification of 17 hospital and community-based 
service improvement strategies. These strategies sought to generate new 
opportunities to improve transfusion patients’ experiences and rectify current 
practice difficulties. Further development of the service improvement 
strategies would benefit from the engagement of key stakeholders and 
continued theory-based design. Some indication has been given to possible 
intervention ideas, such as HCP targeted communication training and the 
consideration of home transfusion. 
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6 General Discussion 
This programme of research explored patients’ and healthcare professionals’ 
(HCPs’) perceptions of blood transfusion through a sequence of three studies. 
Study 1 was a systematic review of existing published studies exploring 
patients’ and HCPs’ perceptions of blood transfusion. Study 2 was a 
qualitative interview study of haematology patients’ and HCPs’ perceptions 
of blood transfusion. Study 3 was a focus group study to explore HCPs’ views 
of patients’ perceptions from study 2 and identify the implications for practice 
and potential strategies to improve current haematology services. This chapter 
will briefly provide an overview of the findings of each study and the overall 
contribution of the findings to the literature, draw on the strengths and 
limitations of the programme of research and present implications for 
research and practice.  
 Findings 
6.1.1 Study 1: Patients’ and HCPs’ perceptions of blood transfusion: 
A systematic review 
The systematic review reported in Chapter 2, first conducted in 2014 and 
updated in 2015 and 2019, included 41 studies reporting patients’ and HCPs’ 
perceptions of blood transfusion. These were published between 1990 and 
2018. Twenty-six studies reported HCPs’ perceptions, and 15 studies 
patients’ perceptions, with no study concurrently exploring the perceptions of 
both groups. Reported perceptions were analysed using inductive qualitative 
synthesis (Thomas, 2003). Overall, the review identified that transfusion was 
considered as carrying low to moderate risk, but that perceived transfusion-
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associated risk, or negative emotions (e.g. concerns about infection risk) were 
associated with the use or consideration of transfusion alternatives (e.g. pre-
operative autologous donation). The inductive synthesis produced six themes 
of patients’ and HCPs’ blood transfusion perceptions organised into a 
conceptual model of blood transfusion perceptions: Safety / risk, Negative 
emotions, Alternatives, Health benefits, Necessity and Decision making. 
Relationships between the constructs in the model were proposed, for 
example, between Alternatives, Safety/risk and Negative emotions. The 
Decision making construct contained perceptions related to behaviours 
observable in the clinical setting, such as patients not questioning transfusion 
decisions and of HCPs’ prescribing behaviours. 
The review identified, however, that perceptions tended to be investigated for 
patients receiving, and HCPs prescribing, transfusions in surgical contexts, 
with results not separated in the analysis and reported per patient or HCP 
group. A gap emerged to investigate the perceptions of under-represented 
transfusion patient and HCP groups, whose perceptions may vary widely 
from patients and HCPs receiving or providing one-off transfusions. Most 
notable was the need to explore haematology patients’ and HCPs’ blood 
transfusion perceptions due to the repeated use of transfusions in haematology 
contexts. Haematology patients would be receiving transfusions on a repeated 
basis for long-term conditions or to support cancer treatment. As patients will 
require transfusions routinely and be able to form perceptions at different 
time-points (e.g. pre and post transfusion provided to a ‘conscious’ patient, 
as opposed to an unconscious patient), it was felt necessary to consider this 
area for more specified investigation.  
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6.1.2 Theoretical mapping 
Chapter 3 documented how constructs from the conceptual model of blood 
transfusion perceptions, developed in Study 1, were mapped against 
constructs from five prominent treatment perceptions frameworks. The 
Beliefs about Medicines Questionnaire (BMQ) (Horne et al., 2004; Horne et 
al., 1999b) items were identified to map most closely to the conceptual model 
constructs. Overall, constructs from the conceptual model were considered to 
provide a framework consistent to the broader treatment perceptions 
literature, providing support for this model to be used in ongoing studies 
investigating patients’ and HCPs’ transfusion perceptions. 
6.1.3 Study 2: Exploring perceptions of blood transfusion in 
haematology 
Study 2 was designed to explore haematology patients’ and HCPs’ 
perceptions of blood transfusion, which was a research gap identified in Study 
1, using semi-structured, qualitative interviews. Fourteen patients and 14 
HCPs receiving and delivering transfusions in haematology outpatient day 
units were interviewed across two UK sites. The patient- and HCP-specific 
interview topic guide used for this study were structured around constructs 
from the conceptual model of blood transfusion perceptions, developed 
through Study 1 and supported through the theoretical constructs mapping in 
Chapter 3. Participants’ responses were coded deductively into constructs 
from the conceptual model with inductive thematic analysis being used to 
generate new themes.  
This study found that patients and HCPs agreed that transfusions were 
necessary and beneficial for haematology patients. However, some negative 
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emotions were reported, for instance related to the downsides of transfusions 
for haematology patients (e.g. health impact). Patient and HCP conceptual 
models were developed for the haematology context to highlight perceptions 
for this specific group compared to the general conceptual model from Study 
1. Additional constructs, such as ‘Burden’ and social and contextual 
constructs: ‘Social connection’, ‘Supportive relationships’ and 
‘Organisational factors’ were added to the haematology models. The findings 
of this study signalled many close ties between patients and HCPs but also 
that some patients may require more support when receiving repeated 
transfusions and that services could potentially be improved to benefit both 
patients and HCPs. HCPs recognised, for example, that they often did not ask 
patients about their views and feelings about receiving blood transfusions, 
thus, in turn factoring this into the care they provide.  
6.1.4 Study 3: BOOST: Building Optimised Outpatient Services in 
Transfusion 
Study 3 was a focus group study that aimed to explore the extent that HCPs 
recognised patients’ transfusion perceptions from Study 2, whilst exploring 
with HCPs potential ways to change services and potentially their practice to 
improve patients’ experiences. Three focus groups were held at two regional 
transfusion committee (RTC) meetings. In total 19 HCPs took part, with six 
HCPs providing further feedback via the free-text response follow-on 
questionnaire. The findings highlighted that participants acknowledged the 
patients’ perceptions and discussed themes related to ‘patient support 
provision’, ‘service efficiencies’ and ‘practice difficulties’ such as 
insufficient links with community HCPs and lower prioritisation of 
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haematology transfusions. HCPs proposed 17 service improvement strategies 
to improve current practice. These were subsequently categorised into 
intervention functions in the Behaviour change wheel (BCW) (Michie et al., 
2011). The majority of proposed improvement strategies fell within the 
‘Service provisions’ ‘Enablement’ and ‘Environmental restructuring’ 
intervention types. This included hospital-based initiatives, such as having a 
standardised transfusion team or unit and expediting haematology lab 
samples. Community-based solutions, such as home transfusion or 
community haemoglobin (Hb) testing were also endorsed. HCPs were also 
asked to think about potential constraints and enablers to implement these 
proposed strategies. Most reported constraints and enablers corresponded to 
the Theoretical Domains Framework (Cane et al., 2012; Michie et al., 2005)  
domain ‘Environmental Context and Resources’ (n=10 strategies) (e.g., 
location specific services, blood sample transfer risk). This indicated that 
opportunities would need to be afforded by the environment (e.g. setting up 
safe community to laboratory sample shipment) for these strategies to be 
successfully adopted and implemented. 
 In conclusion for this study, the taxonomy of Behaviour Change Techniques 
(Michie et al., 2013) was consulted to identify potential interventions 
targeting the constraints and enablers for each strategy suggested by the 
HCPs. These included, for example, the resourcing of local healthcare hubs 
and addressing resource needs to implement community or home transfusion. 
Interventions were evaluated for their practicability and affordability etc., 
against the APEASE criteria (Michie et al., 2014) to establish interventions 
that may have less barriers to implementation.  
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 Contribution to the literature 
The contributions of this research to the evidence base in blood transfusion 
and the broader health psychology treatment perceptions and behaviour 
change evidence base is outlined below. 
6.2.1 Blood transfusion 
This programme of research has helped to address a priority area recognised 
for blood transfusion, of involving patients more greatly in their transfusions. 
Questions related to transfusion often include ‘how can patients, relatives and 
carers be empowered to have greater say about their choices in relation to 
blood transfusion and its alternatives?’ (James Lind Alliance Priority Setting 
Partnership, 2019). Alongside this, there are recommendations in practice to 
involve patients in decision making (Davis et al., 2012a; Davis et al., 2011). 
This programme of research can help facilitate implementation of this in 
practice by providing the supporting evidence base. Study 1 provides a 
general conceptual model of blood transfusion perceptions, and Study 2 
provides haematology specific models. These models help to visually portray 
constructs of patients’ and HCPs’ transfusion perceptions, which may be of 
potential worth to discuss in transfusion decision-making consultations. The 
models also present specific relationships between the constructs, being 
necessary to consider when discussing transfusions (e.g. the influence of 
negative emotions on preferences for alternatives), as this may have a broader 
influence on patients’ transfusion acceptance. Study 3 provided HCP-
generated areas for practice change, which promote patient involvement and 
improved decision-making discussions.  
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6.2.2 Treatment perceptions 
This programme of research has helped to profile the context of blood 
transfusion in the treatment perceptions literature. Prior to this research being 
conducted, transfusion treatment perceptions research was not broadly 
included in health psychology treatment perceptions research, as much as 
studies of repeated treatments, such as asthma medications (Østrem et al., 
2015) or dialysis therapy (Karamanidou et al., 2014). Transfusion is equally 
a life-saving intervention and the coherence of the conceptual model 
constructs to the broader treatment perceptions literature portrays how 
transfusions can be largely considered in the same way as other medicines 
and treatments. This may be helpful to patients who can refer to their standard 
conceptualisations of treatments when in a healthcare context and 
rationalising a treatments necessity (Horne, 1999). Transfusions being 
provided in several clinical contexts, however, is unique to the treatment 
perceptions literature, in that it is used in acute settings and repeatedly for 
cancerous or long-term conditions.  
The haematology interview Study 2 findings correspond with the literature in 
that new constructs such as ‘Burden’ were prevalent alongside contextual and 
social constructs (e.g. ‘Organisational factors’, Supportive relationships’ and 
‘Social connection’), which are known to inform typical treatment 
perceptions, such as needs and concerns (Horne, 2003). ‘Treatment burden’ 
for patients with long term conditions is identified as the loss of freedom and 
independence for some patients (Demain et al., 2015). Relational disruptions 
can also occur due to treatment burden, including strained family and social 
relationships and feeling isolated (Demain et al., 2015). Some of these aspects 
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were reported by the haematology patients interviewed in Study 2, in terms 
of lack of contact with other patients in the unit or life-alterations (e.g. travel). 
Thus, it is important to continue to explore the construct of ‘Burden’ in more 
detail with transfusion patients as treatment burden may impact a 
haematology patient’s life to a greater extent than shared by patients in the 
current interviews.  
However, in the haematology interview Study 2, treatment adherence, a 
commonly measured outcome variable in treatment perceptions research, was 
less of an issue due to the absolute necessity of the transfusions. Although, a 
sense of patients ‘actively accepting’ or ‘modifying’ their treatments (e.g. 
proactively requesting their transfusions) was identified. In many patient 
cases, existing without transfusions would be detrimental to patients’ health, 
thus it may be worthwhile to retain a focus on ‘adherence’ to some degree, 
specific to treatment modification, in order to detect broader patient non-
compliance behaviours.  
6.2.3 Behaviour change 
The focus group Study 3 findings correspond with the literature in that all 
strategies and their constraints and enablers were able to be mapped to 
Behaviour Change Wheel (BCW) and Theoretical Domains Framework 
(TDF) (Cane et al., 2012; Michie et al., 2011) behaviour change frameworks. 
These frameworks provided evidence-based structures to guide the 
organisation of multiple strategies, constraints and enablers, to help present 
the key findings of the study into useful groupings for clearer results 
presentation. Other taxonomies and criteria utilised, such as APEASE 
(Michie et al., 2014), were similarly helpful to guide intervention design 
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ideas. These mapping activities are consistent with current intervention 
development research that applies behaviour change frameworks, with the 
frameworks providing a theoretical basis for implementation (Atkins et al., 
2017). 
 Strengths and limitations of the research 
General strengths and limitations of the research will firstly be addressed, 
followed by a fuller summary of the strengths and limitations of the 
theoretical approach below.  
6.3.1 Strengths 
This programme of research covered a broad time range, beginning with 
Study 1 which was used to identify historic to present day perceptions of 
transfusion (1984-2019), with recognition of the impact that former tainted 
blood scandals may have on perceptions. Ongoing studies, in particular Study 
2, sought to address an important research gap, to investigate the perceptions 
of repeated transfusion patients and HCPs in haematology units. This study 
involved a range of transfusion patients and HCPs in the study across two 
sites and utilised qualitative research methods, which are advocated for use 
in transfusion research (Whittaker, 2002). Study 3 further utilised qualitative 
methods to present patients’ perceptions that were collected in the preceding 
study and mapped the findings that were grounded in current practice to 
behaviour change frameworks. Overall, this programme of research has 
evolved from considering which perceptions patients and HCPs might hold 
to HCPs encouraging patient involvement in how services might be improved 
for their benefit. 
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6.3.2 Limitations 
Both of the primary studies in this programme of research (Study 2 and 3) 
benefitted from interested participants being willing to volunteer their 
involvement. The patients, however, that were interviewed were largely white 
English origin (71%) and Christian religion (79%) and some patients were 
unable to take part due to their lack of English. Although qualitative research 
findings do not aim to be generalisable to the broader population, patients’ 
views in this research are broadly more representative of the views of 
medically stable haematology patients of white English and Christian 
religious and ethnic demographic categories. However, patients’ 
demographics were collected and reported in the results to make this available 
for readers of the research. 
Religious and ethnic disparities are of significance because research has 
shown that patients’ perceptions are influenced by their broader cultural 
influences. One study of rheumatoid arthritis patients found that the patients 
of South Asian origin had higher ‘Overuse’, ‘Harm’, and ‘Concern’ BMQ 
scores compared to patients of White British/ Irish origin, which influenced 
their treatment adherence (Kumar et al., 2008). Some people may associate 
control over their health to higher spiritual powers. HCPs can be seen in such 
cases as intermediaries to help patients reach their destined fate 
(Karamanidou et al., 2014). Given that transfusions are required by people of 
all cultural backgrounds, future research may be used to investigate 
differences between transfusion perceptions across cultural groups. This may 
detect particular patients’ preferences for or against receiving transfusions in 
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the haematology units or at home to suit culturally specific norms or privacy 
preferences (May et al., 2009).  
6.3.3 Strengths and limitations of the theoretical approach 
The strengths of the methodological approach include using the conceptual 
model of blood transfusion perceptions as an overarching framework to 
structure data collection and analysis across the studies. This provided a 
consistent framework for comparing findings across the studies and 
participant groups. The model also facilitated comparison with the broader 
literature, given convergence in the mapping. Using a model that was derived 
from transfusion perceptions and shared linkage with the broader literature, 
was beneficial compared to selecting one particular instrument to apply, such 
as the Beliefs about Medicines Questionnaire (BMQ) (Horne et al., 1999b). 
The BMQ has been scrutinised for its suitability to capture the treatment 
perceptions of specific populations with complex and long-term conditions, 
such as psoriasis suffers (Thorneloe et al., 2017). The authors of this work 
found that BMQ items could easily be misinterpreted or that they should be 
extended upon, for example to cover Psoriasis sufferers ‘underusing’ topical 
medicines to obtain specialist care referrals, instead of focusing purely on 
medicine ‘overuse’ (Thorneloe et al., 2017). Transfusion ‘underuse’ is less 
likely to be an issue for some repeatedly transfused patients, but these patients 
may ‘modify’ their treatment regimes, by cancelling (postponing) planned 
transfusions, which could be detrimental to their health.  
Further strengths of the theoretical approach relate to the conduct of 
comparative semi-structured interviews with patients and HCPs, whereby 
topics, such as transfusion alternatives and decision-making, could be 
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explored from both perspectives. Using this approach, the researcher 
collected data around each construct of the model. In contrast, unstructured 
interviews may have lacked this focus, with the researcher not imposing 
categories of interest, which may have been more suited to exploring topics 
which have not previously been extensively described (Fitzpatrick et al., 
1994).  
The interview study also included a limited number of two sites, raising the 
question of whether patients and HCPs receiving and providing transfusions 
at different haematology units held similar perceptions. Many of the focus 
group participants in Study 3, who were from a different UK region as the 
interview sites, however, acknowledged the patients’ perceptions but with 
some HCPs commenting that their patients receive transfusions, for example, 
in isolated rooms. These patients may hold uniquely different perceptions of 
their transfusions than patients receiving transfusions in an open plan unit, 
potentially having less social interaction, but arguably still holding 
transfusion perceptions associated with the ‘Burden’, ‘Necessity’ and ‘Health 
Benefits’ of transfusion.  
The semi-structured focus groups used in Study 3 was also advantageous to 
provide structure to the discussion around each perception construct 
presented. However, HCPs who participated and engaged with this study 
were more self-selective and could have been HCPs willing and motivated to 
confront patients’ perceptions and consider how their practice and service 
may need to be altered. It is uncertain from this research, how broadly 
haematology HCPs in general would engage with this research topic. Less 
engagement with this topic may also be indicative of lower engagement in 
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practice with patients’ perceptions or service change. It was noticeable that 
the Study 3 follow-on questionnaire response rate was low (50% meeting one, 
23% meeting two). HCPs may have lacked engagement and motivation to 
return the questionnaire or may have felt that they have contributed 
everything they could have to the topic discussion during the focus groups. 
Ethical approval was not sought to re-contact HCPs to encourage 
questionnaire completion, which would have been beneficial.  
The theory-based mapping of the service improvement strategies from Study 
3, was facilitated by the availability and accessibility of behaviour change 
frameworks. As a guiding structure these frameworks were beneficial to 
group intervention types and hypothetical constraints and enablers to TDF 
(Cane et al., 2012; Michie et al., 2011) domains and to guide intervention 
design, considering key issues, such as intervention acceptability and 
effectiveness (Michie et al., 2014). However, when designing ongoing 
interventions patients’, HCPs’ and stakeholders’ perceptions and experiences 
would need to be taken into account, which may shift the intervention focus 
away from the frameworks. The constraints and enablers would no longer be 
hypothetical, and patients, HCPs and stakeholders may wish for the 
developing service to be adapted or altered. For example, for raising patients’ 
awareness of laboratory duties, so far one constraint was cited, that ‘patients’ 
priorities may be different to HCPs’, but more constraints, such as time 
restrictions to provide patients with information, sensitivity factors and 
language barriers may emerge, increasing the complexity of the intervention 
design.  
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 Implications for future research 
There are a number of areas where this research could inform future research 
projects, as outlined below.  
6.4.1 Relationships between constructs and the inclusion of 
psychosocial variables 
There is scope for the conceptual models from Study 2 to be used in ongoing 
research with a larger sample of haematology patients and HCPs using a 
quantitative design, where the constructs would be translated to questionnaire 
subscales. Discriminant content validity would be a method that supports this 
translation, involving six steps, such as construct definition, item selection, 
judging and content validity testing (Johnston et al., 2014). A larger 
quantitative study would enable these constructs to be explored with a larger 
population for their significance and for relationships between the constructs 
to be tested using path analysis or structural equation modelling approaches. 
The strengths of the pathways from perceptions to decision making 
behaviours, for example, transfusion or alternatives prescription and 
transfusion acceptance could then be explored.  
Conducting a larger quantitative study would make it possible for the 
influence of patients’ illness perceptions, quality of life (Salek et al., 2013) or 
other important psychosocial variables to be examined. Patients for whom 
transfusion is a long-term ‘treatment’ option may have varying ‘cure/control’ 
perceptions than for patients who receive transfusions for a shorter length of 
time, often alongside chemotherapy. This is important as ‘cure/control’ 
dimensions have been found to correlate with problem-focused coping, 
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cognitive reappraisal (to change the way that one views their illness) and 
seeking social support (Hagger et al., 2003). Transfusion patients reporting 
high perceived control may be more willing to take an active role in their 
transfusions and be more involved in the unit, such as being an active 
stakeholder or participant in the development of the service improvement 
strategies. Patients who report having a lower quality of life, however, may 
face difficulties to adopt an active role due to poor health or disease burden 
or treatment adverse events (Salek et al., 2013).  
Personality variables are also likely to have an impact on treatment 
perceptions and mood states, such as depression and anxiety, which has not 
so far been measured in this research. Some patients ‘accepted’ the 
transfusions and held a general positive outlook towards their transfusion 
related challenges, which may have been based on their general personality 
traits. For example, ‘conscientiousness’ has been found to be positively 
associated with adherence to medicine regimes and ‘neuroticism’ having a 
negative effect on health behaviour (Booth‐Kewley et al., 1994; Christensen 
et al., 1995). However, for patients with asthma, a high level of negative 
affectivity has been associated with completing behaviours correctly and a 
greater awareness of illness-specific symptoms, due to patients’ worries about 
their asthma (Mora et al., 2007). Thus, it would be important to consider the 
influence of such traits on transfusion patients’ perceptions.  
As patients who were interviewed in Study 2 were taking prescribed 
medicines for other conditions, namely asthma, high blood pressure, diabetes, 
dermatological conditions, hip replacement or transplant recovery, self-
regulation of patients’ health, for this sample may have been additionally 
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challenging. The literature reports that coping with multimorbidity is often 
problematic, in particular taking multiple medicines (Mc Sharry et al., 2013). 
Patients may experience conflicts with managing their haematological 
conditions alongside other disorders, which was not fully explored by this 
research, in addition to the challenges of managing transfusions alongside 
chemotherapy and treatments for the same haematological condition was not 
fully explored. Future research may seek to explore this further and propose 
specified recommendations for practice. For instance, patients with co-
morbidities are often willing to engage in treatment discussions which cover 
the interaction of multiple conditions (e.g. diabetes and depression) and 
discover management techniques beneficial for both (Mc Sharry et al., 2013).  
6.4.2 Longitudinal research 
As many haematology patients will be receiving transfusions for numerous 
months or years, longitudinal research is of relevance to this topic, to 
recognise how patients adjust to transfusion and to how adjustment may 
change or be impacted over time. Longitudinal research is often used to 
explore coping strategies employed by patients, to learn how this may 
moderate or mediate their health outcomes (Hagger et al., 2003). In this 
context, longitudinal research could be used to investigate the views of newly 
diagnosed haematology patients where transfusions are their main treatment 
option or teenage and young adult patients transitioning into adult services. 
Teenage and young adult sickle cell patients often report poor preparation to 
transition to adult-oriented services and insufficient readiness (McPherson et 
al., 2009).  
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6.4.3 HCPs’ perceptions research 
Some HCPs involved in this research (Study 2 interviews) commented that 
they were interested in this research topic and particularly valued the 
opportunity to reflect on their perceptions. Some HCPs acknowledged that 
they were only exposed to hospital-based patient interaction and not how 
patients cope in the community. They were interested in finding out more 
about how patients manage once they are away from the hospital, between 
transfusions. Future research could thus involve HCPs setting priorities for 
research to the same extent as patients, to help generate research questions 
that they wish to discover the answers to. Service improvement has been 
advocated through this research due to current capacity strain and issues with 
low prioritisation of haematology-based transfusions. If service changes are 
implemented (discussed below), research may need to investigate how HCPs’ 
perceptions alter during and as a result of service change. HCPs commented 
in Study 2 that their perceptions seemed to be comparable with their 
colleagues and remained stable over time, reflecting complacency. Radical 
changes to services, such as ‘hospital restructuring’ and ‘contact nurse 
support’ may require support to be equally offered to HCPs to cope with 
running adapted services and implementing such changes. Threats to 
healthcare reform include physician burnout (Dyrbye et al., 2011) but 
organisational efforts put in place can help to manage this, such as small-
group support programmes and stress reduction practices (West et al., 2018). 
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 Implications for practice 
6.5.1 Decision making 
This research has highlighted how central the topic of ‘decision making’ is 
for blood transfusion patients and HCPs, and how even when decision options 
are limited, it is still an elaborated construct for patients and HCPs, and a 
resultant behavioural perception that many cognitive and emotional 
perceptions link to. As a general principle arising from this research, 
transfusions need to be discussed as a part of patients’ decision-making 
conversations, based on the clinical feasibility of this. In the haematology 
context, transfusion discussions could be embedded into the main treatment 
discussion, even when transfusion may only be a supplemental treatment. 
Transfusion is not without risk, and when administered on a repeated basis is 
time-consuming, thus warranted to be included as a part of the full treatment 
discussion. This would help patients to be aware of the transfusions and have 
the opportunity to ask questions. Being more involved in their treatment 
decision making is likely increase patients’ feelings of self-efficacy, which 
will increase patients’ intentions to share in decision making (Stiggelbout et 
al., 2012). Patients having an active role in decision making is also associated 
with many patient benefits, such as better coping with negative emotions (e.g. 
anxiety, distress), greater information receipt and greater reported functional 
ability (Adams et al., 2006; Greenfield et al., 1985; Luce, 2005). 
The conceptual model of blood transfusion perceptions from Study 1 or the 
haematology specific models in Study 2, could be used as guides to inform 
decision-making. The constructs could direct areas for discussion, which may 
be useful if transfusion is the primary treatment, therefore, lack of 
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‘alternatives’ or potential ‘burden’ could be addressed. New HCPs or 
haematology patients with less experience of discussion topics may benefit 
from using a structured set of constructs. HCPs and patients could also be 
involved in developing the models further into decision-aid style documents, 
for example, translating the constructs into decision-aid question topics, 
which may help patients participate in the decision making (Toledo, 2014). 
Decision aids have been found to be beneficial to improve patient knowledge, 
reduce decisional conflict and improve patient-HCP communication (Stacey 
et al., 2017).  
Improving decision-making conversations may also benefit HCPs in some 
haematology units who deal with ‘hard to manage’ patients, as discussed in 
Study 3. These are patients who arrive to the units without an appointment 
with a request to be transfused due to exacerbation of their symptoms. 
Patients may be informed of how to manage their transfusion scheduling and 
the clinical importance of this, alongside briefly being advised of the 
challenges for HCPs to manage capacity demands if patients are non-
compliant with their appointments. Further research or clinical audit could be 
invested into this area to discover the scale of the issue; of patients attending 
outside of their transfusion appointments. This is important as currently some 
HCPs in the focus groups reported sending patients to a less accessible site 
for their transfusion, as a type of sanction, or reluctantly and almost 
begrudgingly transfusing the patients, which caused upheaval to the 
transfusion scheduling. It can be argued that neither solutions are sustainable 
and the service improvement strategy of ‘charging patients for appointment 
non-attendance’ potentially controversial.  
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6.5.2 Patient involvement in their transfusions 
As a large amount of time is spent by transfusion patients in the haematology 
unit, some patients sought and could be supported with additional ideas of 
how to be more involved in their transfusions. This could be, as concluded 
for some patients, helping to choose veins during cannulisation, receiving 
haemoglobin results print outs or holding talks with new student groups of 
HCPs. All of these measures appear to currently aid patients to feel more 
involved in their transfusions and unit activities and enhance their feelings of 
control. There are likely to be numerous additional strategies to facilitate 
patient involvement and this is something that could be discussed at the unit 
level between patients, perhaps at informal events within the units (if 
implemented as a part of service reform) and proposed to HCPs.  
Other ideas to promote patient involvement may target patients who feel 
content perhaps with less ‘social interaction’ in the haematology unit, but who 
would wish to better spend their time at the unit and reduce any feelings of 
boredom. Some patients reported lacking interaction due to other patients 
having different conditions as them or not being as conversational as they 
would wish to be. Some patients also experience fatigue, illness or upset 
during appointments, being a barrier for other patients to approach them to 
socialise. Therefore, ideas could be generated for patients to have access to 
handheld devices or books and magazines etc., whilst being transfused in the 
unit, which could be introduced to patients who may require assistance by 
volunteers; if ‘volunteer support’ was to be implemented during service 
reform.  
Chapter 6 General Discussion 
264  
6.5.3 Service improvement strategies  
There were 17 service improvement strategies generated by HCPs in Study 3 
and the need to develop some of these strategies has been discussed in this 
section. In terms of implications for practice, these strategies could be 
referred to in ongoing research and developed further into practice. The 
strategies may be scaled up into interventions and piloted, potentially 
beginning with the best ranking strategies according to the APEASE (Michie 
et al., 2014) ratings, for example, strategy five: encouraging laboratory, HCP 
and patient role appreciation. Whilst the interventions are being pilot tested, 
the actual constraints and enablers to implementation could be explored, 
which will be real-life vs. hypothetical assumptions to try to resolve.  
A medium ranked intervention, with some uncertainty over the APEASE 
criteria ratings, could also be piloted, such as resourcing local hubs to provide 
community transfusions. Person-based approaches could be used to 
understand and accommodate the perspectives of those who would use the 
intervention, in order to maximise intervention acceptability and 
effectiveness (Yardley et al., 2015). This would involve, for example, in depth 
qualitative research to inform intervention planning, optimisation and process 
evaluation, with complementary theory-based activities conducted in parallel 
(Yardley et al., 2015). Research could be conducted to collect patients’ views 
at different home or community transfusion time-points, for example, during 
a typical community or home transfusion day. These data could be further 
utilised to develop counselling or coaching strategies to help patients manage 
their fears or adjust to transfusion in new environments.  
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It would be important to explicitly specify theories underpinning any 
interventions moving forward to shorten the time needed to develop the 
intervention, optimise the intervention design, identify conditions of context 
necessary for their success and enhance learning from those efforts (Davidoff 
et al., 2015). Interventions to offer HCPs communication skills training, for 
example with cancer patients in outpatient settings, often fail to specify their 
theoretical underpinning (Cegala et al., 2002; Moore et al., 2018). Theories 
of individual behaviour, such as motivational theories, like the Theory of 
Planned Behaviour (TPB) (Ajzen, 1991) may be relevant to use. Applying the 
TPB would help motivate the target group regarding the desired behaviour, 
allow them to experience that colleagues and others in their social 
environment think the change is very important, and provide them with the 
confidence that change will indeed be feasible and achievable (Grol et al., 
2013). Theories directed at organisational change, such as those focusing on 
the characteristics of organisations may be helpful to bring success to factors 
that are technical (e.g. new equipment, improved materials) and 
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7 Conclusion and recommendations 
In summary, this programme of research aimed to explore patients’ and 
healthcare professionals’ (HCPs’) perceptions of blood transfusion. There is 
ongoing research of patients’ and HCPs’ perceptions of blood transfusion, as 
identified in Study 1, which included nine new studies published globally 
since 2015. Perceptions continue to align to the six original conceptual model 
constructs from Study 1, which broadly correspond to constructs from 
treatment perceptions frameworks. On investigating haematology 
perceptions, new themes of blood transfusion perceptions emerged, mostly 
associated with context, social relationships and burden. In the area of 
haematology, where patients receive repeated transfusions, some patients and 
HCPs held negative emotions about the burden of repeated transfusions and 
many patients developed a number of strategies to deal with such perceptions 
over time, such as communicating with HCPs and maintaining a hopeful and 
positive outlook. HCPs, however, deal with a number of service pressures and 
can attribute some challenges to particular causes, such as poor community 
links, alongside being able to propose a number of service improvement 
strategies.  
Behaviour change theoretical frameworks were utilised to develop potential 
intervention options to address constraints and enablers to implementing 
changes in haematology units. Potential interventions include, for example, 
enhancing awareness of laboratory procedures, facilitating community 
transfusions and transfusion unit expansion or reorganisation of existing 
space. These provide opportunities for patients to be more involved in their 
transfusions and in many ways to ‘take transfusions outside the hospital’ by 
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utilising home and community-based transfusions and community-HCP 
resources. Future research is required to utilise constructs from the conceptual 
model of blood transfusion perceptions (general and haematology specific 
models) in larger quantitative studies, for example, to explore the strength of 
relationships between the constructs and the role of variables, such as 
patients’ illness and quality of life perceptions. Implications for practice have 
been raised, such as through the pilot testing of intervention options. This 
would allow for service issues to begin to be remediated and constraints and 
enablers to implementation to be highlighted and explored in real-time.  
 Recommendations for research and practice summary 
7.1.1 Research 
• Quantitative research using the conceptual model of blood transfusion 
perceptions 
• Exploring haematology patients’ perceptions of multiple medicine taking 
• Longitudinal research to explore how patients adjust to transfusion 
• Investigating HCPs’ perceptions alongside service changes 
7.1.2 Practice 
• Discussing transfusion as a part of patients’ treatment decision-making 
discussions 
• Increasing patient involvement in transfusion 





8 Dissemination  
Studies from this programme of research have been routinely presented at UK 
and international conferences since the research began in October 2013. 
Studies 2 and 3 are currently being prepared for submission. 
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 Appendix 2: Systematic review, scoping and full search 
strategies 
Scoping search strategy: 
University of York Centre for Reviews and Dissemination and The 
Cochrane Database of Systematic Reviews 
perception* or representation* or belie* AND blood transfusion 
Systematic review search strategy:  
Embase search strategy for Cochrane CENTRAL and Database of 
Systematic Reviews (CDSR), Database of Abstracts of Reviews of 
Effects (DARE), MEDLINE, EMBASE 
1 BLOOD TRANSFUSION.ti,ab. 
2 (transfus* or pretransfus* or posttransfus* or retransfus* 
or red cell* or red blood cell* or platelets* or fresh plasma 
or frozen plasma or FFP or platelet concentrate*).ti. 
3 (pretransfus* or posttransfus* or retransfus* or red cell 
transfusion* or red blood cell transfusion* or platelet 
transfusion* or plasma transfusion* or fresh plasma or 
frozen plasma or FFP or platelet concentrate*).ab 
4 (blood adj3 (use* or usage* or requir* or administ* or 
need*)).ti 
5 (blood product* or blood component* or blood 
management or blood replacement)).ti. 
6 1 or 2 or 3 or 4 or 5 
7 ((BLOOD TRANSFUSION or (transfus* or pretransfus* or 
posttransfus* or retransfus* or red cell* or red blood cell* 
or platelets* or fresh plasma or frozen plasma or FFP or 
platelet concentrate*) or (pretransfus* or posttransfus* 
or retransfus* or red cell transfusion* or red blood cell 
transfusion* or platelet transfusion* or plasma 
transfusion* or fresh plasma or frozen plasma or FFP or 
platelet concentrate*) or (blood adj3 (use* or usage* or 
requir* or administ* or need*)) or (blood product* or 
blood component* or blood management or blood 
replacement)) adj4 (percei* or perception or belie* or 
attitude* or experience* or perspective* or thought* or 
knowledge or representation* or view*)).ti,ab. 
8 (medic or medics or medical staff or clinician* or doctor* 
or consultant* or registrar* or healthcare* or health 
worker* or nurs* or hospital staff or personnel* or clinical 
staff* or patient* or physician* or recipient* or 
technician* or practitioner*).ti,ab. 
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9 7 and 8 
10 limit 9 to (human and yr="1984 - 2014") 
 
 
EBSCOhost search strategy for PsycINFO, PsyARTICLES 
S1 TI BLOOD TRANSFUSION 
S2 AB BLOOD TRANSFUSION 
S3 TI transfus* or pretransfus* or posttransfus* or 
retransfus* or red cell* or red blood cell* or platelets* 
or fresh plasma or frozen plasma or FFP or platelet 
concentrate* 
S4 AB pretransfus* or posttransfus* or retransfus* or red 
cell transfusion* or red blood cell transfusion* or 
platelet transfusion* or plasma transfusion* or fresh 
plasma or frozen plasma or FFP or platelet 
concentrate* 
S5 TI blood N3 (use* or usage* or requir* or administ* or 
need*)) 
S6 TI blood product* or blood component* or blood 
management or blood replacement) 
S7  TI (percei* or perception or belie* or attitude* or 
experience* or perspective* or thought* or 
knowledge or representation* or view*) 
S8  AB (percei* or perception or belie* or attitude* or 
experience* or perspective* or thought* or 
knowledge or representation* or view*) 
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 N4 (S7 OR S8) 
S10 TI (medic or medics or medical staff or clinician* or 
doctor* or consultant* or registrar* or healthcare* or 
health worker* or nurs* or hospital staff or personnel* 
or clinical staff* or patient* or physician* or recipient* 
or technician* or practitioner*) 
S11 AB (medic or medics or medical staff or clinician* or 
doctor* or consultant* or registrar* or healthcare* or 
health worker* or nurs* or hospital staff or personnel* 
or clinical staff* or patient* or physician* or recipient* 
or technician* or practitioner*) 
S12 S10 OR S11 
S13 S9 AND S12 
(date range and human limiters were applied) 
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 Appendix 3: Systematic review data extraction form 




1.   Authors:        
2.   Title:       
    
3.   Publication year:     
      
4.   Journal reference:      






5.   Stated aims / objectives:     




6.   Study design   
Interview  Randomized controlled trials 
 
Focus 















Case control  
 
Interview  Other:  
 
7.   Research setting Sample identification point   
Primary h/c           Workplace  
Secondary h/c      Academic   
Community h/c     Other:  
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Sampling frame & sampling characteristics 
10.   Patients                                        Sample size 
included  
Eligibility as reported in Methods                  in analysis:  
Transfusion recipient   n=  








Other (e.g. refused 
transfusion etc...) 
  n= 
 
  Total n (patients) 
[  ]  
Comments: 
11.   HCPs                                                Sample size 
included  
Eligibility as reported in Methods                        in analysis:  
Medics  Specialty:  n=  
Nurses  Specialty:  n=  
Other  Specialty:  n= 
 
   Total n (HCPs) 
[  ]  
Comments: 
12. Other comparison groups /  
non eligible subjects  
Yes  Specify 




13. Total N for analysis: [  ] 
 































For patients and HCPs                      Specify: 
1) Age    
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3)   Religion   








   6) Ethnicity   
Other   
 
 
16. Additional participant characteristics 
For patients and HCPs                      Specify: 
1)   Patient’s 
clinical condition 
  
 2)   Transfusion 
indication  
  
3)   Repeat vs. 
one-off patients? 
  






17. Data collection method & instruments used 
Survey    Type: 
Items present           Yes                 Not reported  
Number of items ______ (paste) 
 
Pilot tested?             Yes                  Not reported   




Interview    Type: 
Items present           Yes                 Not reported  
Number of items ______ (paste) 
 
Pilot tested?             Yes                  Not reported   
Validated scale?       Yes                 Not reported   
Details: 
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Items present           Yes                 Not reported  
Number of items ______ (paste) 
 
Pilot tested?             Yes                  Not reported   




18.  Timing of data collection (relative to the transfusion) 
1) Pre-
transfusion  
    
2) During     
     
3) Post 
transfusion 
    
> 24hrs 
  > 1 month 
 
 
> 48hrs   Other:  
> 1 week     





    
General (not 
specified) 









19.  Blood components assessed 
Platelets  Substitutes  















20. Comparison used (e.g. blood transfusion compared to…)  Q20:  
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21. Method of analysis 
                                                           Type: 
Content    
Statistical    
Thematic   




22. Dimensions and themes of perceptions of blood 








23. Content not analysed but presented 
 
 
 Q23:  
24. Presence / absence of theory 
Specify ... 
or 




Conclusions and recommendations 
25.  Conclusions (i.e. Main conclusions, study limitations, 
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Quantitative studies checklist 
criteria (Kmet et al., 2004) 
YES PARTIAL NO N/A 
 
2 1 0 
 
1 Question / objective sufficiently 
described?     
2 Study design evident and appropriate? 
    
3 Method of subject/comparison group 
selection or source of information/input 
variables described and appropriate?     
4 Subject (and comparison group, if 
applicable) characteristics sufficiently 
described?     
5 If interventional and random allocation 
was possible, was it described?     
6 If interventional and blinding of 
investigators was possible, was it 
reported?     
7 If interventional and blinding of subjects 
was possible, was it reported? 
    
8 Outcome and (if applicable) exposure 
measure(s) well defined and robust to 
measurement / misclassification bias? 
means of assessment reported?     
9 Sample size appropriate? 
    
10 Analytic methods described/justified 
and appropriate?     
11 Some estimate of variance is reported 
for the main results?     
12 Controlled for confounding? 
    
13 Results reported in sufficient detail? 
    
14 Conclusions supported by the results? 
    
       Score    
Qualitative studies checklist criteria 
(Kmet et al., 2004) 
  
YES PARTIAL NO N/A 
  2 1 0   
1 Question / objective sufficiently 
described?         
2 Study design evident and appropriate? 
        
3 Context for the study clear? 
       
4 Connection to a theoretical framework / 
wider body of knowledge? 
        
5 Sampling strategy described, relevant 
and justified?         
6 Data collection methods clearly 
described and systematic?         
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7 Data analysis clearly described and 
systematic?         
8 Use of verification procedure(s) to 
establish credibility? 
    
9 Conclusions supported by the results?         
10 Reflexivity of the account? 
        
       
Score    
Kmet, L. M., Lee, R. C., & Cook, L. S. (2004). Standard quality assessment criteria 
for evaluating primary research papers from a variety of fields: Alberta 
Heritage Foundation for Medical Research. 
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 Appendix 4: Table of theories identified in the systematic review 
Theory identified (as 
cited in paper) 
Included paper in 
systematic review 
(author, year) 
Location in cited review paper  
 
1. Theoretical Domains 
Framework (TDF) (Michie 
et al., 2005)  
Francis et al (2009) Intro, Discussion 
Informed topic guide: ‘interview study using 
semi-structured one-to-one interviews, 
based on the theoretical domains’ (p. 629) 
Islam et al., (2012) Intro, Discussion 
Informed topic guide: ‘interview study using 
semi-structured one-to-one interviews, 
based on the TDF’ (p. 3) 
2. The social 
amplification of risk 
(Pigeon et al., 1992)  
Ferguson et al., (2001) Intro: informed study design (p.130), 
Discussion 
Lowe et al., (2001) Intro, Methods: informed study design 
(p.181) 
3. Psychometric model of 




Ferguson et al., (2001) Intro, Discussion 
Informed measure: ‘A series of cognitive 
factors believe to influence risk perception 
were also examined’ (p. 131) 
Lowe et al., (2001) Intro, Methods: informed study design 
(p.181) 
Lee, Mehta & James 
(2003) 
Intro: informed study design (p. 773), 
Discussion 
4. Risk theory (Beck, 
1992; Giddens, 1991) 
Moxey et al., (2005) Discussion 
5. The risk compensation 
theory (Wilde, 1992, 
1994) 
Amin et al., (2004) Intro: informed study design (p.3), 
Discussion 
6. Theoretical Model of 
Willingness to Pay (WTP) 
for Autologous Blood 
Donation (ABD) 
(Eastaugh, 1991)  
Lee et al., (1998) Intro, Discussion  
Informed measure: ‘to determine WTP for 
ABD in our population, each patient was 
asked the following questions…’ (p.1166)  
7. Prospective reference 
theory (Smith, 1992; 
Viscusi, 1989, 1992) 
Lee et al., (1998) Intro, Methods: informed study design (p. 
1165), Discussion  
8. Common Sense Self-
Regulation Model (CS-
SRM)(Leventhal et al., 
2003)  
Khan, Watson & 
Dombrowski (2012) 
Intro, Methods: informed HCP data analysis 
(p.295) (not extracted), Discussion 
9. Beliefs about Surgery 
(Francis et al., 2009b) 
based on Beliefs about 
Medicines Questionnaire 
(Horne et al., 1999) 
Khan, Watson & 
Dombrowski (2012) 
Methods: measure, results, Discussion 
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10. Availability heuristic 
(Tversky et al., 1973)  
Salem-Schatz, Avorn, 
& Soumerai (1990) 
Intro, Discussion 
Informed measure: ‘to evaluate whether 
risk estimates were influenced by clinician’s 
experience…’ (p. 478)  
11. Typology of five 
sources of power (French 
et al., 1959) 
Intro, Discussion 
Informed measure: ‘we also assessed the 
nature of the influence of attending 
physicians on residents’ transfusion 
decisions’ (p. 478) 
12. Parse’s theory of 
human becoming 
(McEwen et al., 2007)  
Adams & Tolich 
(2011) 




Beck, U. (1992) Risk Society: Towards a New Modernity. London: Sage Publications. 
Eastaugh, S. (1991). Valuation of the benefits of risk free blood. Willingness to pay for 
hemoglobin solutions. Int J Tech Assess Health Care, 7(51). 
Francis, J. J., Wileman, S. M., Bekker, H., Barton, G. R., & Ramsay, C. R. (2009b). Beliefs 
about surgery: Development and validation of an instrument to assess 
cognitive representations about surgery, in the context of a chronic illness. 
Psychology and health, 24(10), 1125-1137. 
French, J. J., & Raven, B. (1959). The bases of social power. In D. Cartwright (Ed.), 
Studies in Social Power (pp. 150-167): University of Michigan. 
Giddens, A. (1991). Modernity and Self-identity Self and Society in the Late Modern 
Age. Cambridge: Polity Press. 
Horne, R., Weinman, J., & Hankins, M. (1999). The beliefs about medicines 
questionnaire: the development and evaluation of a new method for assessing 
the cognitive representation of medication. Psychology and health, 14(1), 1-24. 
Leventhal, H., Brissette, I., & Leventhal, E. A. (2003). The Common-sense model of self-
regulation of health and illness. In In L. D. Cameron & H. Leventhal (Eds.) (Ed.), 
The self-regulation of health and illness behaviour (pp. 42-65): London and 
New York: Routledge. 
McEwen, M., & Wills, E. (2007). Theoretical basis for nursing (2nd ed.). Philadelphia: 
Lippincott Williams and Wilkins. 
Michie, S., Johnston, M., Abraham, C., Lawton, R., Parker, D., & Walker, A. (2005). 
Making psychological theory useful for implementing evidence based practice: 
a consensus approach. Quality and safety in health care, 14(1), 26-33. 
Pigeon, N., Hood, C., Jones, D., Turner, B., & Gibson, R. (1992). Risk perception Risk: 
Analysis, Perception and Management. London: Royal Society. 
Slovic, P. (1987). Perception of risk. Science, 236, 280-285. 
Smith, V. (1992). Environmental risk perception and valuation: Conventional versus 
prospective reference theory. In S. Bromley DW, K (Ed.), The social response to 
environmental risk: Policy formulation in an age of uncertainty. Dordrecht: 
Kluwer Academic Publishers. 
Tversky, A., & D, K. (1973). Availability: a heuristic for judging frequency and 
probability. Cognitive Psychol., 5, 207-232. 
Viscusi, K. (1989). Prospective reference theory: toward an explanation of the 
paradoxes. J Risk Uncertainty, 2(235). 
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Viscusi, K. (1992) Fatal tradeoffs: Public and private responsibilites for risk. New York: 
Oxford University Press. 
Wilde, G. (1992). The theory of risk homeostatis: implications for safety and health. 
Risk Analysis, 2, 209-258. 
Wilde, G. (1994). Risk homeostatis theory and its promise for improved safety. In W. G. 
Trimpop RM (Ed.), Challenges to accident prevention: the issue of risk 
compensation processes. Groningen: Styx Publications. 
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 Appendix 5: Themes and subthemes identified in Study 1 
inductive synthesis 
Extracted data Stage 1 > 2 of synthesis Stage 3 of 
synthesis 
Example of extracted content of perceptions 
reported by authors / participant quotes 
(italics)  
Subtheme labels (total 
n=30) 
Number of studies with data 
coded into subtheme  
Themes 
(n=6)  
61.5% of 26 post-operative patients viewed 
transfusion risk as less than surgical risk 
(p.186)(Court et al., 2011). 
“Blood has the potential to kill; therefore, it is 
not like another medication” [Nurse] 
(p.1690)(Heddle et al., 2012). 
Risk compared with other 
treatments 




For 76 physicians and trainees, blood 
transfusion was of intermediate ranking 
[from 10 hazards, i.e. nuclear reactors, 
caffeine, sharing injection needles, 
genetically modified foods] in [terms of] 
dread and severity and knowledge and 
control’ (p.774)(Lee et al., 2003). 
Risk compared with other 
hazards 
(n= 3 HCP studies)  
50% of 482 GPs reported that blood 
transfusion in the 1990s carried a high 
hepatitis C infection risk (p.333)(D'Souza et 
al., 2004). 
87% of 38 post-operative patients perceived a 
low risk of HIV from allogeneic blood 
transfusion (p.24)(Moxey et al., 2005). 
Risk of contracting an 
illness from 
contaminated blood  
(n=8 HCP studies, 6 patient 
studies) 
 
75 GPs and 135 Anaesthetists rated acute 
reaction (40 / 33%) as more likely than 
delayed reaction (1 / 6%) (p.183)(Lowe et al., 
2001). 
67.5% of 126 patients in Bangladesh rated 
allergic reaction as most possible from a 
transfusion (p. 677)(Shah et al., 2012). 
Adverse reaction to a blood 
transfusion 
(n=4 HCP study, 3 patient 
studies) 
None of n=75 GPs and n=135 Anaesthetists 
rated there to be a risk of death from blood 
transfusion (p. 183)(Lowe et al., 2001). 
5% of 126 patients in Bangladesh thought 
that there was a risk of death from a blood 
transfusion (p. 677)(Shah et al., 2012). 
Risk of death from blood 
transfusion 
(n=2 HCP studies, 1 patient 
study) 
‘The current safety of the blood supply was 
suggested as a factor decreasing the 
perceived need for any blood-sparing 
technology’ (p.135)(Graham et al., 2002). 
19% of 73 physicians rated blood transfusions 
as “very often risky” (score of 4) or “always 
risky” (score of 5) (1304)(Vetter et al., 2014). 
Generalised risk vs. benefit 
(n=11 HCP studies, n=1 
patient study) 
29% of 38 post-surgical patients voiced 
concern with receiving allogeneic blood, 
Generalised concern about 
blood transfusion 
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Extracted data Stage 1 > 2 of synthesis Stage 3 of 
synthesis 
mainly due to concern towards contracting a 
disease or infection (91%), receiving wrong 
blood type (18%) or adequacy of screening 
process (9%)’ (p.23)(Moxey et al., 2005). 
93% of 45 physicians would be concerned and 
reduce the level of blood products utilization 
following a new viral and/or bacterial threat 
in the future (p.3)(Amin et al., 2004). 





“I might be concerned in some situations 
about watching and waiting” (p.635)(Francis 
et al., 2009a). 
For 38 medics there was some concern about 
the inappropriate use of PAD blood in that it 
was ‘poorly targeted’ (i.e. collected in 
situations where it was unlikely to be used) 
and given back to the patient regardless of 
need (p.234)(Treloar et al., 2001). 
Concern about use of 
alternatives 
(n=3 HCP studies) 
‘Apart from the worry of infection from a 
blood transfusion [for patients], it was not 
seen to be an uncomfortable procedure. 
(p.598)(Fitzgerald et al., 1999). 
Worry relating to 
transfusion (e.g. risks) 
(n=3 patient studies) 
 
‘Fifty-four [transfusion] recipients (38%) were 
apprehensive about receiving transfusions: 
34 were afraid of transfusion per se’ 
(p.25)(Luby et al., 2001). 
Apprehension about 
receiving a transfusion  
(n=2 patient studies) 
‘Because nurses and physicians consider 
transfusion practice important, the risk is 
enormous and we are so frightened of 
harming patients that everyone meditates on 
the problem’ (FG1 Site 5, p.1690)(Heddle et 
al., 2012).  
38.2% of 73 physicians were concerned about 
medical error adverse events (given wrong 
blood) (p. 1306)(Vetter et al., 2014). 
Fear of transfusion errors 
(n=2 HCP studies) 
‘The participants discussed how they got into 
a “bad mood” (e.g., grumpy, irritable and 
easily upset) when there was a decrease in 
the Hb level. Mood, however, improved after 
blood transfusion’ (p.104)(Ryblom et al., 
2015) 
Improved mood after blood 
transfusion 
(n=1 patient study) 
 
‘One of the main influences on uptake of PAD 
[for clinicians, surgeons & anaesthetists] was 
described as patient demand. Some 
[clinicians and surgeons] commented that 
use of cell-salvage is also restricted because 
it did not reduce the need for allogeneic 
blood transfusion’ (p.232 & 234)(Treloar et 
al., 2001). 
Factors influencing the use 
of alternatives (e.g. 
patient demand, 
suitability & cost) 










I am confident [to watch and wait] provided 
that the patient is stable and in the ICU 
“Depending on the situation, if the patient is 
stable it’s not hard; if they are unstable it is 
Confidence of using 
alternatives 
(n=2 HCP studies) 
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Extracted data Stage 1 > 2 of synthesis Stage 3 of 
synthesis 
very difficult.” (ICU 2) (p. 5)(Islam et al., 
2012). 
‘52% of 77 GPs and 59% of 79 Anaesthetists 
would choose a blood substitute over donor 
blood’ (p.185)(Lowe et al., 2001). 
82% of 38 post-surgical patients preferred to 
use PAD before surgery, either due to 
protection from disease (65%), peace of mind 
(16%), compatibility (19%) or to reduce 
burden on national blood supply (26%) 
(p.25)(Moxey et al., 2005). 
Preference for alternatives 
to allogeneic transfusion 
(n=3 HCP studies, 1 patient 
study) 
‘Willingness to pay [for autologous 
transfusion] increases greatly as dread of 
getting a transfusion of someone else’s blood 
increases’ (p.9)(Lee et al., 1997).  
Willingness to pay for 
autologous transfusion 
(n= 2 patient studies) 
Patients do better in general: “…there is 
accumulating data that shows patients do 
better if you minimize the amount of blood 





(n=3 HCP studies)  
Some hospice patients (n=10) perceived great 
benefit from transfusion while others did not 
“...you know I feel better after, sometimes 
the next day I feel very lively” ’ (P8, 
p.174)(Orme et al., 2013). 
Perceived benefit, (e.g. 
feeling better post 
transfusion)  
(n=3 patient studies) 
Health 
benefits 
Blood transfusion was perceived to be very 
beneficial (Dimension 3: Benefit = very 
important benefit vs. little or no benefit 
[equal to prescription drugs]) (p.774)(Lee et 
al., 2003). 
Benefit compared with 
other treatments  
(n= 1 HCP study) 
 
The participants reported having low 
“motivation” to do usual activities and felt 
indifferent to most things before blood 
transfusion, but after the transfusion, they 
had the mental and physical strength to 
perform various daily activities 
(p103)(Ryblom et al., 2015) 
Experienced benefits (e.g. 
improved strength, 
reduced headaches & 
fatigue) 
(n=1 patient study) 
 
 
76% of 110 patients understood that their 
transfusion was necessary, either due to 
blood loss (mostly patients receiving one-off 
transfusions) or because of low blood count 
(mostly reported by regular recipients) 
(p.169)(Davis et al., 2012). 
Patient understanding of 
the transfusion’s 
necessity  
(n=2 patient studies) 
Necessity ‘Participants noted that blood transfusion 
was needed when walking up and down 
stairs became difficult or when their legs felt 
heavy and hard to move’ (p. 103)(Ryblom et 
al., 2015) 
Need recognised through 
symptoms 
(n=1 patient study) 
Internists, oncologists, geriatricians, family 
physicians and nurses: ‘Indications for 
Clinical indications and 
contraindications  
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Extracted data Stage 1 > 2 of synthesis Stage 3 of 
synthesis 
transfusion’: acute bleeding (89%), functional 
deterioration (73%), and anaemia resulting 
from chemo- and/or radiotherapy (62%)’ 
(p.544)(Leibovitz et al., 2004) 
(n=5 HCP studies, 1 patient 
study) 
‘Patients were more likely to disagree or 
strongly disagree [after transfusion 
counselling] with the fact that doctors relied 




























"I do not recall talking about the transfusion 
or completely understanding about it but all I 
remember thinking is that it was life and 
death and I just wanted to get better” 
(Patient 55; p.169)(Davis et al., 2012). 
Lack of choice or 
questioning of 
transfusion decision  
(n=2 patient studies) 
Major influences on reducing need for 
allogeneic blood transfusion [in clinicians] 
include ‘a “radical change away from 
considering blood transfusion good for 
everybody”; tolerance of lower haemoglobin 
levels …’ (p.232)(Treloar et al., 2001). 
Transfusion prescription: 
cost, availability and 
patient influences 
(n= 6 HCP studies) 
‘The benefits and risks of blood transfusion 
were explained regularly by 91% and 87% of 
the surveyed physicians, respectively’ (p.256) 
(Al-Riyami et al., 2016) 
Patients informed of 
transfusion benefits, risks 
and alternatives 
(n=1 HCP study) 
 
‘Twenty percent of 126 transfusion recipients 
stated that they would refuse blood 
transfusion even if they are in need, because 
of the risk of requiring an infectious disease’ 
(p.677)(Shah et al., 2012). 
Patient transfusion refusal  
(n=1 patient study) 
‘It is noteworthy that 92.8% of professionals 
feel confident to carry out the transfusion 
process’ (p.598)(Tavares et al., 2015) 
Confidence in carrying out 
transfusion process 
(n= 1 HCP study) 
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 Appendix 7: Data saturation table for haematology interview Study 2 
Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Patients 
Awareness of risk / safety (3 of 5 subthemes) 
Discomfort and illness during or post-
transfusion 
5 X  X 7 
Health risks from high iron levels  2 X X  4 
Potential infection or reaction risk  4   X 5 
Health benefits (5 of 6 subthemes) 
Boosting blood levels 6  X X 8 
Keep going with daily life 5 X X  7 
Relief of symptoms such as tiredness 6 X   7 
Anticipated benefits 4  X X 6 
Can take time to feel benefit of transfusion 1  X  2 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Negative emotions (6 of 8 subthemes) 
No concerns or worries with transfusions 8  X X 10 
Attempts to manage worries and fear 6 X X X 9 
Gratitude that transfusions possible 3 X  X 5 
Relaxed during transfusion appointments 4   X 5 
Receiving transfusions unpleasant 3 X   4 
Positive emotions of not needing transfusion 1 X   2 
Alternatives (1 of 4 subthemes) 
Alternatives considered or already in use 5 X  X 7 
Necessity (3 of 5 subthemes) 
Transfusions required as a current and long-term 
supportive treatment 
7 X X X 10 
Need established by HCPs and clinical indicators 7 X   8 
Need for transfusion apparent through 
symptoms 
6 X X  8 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Involvement in decision making (5 of 7 subthemes) 
Willing acceptance of transfusions 6 X   7 
Confronted with limited or no choice 5  X  6 
Transfusion offered with patient involvement in 
choice 
4 X X X 7 
Routine 'automatic' treatment 2   X 3 
More frequent transfusions would be resisted 1 X   2 
Burden (4 of 4 subthemes) 
Transfusion part of routine life  5  X X 7 
Transfusions are inconvenient  4 X   5 
Attendance not a great burden 3  X  4 
Life restrictions, travel 2 X X  4 
Social connection (3 of 5 subthemes) 
Patient involvement generally positive 4 X  X 6 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Lack of interaction or activity during 
transfusions 
4   X 5 
Interaction with other patients 4 X X  6 
HCPS 
Awareness of risk / safety (6 of 6 subthemes) 
Risks mitigated by safe transfusion practices 9 X X X 1
2 
Risks and benefits established with patients 7 X  X 9 
Iron overload considered a key risk 5 X X  7 
Infections, antibodies and reactions risks 6   X 7 
Short and long term medical and psychological 
impact 
4 X X  6 
Risk of not providing a transfusion 2 X X X 5 
Alternatives (4 of 4 subthemes) 
Alternatives considered or already in use 8  X X 10 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
No alternatives, transfusion the only option 5  X X 7 
Support for greater consideration and use of 
alternatives 
4  X X 6 
Committed to giving regular transfusions once 
started 
2  X  3 
Burden (2 of 2 subthemes) 
Anticipated attendance burden for patients 9 X  X 11 
Transfusion has become a part of patient's 
routine life 
5  X X 7 
Health benefits (6 of 6 subthemes) 
Symptom improvement, making patients feel 
better 
9 X X  11 
Supportive care to carry on with normal daily 
living 
9  X  10 
Benefit lasts a limited time only 7  X  8 
Shared HCP agreement of transfusion benefits 4   X 5 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Patient questioned on benefits to provide / 
continue transfusions 
4  X  5 
Some risk-benefit for patients questionable 2  X  3 
Necessity (4 of 5 subthemes) 
Transfusions support chemotherapy or used to 
treat anaemia 
9 X X X 12 
Transfusions are vital, aiding survival 8  X X 10 
Transfusions given to protect health 7  X  8 
Necessity established using clinical and patient 
factors 
7   X 8 
Negative emotions (5 of 7 subthemes) 
Practice concerns and frustrations 9   X 10 
Patient anxiety and upset with receiving regular 
transfusions 
8 X X  10 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Concern about downsides of transfusions for 
patients 
8 X X  10 
Patients' unexpressed potential negative 
emotions 
7 X X  9 
Upset in witnessing patients' worsening health or 
death 
2   X 3 
Involvement in decision making (6 of 8 subthemes) 
HCPs advocate and involve patients in decisions 10 X X X 13 
Team decision on transfusion prescription 12   X 13 
Patient autonomy in their own transfusion 
decisions 
9 X X  11 
Individual transfusion regime for each patient 8  X X 10 
Transfusions prescribed appropriately using 
guidelines 
5 X X X 8 
Barriers to discussing transfusion or obtaining 
consent 
3  X X 5 
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Subthemes present in the final three patient 
interviews 
N of patients 
reporting data to 
these 
subthemes 
Participants 12-14 (X indicates 







 (interviews 1-11) 12 13 14  
Organisational factors (5 of 5 subthemes) 
Solutions needed to improve processes and ease 
capacity strain 
6  X  7 
Solutions needed to enhance communication 5  X  6 
High and costly blood use for hospital 5 X   6 
Constraints to greater discussion of patients’ 
views 
5  X  6 
Complicated management of transfusion slots 4   X 5 
Stability and variability of transfusion perceptions (3 of 3 subthemes) 
Views consistent and similar to colleagues 6   X 7 
Views broadened through haematology exposure 4 X X X 7 
Patients' transfusion perceptions variable 1   X 2 
 
 
  Patient recruitment log v6 22 Dec 2015  
1 Adams, K. W., & Tolich, D. (2011). Blood transfusion: the patient's experience. The American journal of nursing, 111(9), 24-22.  
2 Alzheimer's Society. (2009) What is mild cognitive impairment (MCI)? Retrieved 3rd Nov 2015; 
https://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=120     
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 Appendix 8: Study 2 patient recruitment log 
Study: Exploring perceptions of blood transfusion in haematology 
Instructions for Local Collaborator facilitating patient recruitment:  
Please complete this log for all patients receiving blood transfusions between (date …….) and 
(date …..). This is to record if patients are eligible to take part in the study and the outcomes of 
invitations.  
Inclusion: Patients may be included if they meet all of the following criteria:  
• aged above 18 years old and attending to receive a blood transfusion 
• clinically stable (alert & oriented, stable vital signs, without respiratory or cardiac difficulty or 
uncontrolled pain1 
Exclusion: Patients should not be invited to participate in the study if they meet any of the following 
criteria:  
• aged under 18 years old 
• unable to understand spoken English or respond verbally in English 
• considered by you, or another staff member not suitable to participate, i.e. patients are 
unable to provide consent, have a cognitive impairment (such as thinking, knowing and 
remembering2) or participation not advisable per medical advice  
I will be on site to provide patients with more information about the study, and to conduct any interviews. I will 
collect this log from you at approx. (time ….) each day.





Meets all inclusion 
criteria – patient 
interested in study 
(please tick) 
Telephone number 
(if patient consents 
to provide for a call 
back) 
Meets exclusion criteria 
(please tick) 








Yes:  Today 
         Call back 




i.e. 020 123 4657 
 
 
 Below 18 years old 
 Limited English 
 Not suitable for this 
study 







Yes:  Today 
         Call back 




  Below 18 years old 
 Limited English 
 Not suitable for this 
study 




Yes:  Today 
         Call back 




  Below 18 years old 
 Limited English 
 Not suitable for this 
study 
 Patient has no time 
  




 Appendix 9: Study 2 participant information sheet (patients) 
Study title: Exploring perceptions of blood transfusion 
in haematology 
This study is being run by City University London, School of Health 
Sciences, and invites patients to take part in an interview about their 
perceptions of blood transfusion. Please read through this information 
sheet carefully and please ask the researcher if anything is unclear or 
if more information is needed.  
Study information: 
Perceptions are thoughts that are used to describe situations or things, 
such as treatments. Patients’ perceptions of their treatment, such as 
how it may improve one’s health, can have an effect on how patients 
cope with their health condition.  
Perceptions may be different across different types of patients 
receiving transfusions, so it might be helpful to explore what patients 
think of transfusion in particular patient groups. Specifically, what 
haematology patients think about transfusions has not been 
investigated in detail. Therefore, this study has been designed to 
explore your views of transfusion.  
What this study involves:  
1. A one-off interview with a researcher lasting between 20 
and 40 minutes 
2. The completion of a short questionnaire to collect 
information, such as gender, age, diagnosis, blood products received, 
and other treatments 
The interviews will be audio recorded, and the interview questions 
have been approved by the South Central Hampshire B Research 
Ethics Committee and a consultant haematologist.  
When and where will I be interviewed? 
You have the option to be interviewed today, in the haematology day 
unit, before you have your transfusion, during your transfusion, 
or after your transfusion. Alternatively, you can take more time to 
decide whether or not to take part in this study, and may provide the 
researcher or the [nurse] who informed you about the study with your 
telephone number for a call back from the researcher on the next 
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working day (Mondays to Fridays), to see if you would like to be 
interviewed on the telephone.  
Am I eligible to take part? 
Patients are eligible to take part if they meet all the options below: 
Aged 18 years or older  
Attending the haematology unit today for a blood 
transfusion  
What are the benefits or risks of taking part? 
It may be helpful or interesting to participate in research about views 
of blood transfusion. This might also help improve our understanding 
about what patients think about transfusion. However, it is understood 
that discussing your transfusions may feel intrusive or make you feel 
upset. Please be assured that the researcher wishes to make your 
participation as comfortable as possible, and you can ask to pause, or 
stop the interview as you wish, or refuse to respond to any questions.  
Who has reviewed this study? 
All research in the NHS is looked at by an independent group of 
people, called a Research Ethics Committee, to protect your interests. 
This study has been reviewed and given favourable opinion by the 
South Central Hampshire B Research Ethics Committee. 
Protecting your information and confidentiality: 
The information that you provide will not be shared with your health 
providers or have any implication on the care that you receive. All 
information that you provide is confidential and any information 
revealing your or other peoples’ identities or identifiable places will be 
made anonymous.  
All information will be handled securely, stored in locked cabinets and 
analysed on password-protected computers. Only the researcher’s 
supervisors at the university will have access to your full interviews to 
help with the analysis of the data. The clinical member of staff who has 
consented for this study to be conducted at this hospital will only have 
access to your interview data if you consent for him or her to do so, 
such as if you wish for anything mentioned in the interview to be 
passed on to them. 
How your information will be used: 
Your information will be analysed with other participating patients’ 
information and reported in the researcher’s university thesis and in a 
research paper for a scientific journal. Parts of these results may be 
used to develop further research projects and direct quotations from 
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the interviews may be used in the results, but all findings will be 
reported anonymously so that individual patients will not be 
identifiable. All participants will have the option to receive a copy of the 
results and research paper.  
Do I have to take part? 
Participation is voluntary and no one is obliged to take part. Patients 
wishing, at any point, to discontinue the interview, or for their 
information to be removed, may withdraw from the study without giving 
a reason at any time up to the point that the results are reported. This 
will not affect patients’ medical care or legal rights. In the event of a 
loss of capacity to consent, the research team would retain personal 
data collected and continue to use it confidentially in connection with 
the purposes for which consent is being sought. This could include 
further ethically approved research after the current project has ended. 
Complaint procedures: 
City University London has established a complaints procedure via the 
Secretary to Senate Research Ethics Committee. To complain about 
the study, you need to phone 020 7040 3040. You can then ask to 
speak to the Secretary to the Senate Research Ethics Committee and 
inform them that the name of the project is ‘Exploring perceptions of 
blood transfusion in haematology’.  
You can also write to the Secretary at: 
Anna Ramberg 
Secretary to Senate Research Ethics Committee 
Research Office, E214 
City University London 
Northampton Square 
London, EC1V 0HB 
Email: Anna.Ramberg.1@city.ac.uk 
How to contact the researcher:  
  
What to do next: 
Please read the attached informed consent form. This is required to 
collect your consent to participate. Please then inform the [nurse] or 
me that you would like to take part, either today, or for a call back to 
discuss the study.  
Until (date ….) I will be in the haematology unit 
and will be around to discuss the study with 
you, please come and talk to me.  
If you do not see me around, my contact details 
are below, please leave a voicemail message if 
your call is forwarded to voicemail.  
My name: Brittannia Abdul-Aziz 
Telephone: 020 7040 5807 
E-mail: brittannia.abdul-aziz.1@city.ac.uk 
 




 Appendix 10: Study 2 participant information sheet (HCPs) 
Study title: Exploring perceptions of blood transfusion 
in haematology 
This study is being run by City University London, School of Health 
Sciences, and invites healthcare professionals (HCPs) working in the 
haematology unit to take part in an interview about their perceptions of 
blood transfusion. Please read through this information sheet carefully 
and ask the researcher if anything is unclear or if more information is 
needed.  
Study information: 
This interview study informs a broader programme of research 
investigating perceptions of blood transfusion. Perceptions are 
thoughts, or beliefs that inform behaviour, and decisions preceding 
behaviour. As the provider of treatment, HCPs’ perceptions are 
important to explore.  
Blood transfusions are frequently delivered in haematology units. 
However, through a systematic review recently conducted by our 
research group, perceptions of HCPs working in haematology were not 
widely researched. In a few cases, haematology HCPs’ perceptions 
were reported together with the perceptions of HCPs working in 
different clinical areas, which may not adequately reflect perceptions 
of providing transfusions to patients in haematology.  
Therefore, this study aims to find out HCPs’ perceptions of blood 
transfusion to contribute to the blood transfusion treatment perceptions 
evidence-base.  
What this study involves:  
1. A one-off interview with a researcher lasting between 20 and 
40 minutes 
2. The completion of a short demographic questionnaire to 
record participants’ information, such as clinical role, years of clinical 
and haematology experience  
The interviews will be audio recorded, and the interview questions 
have been developed in consultation with a consultant haematologist 
and approved by the South Central Hampshire B Research Ethics 
Committee.  
When and where will I be interviewed? 
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You have the option to be interviewed in person in the haematology 
unit or elsewhere convenient on hospital site. Alternatively, you can 
take more time to decide, and can be interviewed also by telephone. 
Please provide the researcher with your contact details (see ‘how to 
contact the researcher’ below).  
Am I eligible to take part? 
Healthcare professionals are eligible to take part if they meet 
the criteria below: 
Currently working in the haematology unit  
Interact with blood transfusion patients, i.e. to discuss or 
deliver transfusions  
What are the benefits or risks of taking part? 
It may be interesting to participate in research about healthcare 
professionals’ perceptions of blood transfusion and also rewarding to 
contribute to research where a gap in the knowledge base exists. 
Please be assured that we wish to make your participation as 
comfortable as possible and you can ask to pause, or stop the 
interview as you wish, or refuse to respond to any questions at any 
time.  
Who has reviewed this study? 
This study has been reviewed and given favourable opinion by the 
South Central Hampshire B Research Ethics Committee.  
Protecting your information and confidentiality: 
The information that you provide will be kept confidential. It will not be 
shared with your patients, line manager or your other colleagues. Any 
information revealing your or other peoples’ identities or identifiable 
places will be made anonymous.  
All information will be handled securely, stored in locked cabinets and 
analysed on password protected computers. Only the researcher’s 
supervisors at the university will have access to your anonymised 
responses to help with the data analysis. The clinical member of staff 
who has consented for this study to be conducted at this hospital will 
only have access to your interview data if you consent for him or her 
to do so, such as if you wish for anything mentioned in the interview to 
be passed on to them. 
How your information will be used: 
Your questionnaire and interview data will be analysed with the data 
from other HCPs from a few different hospital sites. The results will be 
reported in the researcher’s PhD thesis and in a peer-reviewed journal 
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publication. Parts of the results may also be used to develop further 
research projects and direct anonymised quotations may be used. All 
participants will have the option to receive a copy of the results and 
journal publication.  
Do I have to take part? 
Participation is voluntary and no one is obliged to take part. 
Participants wishing, at any point, to discontinue the interview or for 
their information to be removed, may withdraw from the study without 
giving a reason. This will not affect their legal rights. Up until the results 
are reported in the researcher’s thesis and the journal publication, your 
information can be removed and not used. In the event of a loss of 
capacity to consent, the research team would retain personal data 
collected and continue to use it confidentially in connection with the 
purposes for which consent is being sought. This could include further 
research after the current project has ended.  
Complaint procedures: 
City University London has established a complaints procedure via the 
Secretary to Senate Research Ethics Committee. To complain about 
the study, you need to phone 020 7040 3040. You can then ask to 
speak to the Secretary to the Senate Research Ethics Committee and 
inform them that the name of the project is ‘Exploring perceptions of 
blood transfusion in haematology’. 
You can also write to the Secretary at: 
Anna Ramberg 
Secretary to Senate Research Ethics Committee 
Research Office, E214 
City University London 
Northampton Square 
London, EC1V 0HB 
Email: Anna.Ramberg.1@city.ac.uk 
How to contact the researcher:  
  
What to do next: 
Please read the attached informed consent form. This is required to 
collect your consent to participate. Please then inform the [nurse] that 
may have told you about the study, or the researcher, that you are 
available to be interviewed, or when you may be available.  
Until (date …) I will be in the haematology unit 
(location ……) and I will be around to discuss the 
study with you, please feel free to approach me.  
If you do not see me around, I am contactable on 
the following details. If you are telephoning me and 
I do not answer, please leave a voicemail message.  
 
My name: Brittannia Abdul-Aziz 
Telephone: 020 7040 5807 
E-mail: brittannia.abdul-aziz.1@city.ac.uk 
 Site ID Participant consent form 
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 Appendix 11: Study 2 consent form     
Site name:     Participant ID for this study: 
Title of Project: Exploring perceptions of blood transfusion in 
haematology 
               Please initial box        
1. I confirm that I have read the Participant Information Sheet 
dated.................... (Version............) for the above study. I have 
had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily. 
 
2. I understand that the researcher wishes to interview me about 
blood transfusion and that the interviews will be audiotaped and 
reported in the researchers’ university dissertation, a scientific 
publication, and may be used to inform further ethically approved 
research.  
 
3. I understand that the researcher wishes to collect information 
about me on a Questionnaire. 
 
4. I understand that the researcher will make all information that I 
provide anonymous and will protect my identity from being made 
public. Direct quotes from the interviews may be used, but these 
will also be made anonymous. 
 
5. I understand that my participation is voluntary and that I am free to 
withdraw at any time without giving any reason and without my 
medical care or legal rights being affected. 
 
6. I agree to City University London recording and processing this 
information about me. I understand that this information will be 
used only for the purpose(s) set out in this statement and my 
consent is conditional on the University complying with its duties 
and obligations under the Data Protection Act 1998. 
 
7. I understand that relevant sections of my care record and data 
collected during the study may be looked at by responsible 
individuals from City University London and [insert NHS Trust 
name …………………………….] or from regulatory authorities, 
where it is relevant to their taking part in this research. 
 
8. I agree to take part in the above study. 
 
Name of Participant                       Date                             Signature 
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 Appendix 12: Study 2 Demographic questionnaire 
(patients) 
Please complete the below questionnaire after the interview. This 
information is needed to assist with how the results are interpreted.  
 






3. Ethnic group or background 
                                                                    Please tick 





Gypsy or Irish Traveller   
Any other White background, please 
describe 
 
Mixed/Multiple ethnic groups 
White and Black Caribbean   
White and Black African   
White and Asian   
Any other Mixed/Multiple ethnic 
background, please describe 
 
Asian/Asian British 
Indian   
Pakistani  
Bangladeshi   
Chinese   
Male Female Prefer 
not to 
provide 







Site ID Participant study ID 
338 




African   
Caribbean   
Any other Black/African/Caribbean 
background, please describe 
 
Other ethnic group 
Arab  
Any other ethnic group, please 
describe 
 




No religion  
Christian (including Church of England, 








Any other religion, please describe  
Prefer not to provide  
5. Highest level of education completed 
 Please tick 
No formal education  
GCSE / O’Levels  
A Levels / college certificate  
University level  
Site ID Participant study ID 
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Graduate / professional  
Prefer not to provide  
 


















8. Have you ever received other blood products? 
 Please tick all 




Lymphoma (including HD and 
CLL) 
 
Acquired haemolytic anaemia  




Other, please specify   
Don’t know  
 Please tick 





Don’t know  
 Please tick 
Red blood cells  
Platelets  











Thank you for completing this questionnaire.  
As mentioned, this information will be used to describe the patients 
involved in the study and to assist with how the results are interpreted. 










Don’t know  
Please list below (e.g. iron 
chelation therapy) 








Don’t know  
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 Appendix 13: Study 2 HCP demographic questionnaire  
Please complete this brief survey after the interview. This information 
is needed to assist with the interpretation of the results. 
 

















4. Experience  







Prefer not to 
provide 
 
Consultant Haematologist  
Consultant (other), please specify  
Specialist Registrar  
Specialist House Officer /CMT  
Foundation doctor  
Haematology Specialist Nurse  
Nurse (other), please specify  
Transfusion Practitioner  
Other role, please specify  
Please insert months 
or years below 
 
  Please insert 
months or years 
below 
 
Site ID Participant study ID 
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5. Interaction with transfusion patients in the 
haematology unit 







       
 





To administer blood 
products 
Both Other  
(please 
specify) 
     
 
Thank you for completing this questionnaire.  
I will be using this information to describe the sample of health 
professionals that I interviewed, and to assist with the interpretation 








 Appendix 14: Coding book for Study 2 haematology interview transcripts 
major theme 
label 
Awareness of risk / safety Health benefits Negative emotions 
Contrast of 
theme 










associated with blood 
transfusion. 
Reports of safety 
measures used in 
blood transfusion 




Mention of the 
physical or 
psychological 
benefits of the 
transfusion 
Perceptions 
associated with the 


















This could also include 
perceptions of the 
level of risk and the 
extent that risks can 






transfusion and harm 
caused to patient) and 
beliefs about adverse 
This could also 
include that 













of what people 
thought the 
benefits should be. 
Could also be 
benefits patients / 
HCPs report of not 
having transfusions 
This includes that 
health benefits can 
be inconsistent or 














and that the 
quote more so 






Risk explained to 
patients or patient 







"I think one of the big 
downsides are … being 
exposed to, erm, so many 
blood transfusions, they 
develop antibodies , which 





"Makes me feel better 
again" 
"Transfusion sometimes 
makes a difference, 
sometimes does not" 
 
"I was worried at 
first, but now that 
does not worry me" 






Alternatives Involvement in decision making Necessity 
Contrast of 
theme 







Necessity Absence of 
necessity 
Definition Perceptions related to 
alternative treatments 
for patients rather 







to/not to transfuse, 
how the transfusion 
decision was made 
or communicated, 
and the patients' 
role in that process. 
Information about 
the HCPs' role in the 
Perceptions explicitly 
identifying when a 
decision did not 
seem to occur about 
the transfusion or 
that patients were 
not involved in the 
decision 
Perceptions of the 
need for the 
transfusion (e.g. 















the need or 
patients 
questioning the 










discussion of what 
alternative options 
could be or that 
watching and waiting 
or not giving a 
transfusion may be the 
alternative 
 
Features of the 
decision making about 
alternatives 
specifically 
This may include 
that alternatives 
were considered 




"I order it", "send it 
off", "calling lab".  
 
Can include 
perceptions of the 
use of blood (e.g. 
that it is prescribed 
appropriately) 
 How the need for 
the transfusion is 
established (e.g. 
by clinical tests) 
 
Vital essential 




may not be 
needed in the 
future for the 
patient or doubt 






"alternatives are considered 
when making the decision" 
  "I felt I had no choice, I 
just listened to the 
doctor who made the 
decision" 
"it happened so quick, 
next thing I knew I was 
having the transfusion, 
there was no decision" 
"It was absolutely 




not the only thing 
that may help 
patients with X 
condition” 
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 Appendix 15: Reasons for patient exclusion from study 2 
Excluded patients site 1 (n= 16) n of 
participants 
Reasons:   
Advised by screening personnel not to invite 4 
On patient list but transferred to ward for 
transfusion or since deceased 
3 
Transfusion for non-haematology but oncology 
patient 
2 
Refused to participate  2 
Non-English language  1 
Cognitive impairment (dementia)  1 
Already screened or interviewed (e.g. patient 
returning for a weekly transfusion)  
1 
Researcher conducting another interview / busy 
at the time 
1 
Transfusion cancelled 1 
Excluded patients site 2 (n=29) n of 
participants 
Reasons:   
Non-English language  5 
Already screened or interviewed (e.g. patient 
returning for a weekly transfusion)  
5 
No transfusion needed on the day, patient sent 
home  
4 
Researcher conducting another interview / busy 
at the time  
3 
Not approached by researcher - patient in 
distress  
3 
Refused to participate  2 
Transfusion cancelled  2 
Uncertainty if the participant would receive a 
blood transfusion  
2 
Too ill to be invited to the study  1 
Hearing impairment  1 




28 August 2018 
Dear Brittannia, Jill and Fabiana
Re:  BOOST: Building Optimised Outpatient Services in Transfusion: A panel discussion 
informed by patients’ perceptions
Thank you for forwarding amendments and clarifications regarding your project.  These have now
been reviewed and approved by the Chair of the School Research Ethics Committee.
Please find attached, details of the full indemnity cover for your study.
Under the School Research Governance guidelines you are requested to contact myself once
the project has been completed, and may be asked to complete a brief progress report six
months after registering the project with the School.








London EC1V 0HB 
Tel: +44 (0) 20 7040 5704 
www.city.ac.uk 
School of Health Sciences
10.16 Appendix 16: Study 3 ethics approval letter
Participant Information Sheet v3 3rd August 2018  
School of Health Sciences 
348 
 Appendix 17: Study 3 participant 
information sheet  
Title of study: BOOST: Building Optimised Outpatient 
Services in Transfusion: A panel discussion 
informed by patients’ perceptions 
We would like to invite you to take part in a research study being 
conducted by a PhD student researcher from City, University of London 
as a part of a doctoral degree in Health Psychology. Before you decide 
whether you would like to take part it is important that you understand why 
the research is being done and what it would involve for you. Please take 
time to read the following information carefully and discuss it with others if 
you wish. Ask us if there is anything that is not clear or if you would like 
more information. 
What is the purpose of the study?  
Interviews have been conducted at two UK haematology units in 2016, 
which explored patients’ and healthcare professionals’ (HCPs’) 
perceptions of blood transfusions provided for patients with 
haematological disorders. This research found that whilst patients held 
many beliefs about the necessity and benefit of transfusion, there were 
areas where patients may require more support. This may be for new 
patients receiving repeated transfusions or for patients holding concerns 
about the transfusion procedure or the time spent having transfusions.  
This research study invites approximately 20 transfusion healthcare 
professionals to take part in a focus group meeting to consider the 
interview findings. You will have opportunity to inform us of any possible 
future changes to practice that may benefit transfusion patients’ 
experiences, or the delivery of blood transfusions to this patient population 
in general.  
 
What this study involves 
• A one-off audio-recorded focus group with up to ten healthcare 
professionals attending the Regional Transfusion Meetings on 11th 
September / 7th November 2018.  
 
• The focus group will last for one hour and you will be provided with the 
opportunity to complete a follow-on questionnaire to provide your views 
on perceptions that we may not have time to discuss in the meeting.  
The PhD researcher, Brittannia Volkmer will facilitate the focus group, co-
facilitated by Dr Simon Stanworth, Consultant Haematologist, NHS Blood 
and Transplant/ Oxford University Hospitals NHS Foundation Trust.  
 
At the start of the focus group the arrangements for the meeting will be 
introduced and you will have the opportunity to introduce yourself to the 
other members. Background to the study will be provided and the patients’ 
perceptions for discussion will be verbally introduced and circulated on 
laminated card. You will be part of a panel (group) discussion about each 
category of perception presented and may contribute as much or as little 
as you wish to, allowing time for each member to share their views. After 
50 minutes, if not before, the facilitator will initiate a closing discussion. 
Participant Information Sheet v3 3rd August 2018  
School of Health Sciences 
349 
This is where you may wish to collaboratively decide upon any priority 
changes to implement, and how this might occur. Both the facilitator and 
co-facilitator will take some notes during the meeting of key points arising 
from the discussion to provide a summary to help with the closing 
discussion.  
 
There will be some light refreshments, such as drinking water and biscuits 
available in the meeting.  
 
As there is limited time to discuss all of the perceptions from the previous 
interview study, you will be provided with a follow-on questionnaire at the 
end of the meeting to provide your views on six separate themes of 
perceptions. This will be to take away, for you to voluntarily complete and 
return to the researcher in a self-addressed envelope provided or by e-
mail.  
 
Why have I been invited? 
You have been invited to take part because you have been identified as 
a transfusion health professional (e.g. consultant, registrar, doctor, nurse, 
transfusion practitioner).  
 
What are the benefits or risks of taking part? 
This is a low-risk study. Benefits include being able to learn more about 
the perceptions of haematology patients who were interviewed. Your 
involvement is essential to shape any required practice changes for the 
patient’s benefit and to aid improvement to haematology unit service 
delivery.  
An abstract of the findings of this meeting will be submitted for presentation 
to the National Transfusion Meeting. You will not be personally named on 
this abstract, to protect your identity, but it will be stated that ‘this work has 
been developed in collaboration with a panel from the South Central 
Regional transfusion team’. 
 
Do I have to take part?  
Your participation is voluntary and you are not obliged to take part. If you 
wish to withdraw you may do so and your information will be removed 
without you having to provide a reason. You may also briefly step out of 
the meeting or leave entirely during the course of the meeting if you need 
to do so, without having to provide the facilitator with a reason.  
 
Protecting your information and confidentiality 
As this study involves a focus group, the researcher wishes to provide as 
much confidentiality as possible to all participants. Therefore, by taking 
part you agree not to disclose personal views that you heard in the focus 
group once it has finished. Please also act with discretion not to reveal the 
names of other participants in the group with you. Any information 
revealing your or other people’s identities or identifiable places on the 
audio recording will be made anonymous during transcription, which may 
be completed by a specialist transcription service.  
All information will be handled securely, stored in locked cabinets and 
analysed on password protected computers. Data will be stored at City, 
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University of London for 10 years and will then be destroyed. The 
researchers’ academic supervisors at City, University of London, will have 
access to anonymised responses to help with data analysis.  
 
How your information will be used 
The data collected will be reported in the researcher’s PhD thesis, and 
submitted for presentation to the National Transfusion Meeting (NTA). A 
peer-reviewed journal publication will also be prepared by the researcher 
and submitted for publication. Parts of the results may also be used to 
develop further research projects and direct anonymised quotations from 
the focus group may be used. All participants will have the option to 
receive a copy of the results, the NTA meeting abstract and journal 
publication outputs.   
 
City, University of London is the data controller for the personal data 
collected for this research project. Your personal data will be processed 
for the purposes outlined in this notice. The legal basis for processing your 
personal data will be that this research is a task in the public interest, that 
is City, University of London considers the lawful basis for processing 
personal data to fall under Article 6(1)(e) of GDPR (public task) as the 
processing of research participant data is necessary for learning and 
teaching purposes and all research with human participants by staff and 
students has to be scrutinised and approved by one of City’s Research 
Ethics Committees.   
Complaint procedures 
If you have any problems, concerns or questions about this study, you 
should ask to speak to a member of the research team. If you remain 
unhappy and wish to complain formally, you can do this through City’s 
complaints procedure. To complain about the study, you need to phone 
020 7040 3040. You can then ask to speak to the Secretary to Senate 
Research Ethics Committee and inform them that the name of the project 
is: BOOST: Building Optimised Outpatient Services in Transfusion: A 
panel discussion informed by patients’ perceptions 
You could also write to the Secretary at:  
Dr Anna Ramberg 
Research Governance & Integrity Manager  
Research & Enterprise  
City, University of London 
Northampton Square 
London 
EC1V 0HB                                      
Email: Anna.Ramberg.1@city.ac.uk 
City holds insurance policies which apply to this study. If you feel you have 
been harmed or injured by taking part in this study you may be eligible to 
claim compensation. This does not affect your legal rights to seek 
compensation. If you are harmed due to someone’s negligence, then you 
may have grounds for legal action.  
Participant Information Sheet v3 3rd August 2018  
School of Health Sciences 
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Raising concerns about how your personal data will be used after 
participation 
In the first instance you should raise any concerns with the research 
team, but if you are dissatisfied with the response, you may contact the 
Information Compliance Team at dataprotection@city.ac.uk  or phone 
0207 040 4000, who will liaise with City’s Data Protection Officer Dr 
William Jordan to answer your query.  
If you are dissatisfied with City’s response you may also complain to the 
Information Commissioner’s Office at www.ico.org.uk 
Who has reviewed the study? 
This study has been approved by City, University of London School of 
Health Sciences Research Ethics Committee. 
 
Further information and contact details 
To take part in this study please e-mail the researcher on the below e-
mail with your interest and return a signed copy of the consent form. 
Please also e-mail the researcher if you would like to find out more 
information about the study.  
 
Name of Primary researcher: Brittannia Volkmer 
E-mail: brittannia.volkmer@city.ac.uk 
Clinical Collaborator: Dr Simon Stanworth 
Academic Supervisors: Professor Jill Francis, City, University of London 
and Dr Fabiana Lorencatto, University College London 
 
Thank you for taking the time to read this information sheet 
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 Appendix 18: Study 3 recruitment flyer 
Participate in BOOST 
Building Optimised Outpatient 
Services in Transfusion 
A panel discussion informed by patients’ perceptions 
Do haematology outpatients require more support to cope 
with repeated blood transfusions? 
 
Your involvement is essential to shape any required practice 
changes for haematology delivered transfusions.  
Become a panel member to contribute to an abstract of this 
study to be submitted for presentation at the National 
Transfusion Meeting. 
Researcher contact details: Brittannia Volkmer, 
brittannia.volkmer@city.ac.uk City University London, School of 
Health Sciences, Northampton Square, London EC1V0HB 
This study (PhD/18-19/02) has been reviewed and ethically 
approved by: City University of London, School of Health Sciences, 
Research Ethics Committee.  
BOOST involves a 45-
minute audio-
recorded focus group 
meeting to share 
views on haematology 
patients’ perceptions 
of blood transfusion  
Focus groups will be running on 7th November 
at Transfusion  
Bites at 
11:15 am and   1.30pm 
(main meeting room) 
For more information please speak to the researcher, 
Brittannia who has handed you the flyer, and request a 
Participant Information Sheet. Please sign up or attend 
shortly before the start time.  
BOOST consent form v2 19th June 2018   School of Health Sciences 
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 Appendix 19: Study 3 consent form      
Participant ID: 
Title of Project: BOOST: Building Optimised 
Outpatient Services in Transfusion: A panel 
discussion informed by patients’ perceptions 
Name of Researcher: Ms Brittannia Volkmer, MSc         Please initial 
each box        
1. I confirm that I have read the Participant Information Sheet dated 
3rd August 2018 (Version 3) for the above study. I have had the 
opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
 
2. I understand that the researcher wishes for me to take part in an 
audio recorded focus group with other health professionals about my 
views of patients’ blood transfusion perceptions and possible 
recommendations to change practice. I understand that a follow-on 
questionnaire will be provided, which I have the option to complete. 
 
3. This information will be held by City as data controller and 
processed for the following purposes: to report in the researchers’ 
university thesis, a conference presentation and a journal publication 
and lawful basis for processing under General Data Protection 
Regulation (GDPR) for personal data. I agree to the use of anonymised 
quotes in these reports. The findings and direct anonymised quotes 
may also be used to inform further ethically approved research. 
 
4. I understand that any information I provide aims to be treated 
confidentially within the focus group. No information that could lead to 
the identification of any individual will be disclosed in any reports on 
the project. Identifiable audio recordings may be shared with a 
transcription service that abides by GDPR. 
 
5. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason or being penalised or 
disadvantaged in any way. 
 
6. The information I provide will be held by City as data controller 
and I agree to City recording and processing this information about me. 
I understand that this information will be used only for the purpose(s) 
set out in this statement and my consent is conditional on City 
complying with its duties and obligations under the GDPR. 
 
7. I agree to the arrangements for data storage, archiving, sharing. 
 
8. I agree to take part in the above study. 
Name of Participant            Date  Signature 
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BOOST: Building Optimised Outpatient Services 
in Transfusion












■Background to the project




■To engage in active and open discussion about the
patients’ perceptions being presented
■To devise, where necessary, any 
recommendations for practice change
■To consider which recommendations are of priority 
to address and how this might be done
Systematic review








Abdul-Aziz, Lorencatto, Stanworth & Francis (2018)
■What are patients’ perceptions of blood 
transfusions?
■Haematology day units x2 
■Individual, face-to-face, semi-structured 
interviews
Perceptions of blood transfusion: haematology
10.20 Appendix 20 BOOST Study 3 PowerPoint slides
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Perceptions of blood transfusion: haematology
■N=14 patients
■Male 43%, median age= 68
■Conditions: Aplastic Anaemia
(3), Thalassemia (2), other 
Anaemia or mixed haematological
disorders (4), Myelodysplasia (2),
Myelofibrosis (2), Myeloma (1)
■Transfusions: RBC only = 10 
patients 
■Interviews during transfusion = 12
Deductive content analysis into 
model and inductive thematic 



















■Creative process informed by Experienced-based 
design principles (Brocklehurst et al., 2018)
‘Involves service users and professionals working together over 
a period and throughout the change process as the co-designers
of a service’ (Bate & Robert, 2006)
This meeting – share patients’ priority perceptions of top three 
themes, using laminated cards, for discussion
I will initiate breaks to summarise discussion
Wrap up discussion at end
Today’s meeting
■Discussion prompts:
Are these perceptions that you also hear about from patients?
Do you think that patients might need more support to deal 
with these perceptions and experiences?
Is there something that could be done within the health service 
to improve patients’ experiences?
Would there be any constraints to this?

















Can it be improved 
further?
Many levels for 
intervention >
Adapted from Dahlgren & Whitehead, 1991 and NICE guidance for behaviour 
change at population, community and individual levels, 2007; 2014
Theme #1
For some patients, 
having transfusions was 
seen as unpleasant and 
the frequency and 
duration caused 
frustrations. 
• Some patients had no concerns 
about receiving repeated 
transfusions, or managed their 
worries by remaining hopeful and 
positive. 
• Some patients enjoyed attending; 
as a time-out and they were 
grateful for the transfusions. 
Study 3 focus group slides version for 
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Theme #2 Some patients recalled 
being involved in the 
transfusion decision-
making, and that they 
willingly accepted the 
transfusion. 
Other patients reported 
that they deferred the 
decision making to the 
doctors or had limited 
involvement, mainly 
because transfusion 
was their only option.
Theme #3
Yet, some patients do not 
know how much blood 
they will receive until they 
get to the hospital, or are 
unable to predict a 
routine with it.
• Some patients knew when they 
needed their transfusion as they 
felt tired, low in energy and 
experienced headaches. 
• Overwhelmingly, patients reported
that their transfusions are 
essential to prolong their life and 
aid survival. 
Closing summary
■Key patient needs and proposed refinements were …
■Open discussion: priorities to implement first and thoughts
about achieving this
■Next steps: process of change
■Follow on questionnaire
Thank you for taking part
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 Appendix 21: 
Study 3 participant ‘follow on’ questionnaire  
Title of study: BOOST: Building Optimised 
Outpatient Services in Transfusion: A panel 
discussion informed by patients’ perceptions 
This questionnaire is a follow up to the focus group that you attended. Please 
insert your comments to each theme and question below and return the 
questionnaire to the researcher in the envelope provided or e-mail a scanned 
copy to brittannia.volkmer@city.ac.uk Please elaborate as much as you would like 
to, extra space has been provided at the end of the questionnaire.  
Theme 4: 
Most patients reported that their transfusions enabled them to 
keep going with their daily lives, reduced symptoms and boosted 
their blood levels. Transfusions were seen as helpful for patients to 
manage their conditions.  
One patient with CLL and Aplastic anaemia and another with 
Myelodysplasia, reported feeling drained sometimes after the 
transfusion. Or felt the same after the transfusion as they did 
before.  
1. Are these perceptions that you also hear about from 
patients? 
2. Do you think that patients might need more support to deal 
with these perceptions and experiences? 
3. Is there something that could be done within the health 
service to improve patients’ experiences? 
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5. Are there things that may help change to occur?  
[ongoing themes listed but presented in the same format with 
the same questions and boxed as above]: 
Theme 5: 
Some patients interacted with other patients in the unit and were 
well involved in their transfusions, such as through their contact with 
staff able to answer their questions.  
 Other patients reported limited interaction with patients who had 
different health conditions. Some patients did not wish to interact 
with other patients when attending, for example, to respect their 
privacy).  
Theme 6: 
Many patients are aware of the risks involved with receiving their 
transfusions, mainly of high iron levels and what impact this can have 
on their body. 
Other patients focussed more on pain that they get from having the 
cannula inserted, and one patient mentioned about a chest 
tightening sensation towards the end of the transfusion. 
Theme 7: 
Some patients receiving repeated transfusions felt that transfusions 
become a part of their routine life, and that regular attendance is not 
a great burden to them. 
For other patients, repeated transfusions were seen as inconvenient, 
meaning lengthy appointments, frequent trips to the hospital, and 
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Theme 8: 
Some patients talked about medications they are taking (e.g. 
Cyclosporine), feeling that this helped to keep their blood count up 
or reduce the number of transfusions needed. Other patients felt 
that their body could correct depleted cells, reducing how often they 
would need transfusions.  
Otherwise, patients acknowledged that there were no alternative 
treatments that were feasible (e.g. bone marrow or stem cell 
transplant) and some treatments had been unsuccessful for them 
(e.g. ATG immunoglobulin). 
Theme 9: 
Around a quarter of patients interviewed commented specifically on 
platelets. For example, they did not understand what platelets did 
but preferred them because they infuse quicker or the effect of a 
boosted platelet count was experienced more quickly or intensively. 
 
Additional space for responses (please include theme/question number if 
relevant): 
 
Thank you for taking the time to complete this questionnaire. Please return it to 
the researcher using the envelope provided or e-mail a scanned copy to 
brittannia.volkmer@city.ac.uk 
Appendix 22: Focus group diary 
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 Appendix 22: Reflective diary from study 3 focus groups  
Focus group 1 
The six participants who took part in focus group 1 were comprised of a range 
of clinical specialities, who interacted well with each other, putting the 
researcher at ease for her first focus group. The participants held conforming 
opinions with each other, which showed a good level of ‘consensus’, but this 
often made it challenging to break into the group discussion as many 
constraints to change and service difficulties were raised, recycled and 
contagiously discussed throughout the group. Some participants in focus 
group 1 were also cut-off during their points, had their ideas over-ridden or 
had their sentences finished off by one or two more prominent group 
members. This could have led to missed-opportunities for service proposals 
to be expressed and on reflection, this group may have worked better as a 
smaller group, giving more members the opportunity to develop their ideas. 
Overall, I felt that this group was very dynamic and accepting of the 
researcher and her aims for the focus group. The group and discussion 
outcomes provided a very positive start for the BOOST data collection.  
Focus group 2 
This was the largest focus group conducted during a morning break in the 
‘Transfusion Bites’ day, where time was limited, so the researcher felt more 
hurried to explain the study and begin to introduce the themes. The group 
was comprised of a diverse range of specialities and HCPs with experience 
in different settings, which brought diversity to the group and it is likely that 
group members benefitted from hearing real-life scenarios and experiences 
from other members. There was an improved sense of group equality, 
compared to focus group 1 and active listening and respect for each other’s’ 
opinions, and the researcher felt that her position and themes that she was 
presenting were accepted. There were often silent members of the group, so 
the researcher had to work harder to initiate discussion, however. Compared 
to the two other focus groups, the researcher felt that members of this group 
were more likely to have left the focus group feeling unsure if their contribution 
was sufficient or whether the aims of the session have been achieved. The 
researcher sensed this towards the end of the focus group, which was time 
restricted before a follow-on session for the HCPs, so reassured them that 
their views were important and valuable for the study.  
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Focus group 3 
This was an all-female participant focus group that immediately felt very 
comfortable, less formal and close-knit compared to the other two groups. 
The focus group took place towards the latter end of the lunch break, so some 
participants had food or drink with them, and as a group we sat huddled 
around a smaller set of chairs with less physical boundaries. As for the 
previous groups, in the first focus group the researcher stood, whilst the 
participants sat in a classroom-style set up, and for the second group, the 
participants sat spaced out across two low tables. In this third group, there 
were some participants with the same role, so the power balance was more 
equal and there was a sense that participants felt comfortable expressing 
their opinions and although time was limited it was felt that depth and 
‘saturation’ of ideas was achieved and that the focus group had a more 
natural beginning, middle and end. In general, it was felt that group members 
understood each other’s positions well, with interest sparked when hearing 
real-life accounts and compassionate listening was displayed. There was an 
overwhelming greater sense of positivity and an attitude of change at this 
focus group, and equally somewhat in focus group 2. Many participants 
commented that they left the group feeling re-energised to interact with their 
patients with a greater level of consideration and empathy. 
